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Mohammad Shaqur RahmanAbstract
Prognostic models are developed to guide the clinical management of patients or to
assess the performance of health institutions. It is essential that performances of these
models are evaluated using appropriate validation measures. Despite the proposal of
several validation measures for survival outcomes, it is still unclear which measures
should be generally used in practice. In this thesis, a simulation study was performed
to investigate a range of validation measures for survival outcomes in order to make
practical recommendations regarding their use. Measures were evaluated with respect
to their robustness to censoring and their sensitivity to the omission of important pre-
dictors. Based on the simulation results, from the discrimination measures, G onen and
Heller's K statistic can be recommended for validating a survival risk model developed
using the Cox proportional hazards model, since it is both robust to censoring and
reasonably sensitive to predictor omission. Royston and Sauerbrei's D statistic can be
recommended provided that the distribution of the prognostic index is approximately
normal. Harrell's C-index was aected by censoring and cannot be recommended for
use with data with more than 30% censoring. The calibration slope can be recom-
mended as a measure of calibration since it is not aected by censoring. The measures
of predictive accuracy and explained variation (Graf et al's integrated Brier Score and
its R2 version, and Schemper and Henderson's V ) cannot be recommended due to their
poor performance in the presence of censored data.
In multicentre studies patients are typically clustered within centres and are likely
to be correlated. Typically, random eects logistic and frailty models are tted to
clustered binary and survival outcomes, respectively. However, limited work has been
done to assess the predictive ability of these models. This research extended existing
validation measures for independent data, such as the C-index, D statistic, calibra-
tion slope, Brier score, and the K statistic for use with random eects/frailty models.
Two approaches: the `overall' and `pooled cluster-specic' are proposed. The `over-
all' approach incorporates comparisons of subjects both within-and between-clusters.The `pooled cluster-specic' measures are obtained by pooling the cluster-specic es-
timates based on comparisons of subjects within each cluster; the pooling is achieved
using a random eects summary statistics method. Each approach can produce three
dierent values for the validation measures, depending on the type of predictions: con-
ditional predictions using the estimates of the random eects or setting these as zero
and marginal predictions by integrating out the random eects. Their performances
were investigated using simulation studies. The `overall' measures based on the con-
ditional predictions including the random eects performed reasonably well in a range
of scenarios and are recommended for validating models when using subjects from the
same clusters as the development data. The measures based on the marginal predic-
tions and the conditional predictions that set the random eects to be zero were biased
when the intra-cluster correlation was moderate to high and can be used for subjects in
new clusters when the intra-cluster correlation coecient is less than 0.05. The `pooled
cluster-specic' measures performed well when the clusters had reasonable number of
events. Generally, both the `overall' and `pooled' measures are recommended for use in
practice.
In choosing a validation measure, the following characteristics of the validation data
should be investigated: the level of censoring (for survival outcome), the distribution
of the prognostic index, whether the clusters are the same or dierent to those in the
development data, the level of clustering and the cluster size.
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xviiChapter 1
Introduction
1.1 Context of this research
In medicine, prognosis literally means forecasting, predicting or estimating the proba-
bility or risk of an individual's future health outcomes, such as illness, or complication,
or death. For example, in oncology, it may be important to predict the probability of
survival beyond a specic time point for cancer patients, and, in cardiology, to predict
the risk of developing a cardiovascular disease or death from a cardiovascular disease.
Prognostic studies are usually carried out to predict patients' future health status as ac-
curately as possible using their clinical and demographic characteristics. For example,
the study carried out by Ambler et al. [1] focuses on predicting the risk of in-hospital
mortality for patients following heart valve surgery. Similarly, the Nottingham prog-
nostic index derived by Galea et al. [2] is used to estimate the risk of cancer recurrence
or death in breast cancer patients.
Prognostic studies are similar to aetiological studies in terms of design and anal-
ysis, but have dierent purposes: the former focuses on predicting health outcome of
interest while the latter on explaining their causes [3]. In particular, aetiological stud-
ies investigate the association between risk factors and an outcome of interest, with
possible adjustment for other factors (confounders), typically using a multivariable sta-
tistical model. Prognostic studies also use a multivariable statistical model to identify
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all important predictors that are potentially associated with the outcome and, using a
combination of these, provide prediction algorithms or rules to predict the risk of fu-
ture outcome. These algorithms are commonly known, in the literature, as prognostic
models or prediction models [4{10].
Prognostic models are increasingly being used in various settings of clinical re-
search such as cardiology, intensive care medicine, and oncology to estimate individual
patients' prognosis and/or to classify patients into clinical risk groups with dierent
prognoses, for example, low, medium, and high. The clinical use of these models mainly
consists in providing information for patients about the future course of their illness (or
their risk of developing illness) and in guiding doctors on joint decisions with patients
to plan for possible treatment.
Prognostic models may be useful in cost eectiveness programs or to select ap-
propriate tests or therapies in patient management including decisions on withholding
or withdrawing therapy. For example, models may be used to classify patients with
good prognosis for whom adjuvant therapy would not be (cost-)eective, or a group
of patients with a poor prognosis for whom more aggressive adjuvant therapy would
not be justied [9, 11]. These models may also be used to select homogeneous groups
of patients for clinical trials, for example, to select patients with a low risk of cancer
recurrence for a randomised trial on the ecacy of radiotherapy after breast conserving
resection. Finally, prognostic models may be used to assess the performance of clin-
icians or hospitals and to conduct comparisons between them after adjusting for the
case-mix of patients. For example, the clinical risk index for babies (CRIB) [12] is used
to predict the risk of mortality for newborn babies and to assist comparative assessment
across the neonatal intensive care units by case-mix-adjusted risk predictions.
Although the use of prognostic models in clinical management is promising, clini-
cians will be reluctant to use these models unless they can trust their predictions [13].
Therefore, the prime goal of prognostic studies should be to develop such a model which
is statistically valid and clinically useful. To facilitate such clinical prognostication suc-
cessfully, researchers [4{10, 14, 15] have paid attention to the methodological aspects of
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prognostic studies and models, particularly focusing on the validation of models' pre-
dictive performance. The general idea of validating a prognostic model is to establish
that it performs well for patients other than those used to develop the model [7, 14{16].
Prognostic models are usually developed using multivariable regression models. For
example, logistic regression is commonly used for binary outcomes while Cox propor-
tional hazards regression is used for survival outcomes. Often an index is developed
from a prognostic model based on weighted sum of the predictors in the model, where
the weights are the estimated regression coecients. This is known as the `prognostic
index' and can be used to classify patients into dierent risk groups, for example, low,
medium, and high. Building a prognostic model from a set of candidate predictors is
a complex process [17{19], and there is no widely agreed approach to this. However,
the importance of carefully dealing with some of the statistical and clinical aspects of
developing a prognostic model, such as choosing clinically relevant patient sample, se-
lecting important predictors, modeling continuous predictors, having adequate sample
size, and handling missing data, if any, is widely accepted. These aspects are discussed
in details in some recent studies; see, for example, Royston et al. [4], Altman [9], and
Omar et al. [10].
Compared to the methodology published in the literature on the development of
prognostic models, the methodology for validating their predictive performance is not
well developed [7, 20]. However, validation of the predictive performance of a newly
developed model or a model updated from an existing one plays a key role in prognostic
studies. This research focuses on the methodological aspects of validating a prognostic
model. Validating a prognostic model implies gaining evidence that it performs well
for new patients dierent from those used to develop the model. This idea is motivated
by the fact that the predictive ability of a model is likely to be overestimated in the
sample of patients used to develop the model (training/development data), compared
to the predictive ability of the model in other patient samples (test/validation data),
even if both samples are derived from the same population [7, 8, 15, 21].
Dierent types of validation process have been discussed in the literature [7, 16].
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The most commonly used processes include (i) splitting a single dataset (randomly
or based on time) into two parts, one of which is used to develop the model and
the other used for validation, (internal or temporal validation) and (ii) validating on an
independent dataset collected by dierent centres or investigators (external validation).
Apart from the type of validation process, there are several aspects of a model that are
usually assessed on new data. These include (i) the agreement between the observed and
predicted outcome of interest for a group of patients (calibration) or individual patients
(accuracy scores), (ii) the ability of the model to distinguish between patients who do
or do not experience the outcome of interest (discrimination) [7, 22]. Another aspect
that is sometimes used to assess the model's predictive performance is the concept of
`explained variation', which refers to the proportion of variation in the outcome that can
be explained by the predictors in the model [23]. Intuitively, high explained variation
depends on making a wide range of accurate predictions. This aspect captures both
the calibration and discrimination of the model.
The methodology for validating prognostic models with independent binary out-
comes are reasonably well developed; for example, see Omar et al. [10], Steyerberg
et al. [24], and Royston and Altman [25]. Although a number of validation measures
have been proposed for survival outcomes, it is still unclear which measures should
be used in practice. This research evaluates some of the proposed measures in order
to make practical recommendations. Furthermore, patients' health outcomes may be
clustered within large units. For example, in a multi-centre study, patients within the
same hospitals are likely to be more similar compared to patients across hospitals. This
correlation between patients within a hospital is known as clustering. Random eects
logistic and frailty models which can take account of this clustering have been proposed
for the analysis of clustered binary and survival outcomes, respectively. In risk predic-
tion research, this clustering is often ignored both in the process of model development
and the validation of the models predictive performance. Limited work has been done
to assess the predictive ability of models developed with clustered outcomes, regardless
of the types of outcomes (binary or survival). This research also focuses on the use
of these models for risk prediction for clustered data and the validation methods for
assessing the predictive performance of the models.
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1.2 Objectives of this research
The primary objective of this research is to consider the methodological aspects of
validating a prognostic model, particularly focusing on the validation measures that
could be useful in assessing the predictive performance of the model.
Several validation measures have been proposed for models with independent sur-
vival outcomes, but it is still not clear what measures should be generally used. One of
the objectives of this research is to review some of the proposed measures and evaluate
these by a simulation study based on two real datasets in order to make recommenda-
tions for their use in practice.
Furthermore, limited work has been done for validation measures for models de-
veloped with clustered outcomes. This research discusses possible extensions of some
of the standard validation measures that have been used for independent binary or
survival outcomes for use with models for clustered outcomes. An application of these
measures is illustrated using data on patients who underwent heart valve surgery (bi-
nary outcome: in-hospital mortality) and child mortality data (survival outcome: time
to event, died/alive, by the 5th birthday). A simulation study is further conducted
to investigate the properties of the new measures under various simulation scenarios
formulated by varying the number of clusters and their size, varying the intra-cluster
correlation between subjects within a cluster, and for survival outcomes, varying the
degree of censoring.
The real data presented in this thesis are mainly used to illustrate and evaluate
validation measures. The clinical motivation for developing the risk models is not
the main focus here; it is assumed that the model development has been carried out
appropriately.
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1.3 Organization of this research
This research is organised as follows. Chapter 2 discusses the motivation and general
procedures for validating a prognostic model. This chapter also discusses a literature
review of validation measures that have been proposed for models with binary and
survival outcomes.
Chapter 3 evaluates some of the validation measures for models with independent
survival data. In particular, this chapter includes a motivation for choosing the mea-
sures to be evaluated, their calculation for the Cox proportional hazards model, and a
simulation study based on two clinical datasets.
In Chapter 4, some of the standard validation measures that have been used for
independent binary outcomes are extended for use with models for clustered binary
outcomes. This chapter particularly discusses the detailed calculation of these measures
for random intercept logistic model, starting with a description of the model and its
possible approaches to prediction. An illustration of these methods using real data and
a simulation study to assess their performance are also discussed.
Chapter 5 discusses possible extensions of some of the standard validation measures
for use with models for clustered survival data. Specically, this chapter discusses a
frailty model along with its dierent approaches to prediction, and the detailed calcu-
lation of the validation measures for the frailty model. This chapter also includes an
illustration of the new methods using child mortality data and a simulation study to
assess the properties of the methods.
Chapter 6 starts by summarising the research and the ndings, then discusses some
recommendations for use in practice, and ends by discussing the possibilities for future
research.
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Validating a prognostic model
2.1 Introduction
A vital aspect of the prognostic modelling process is to consider whether a model
developed using a patient-sample is transportable to other patients from a relevant
but dierent population, who are dierent in terms of patient characteristics. This
concept is generally referred to as validity (or generalisability), and a model that is
found to have such quality is said to have been validated [26]. A validated model may
be recommended for use as a clinical decision making tool. Dierent types of model
validity have been discussed in the literature. These include `internal', `temporal', and
`external' validity. When conducting a validation study, there are some key aspects of
a model that need to be evaluated. These include `calibration', `discrimination' and
`explained variation'. This chapter discusses all these aspects of validating a prognostic
model and includes a brief literature review of existing validation measures, starting
with a motivation for validating a model.
2.2 Motivation for validating a prognostic model
There are several reasons why we need to validate the performance of a prognostic
model. One of the main reasons is that we need evidence of the accuracy of predictions
made by the model before using it in clinical practice. Furthermore, a prognostic
model that accurately predicts for patients in the development data may not perform
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similarly for new patients from a dierent but relevant population [7, 26]. Therefore, to
establish that the model is useful to clinicians who would use it, it is essential to evaluate
(validate) its predictive performance particularly on new data dierent from which the
model was derived. There are several statistical and clinical reasons discussed in the
literature [7, 14, 16, 20, 27] explaining why a prognostic model may perform poorly on
new data. The reasons are discussed below:
(i) Inadequate design of prognostic studies:
The inadequate design of prognostic factor studies may lead to overoptimistic
results [7, 18]. The design may be inadequate if there is no standard inclusion and
exclusion criteria for selecting patients (many patients may be excluded because
of missing data), no justication for the choice of treatments, an inadequate
sample size, and an inadequate number of events of interest per predictor. For
more details, see Altman and Royston [7], Harrell et al. [28], and Peduzzi et al.
[29, 30].
(ii) Lack of a standard approach to developing the model:
A prognostic model may not perform well for new patients if the model was
inadequately developed in the original sample. The model may be developed,
for example, using `stepwise variable selection algorithm', by which one selects
the best model from many alternative models, but these methods usually have
data-dependent aspects. These aspects are likely to lead to an overoptimistic
assessment of the predictive performance. For more details, see Altman and
Royston [7], Altman et al. [14].
(iii) Dierences between patients' characteristics in the development and validation
data:
Even if the model is adequately developed, it may not perform well for new
patients. This may be because there are dierences between the characteristics of
the patients in the development and validation data. This is known as a dierence
in `case-mix' [7, 15, 20]. Both the discrimination and calibration of a model could
be aected by the dierence in `case-mix'. For example, if age is one of the
predictors included in the model and ranges from 60 to 80 years in the validation
sample and 20 to 80 years in the development sample, then the discrimination
(between patients who experienced the outcome and who did not) in the more
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homogeneous validation population would be expected to be worse than in the
more heterogenous development population [20]. Another example would be if
the validation sample contains relatively more patients with hypertension than
the development sample, and presence of hypertension increases the probability of
the outcome but hypertension was not included in the model (missed predictor),
then the predicted probability derived from the model may be underestimated in
the validation population [15, 20].
2.3 Validation procedure
This section discusses a procedure for validating a prognostic model, following the val-
idation strategies discussed in the literature [7, 14]. Typically, a validation procedure
involves (i) designing a validation study, which describes the development and valida-
tion data and what type of validation process one should choose, and (ii) identifying
the aspects of the model, for example, calibration and discrimination that need to be
validated.
2.3.1 Design of a validation study
The main validation processes discussed in the literature are internal validation, tempo-
ral validation, and external validation study [7, 14, 16, 20, 27]. These are now discussed
in the following subsections.
2.3.1.1 Internal validation
The key feature of internal validation process is that only one dataset (the primary
data) is used. The most common approach is to randomly split the data into two
parts (often 2:1) before model development begins [7, 14, 20]. The rst part, which
is usually called the `development' set, is used to develop the model and the second
part, called the `validation' set, is used to evaluate the model's predictive performance.
This data-splitting process has some limitations. For example, this process is likely to
provide overoptimistic results on the model's performance. In addition, the estimates
of the predictive performance from this procedure may be unbiased, but they tend to
be imprecise [31]. A possible reason is that both datasets are very similar as they
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were extracted from the same underlying population. Furthermore, one issue that
commonly arises in data-splitting process is how to split the data; there is no guideline
on what proportion of patients should be in the development and validation sets [7, 32].
Some alternative, but better, approaches are to use a resampling technique such as
`bootstrapping' and `cross-validation'. These resampling techniques are commonly used
to overcome overoptimism [7, 33{35].
Briey, bootstrapping [36] involves taking a large number of samples with replace-
ment from the original sample, of the same size as the original data set. Then models
may be developed in the bootstrap samples and validated in the original sample. In
cross-validation, for example, k-fold cross-validation, the original sample is partitioned
into k subsets, one of which is used to validate the model and the remaining k   1
subsets are used to develop the model. This procedure is repeated k times. To improve
the eciency of the cross-validation, the whole procedure can be repeated several times
taking new random subsamples [35]. The most extreme cross-validation technique is to
leave one subject out at a time, which is equivalent to the jack-knife technique [36].
2.3.1.2 Temporal validation
In principle, temporal validation approach is similar to internal validation using data-
splitting. In this procedure, a single dataset is partitioned into two cohorts observed
at dierent time points. The model is usually developed with data from one cohort of
patients collected at a particular time point and is evaluated on a subsequent cohort
from the same centre(s). Temporal validation is a prospective evaluation of a model,
independent of the original data and the development process [7]. In addition, this
approach can be considered as external validation with respect to time.
2.3.1.3 External validation
In this procedure, the performance of the model is evaluated on new data collected from
a relevant patient population in a dierent centre. The second dataset, the validation
set, must have information available on all the predictors in the model. The acceptable
degree of similarities (or dissimilarities) between development and validation popula-
tions from which the samples were drawn is a matter of debate. However, it would
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not be reasonable to expect that a model developed on a sample of older patients to
perform well in younger patients. Of the three validation processes discussed above,
only the external validation process appears to serve the purpose that a prognostic
model should be transportable (or generalisable) to new patients [7, 14].
2.3.2 Key aspects of a model that need to be validated
This section discusses the key aspects of a model that need to be validated. These
include (i) the agreement between the observed and predicted outcome of interest for
a group of patients (calibration) or for an individual patient (accuracy score), and
(ii) the ability of the model to distinguish high risk patients from those with low risk
(discrimination) [7, 15, 22]. Another aspect that is used to assess the overall predictive
performance of the model (both the calibration and discrimination simultaneously) is
the concept of `explained variation' [23, 35, 37]. The more the variability in the outcome
explained, the better the predictive ability of the model. All these aspects are discussed
in detail below.
2.3.2.1 Calibration
Calibration is an important aspect of a prognostic model that considers the answer to
the question `Are the predictions made by the model reliable?' More specically, the
calibration aspect of the model refers to the agreement between the predicted outcome
of interest and the observed outcome. For example, for a group of 100 patients, if the
probability that the event of interest will occur is predicted by the model to be 10%,
then the model would be well calibrated if it actually does occurs for approximately
in every 10 out of 100 patients. This suggests that the model has good predictive
ability. When such agreement is quantied for an individual prediction by means of a
loss function, for example, squared error loss, then it is called an `accuracy score'.
2.3.2.2 Discrimination
Discrimination is the ability of the model to distinguish between patients with high
risk for a given event and patients with low risk for that event. A model with reason-
ably good discriminatory ability shows a wide spread in the distribution of predicted
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probabilities. For example, such a model might predict probabilities close to 100% for
patients who had experienced the event of interest and probabilities close to 0% for
patients who did not experience the event.
2.3.2.3 Distinction between calibration and discrimination
There is a conceptual dierence between the discrimination and calibration aspects
of a model. Good calibration does not necessarily lead to good discrimination in the
model. In fact, an well calibrated model can exhibit poor even no discrimination.
This phenomenon is illustrated by a hypothetical example of two models. Figure 2.1
Figure 2.1: Plots to show the distinction between calibration and discrimination. Plots
are for two hypothetical models (M1 and M2) with equal (perfect) calibration but dierent
discriminatory abilities.
demonstrates the assessments of two well calibrated models, say M1 and M2, which
have dierent discriminatory abilities. In case of both models, the predicted and ob-
served probabilities for each of the six groups agree with each other, indicating perfect
calibration. However, the predicted probabilities made by the model M1 ranges be-
tween 10% and 95% indicating strong discriminatory ability, whereas those of model
M2 ranges between 40% and 55% indicating weak discriminatory ability. Generally for
clinical purposes, one would like to have both good calibration and discrimination in a
model. However, of these two aspects, the primary focus should be on good discrimi-
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nation [8]. This is because if there is mis-calibration, re-calibrated is possible, but poor
discrimination can not be xed to a good discrimination.
2.3.2.4 Overall performance
This aspect of a model quanties the accuracy of predictions for each patient or for
a group of patients (calibration) and also quanties the spread in predictions (dis-
crimination). Therefore, by assessing this aspect one validates both the calibration and
discriminatory ability of the model, often referred to as `overall' predictive performance.
This aspect is also known as `explained variation'. A value of explained variation is
interpreted as the proportion of variation in the outcome that can be explained by the
predictors in the model. Intuitively, good calibration and strong discrimination im-
plies a high value of explained variation [23, 38]. In the previous hypothetical example
illustrated by Figure 2.1, the model M1 exhibits more explained variation than M2.
2.4 Measures that assess the predictive ability of a model
Measures that assess the predictive ability (calibration or discrimination or both) of a
model can be considered as estimates of underlying parameters, which summarise the
intrinsic ability of the model to predict accurately and to discriminate well between
patients in the target population. Such measures are usually known as validation
measures. This section briey discusses some popular validation measures that have
been proposed in the prognostic modelling literature.
2.4.1 Measures of calibration
The calibration of a model can be assessed graphically, with predictions made by the
model on the x-axis and the observed outcome on the y-axis. This plot is known as
calibration plot [39]. If the model's predictions agree with the observed outcomes over
the entire range of predictions, the plot will show a 45-degree line. For an outcome
with normal distribution, the calibration plot can be achieved from a scatter plot of
observations against predictions. For a binary outcome y , the y-axis of the plot contains
only 0 and 1 values. To estimate the observed proportions of the outcome for each
patient in relation to the predicted probabilities, a smoothing technique, such as the
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loess algorithm [40], can be applied [24]. The plot can also be obtained by grouping
patients with similar predicted probabilities and then by comparing the mean observed
outcome with the mean predicted probability obtained for each group of patients. For
example, one can plot the observed outcome by decile of the predicted probabilities,
which is essentially a graphical illustration of the Hosmer-Lemeshow test [41].
Figure 2.2: Theoretical calibration plots to assess the agreement between the observed
proportion and predicted probability with a dot line through all outcome value (0 and 1):
(a) ^  = 0, ^  = 1; (b) ^  = 0, ^  = 0:74; (c) ^  =  0:65, ^  = 1 ; (d) ^  =  0:65, ^  = 0:74.
The calibration plot can be summarised by tting a (regression) line of the observed
proportions on the predicted probabilities, which results in an intercept ^  and slope ^ .
For a plot showing a 45-degree line, ^  = 0 and ^  = 1 (Figure 2.2a). This approach to
summarise the calibration aspect of a model was originally proposed by Cox [42] and
was further considered by Miller et al. [39] for a model with binary outcomes. The
intercept and slope of the calibration line can be estimated using a logistic regression
model with the predicted `prognostic index' derived from the model for the validation
142.4 Measures that assess the predictive ability of a model
sample as the only predictor. The `prognostic index' is the linear combination of the
predictors in the model weighted by the estimated regression coecients.
If the estimated slope ^  is much smaller than 1, it indicates optimism (overtting).
This implies that the predictions are too extreme: the predictions are too low for low
risk subjects and too high for high risk subjects (Figure 2.2b). If the opposite occurs,
that is, the estimated slope is much larger than 1, it indicates that the predictions are
too high for low risk subjects and too low for high risk subjects [38, 40]. The estimated
intercept ^  assesses the overall agreement between the observed and the predicted
outcomes, that is, the agreement between the sum of all predicted probabilities and
total number of observed outcomes. This is referred to as `calibration-in-the-large'. If
the intercept ^  is much dierent from 0, it may indicate that the predicted probabilities
are systematically too high (^   0, Figure 2.2c) or too low (^   0). If both the slope
and intercept are far away from 1 and 0, respectively (Figure 2.2d), the interpretation
of miscalibration is dicult, because the values of both slope and intercept are highly
correlated [38].
For survival outcomes, a calibration plot could be a plot of Kaplan-Meier (K-M)
estimates of survival probabilities at a selected time point, say t, against the survival
probabilities predicted by the model at t. In a similar manner to that for binary
outcomes, the plot can be achieved by grouping patients with similar predicted prob-
abilities, which can be determined by the decile of predicted probabilities at t, and
then by comparing the mean K-M probabilities with the mean predicted probabilities
for each group of patients [38].
Furthermore, the slope of the calibration line can be estimated from a regression
analysis using, for example, the Cox proportional hazards (PH) model with the `prog-
nostic index' as the only predictor [43, 44]. The intercept of the calibration model can-
not be calculated directly using the Cox PH model, as it does not estimate an intercept,
but it includes the intercept within the baseline hazard. If the intention is to validate
the whole model, that is, both the slope and intercept, the time-axis needs to be trans-
formed into the cumulative baseline hazard obtained from the model. Then a Weibull
152.4 Measures that assess the predictive ability of a model
model in an accelerated failure time (AFT) formulation of this transformed time scale
with the `prognostic index' as a single predictor can be used to assess the whole model
[43, 44]. The resulting model takes the form: ln(t) =  +   prognostic index + e,
where e is distributed as the logarithm of a negative exponential. The whole model
is strictly well calibrated if ^  is close to 0, ^  is close to -1, and ^  is close to 1. Note
that the Weibull model is also a proportional hazards model with regression coe-
cient  =  =. For more details, see van Houwelingen and Thorogood [43] and van
Houwelingen [44].
2.4.2 Measures of discrimination
A number of measures have been published in the literature to assess the discrimina-
tory ability of prognostic models. The most commonly used measure is the concordance
probability, which is also called the concordance statistic or C-index. Another mea-
sure is based on prognostic separation that quanties the spread of the observed risks
across the range of predicted risks. This measure is known as a measure of prognostic
separation or a separation statistic.
2.4.2.1 Measures based on concordance probability
Concordance probability (C-index) quanties the concordance between the ranking of
the predicted and observed outcomes. For binary outcomes, concordance is measured
between the predicted and observed event of interest. Whereas for survival outcomes,
concordance is measured between the observed and predicted orders of failure. For
binary outcomes, the concordance statistic (or C-index) is identical to the area under
the receiver operating characteristic curve (AUC) [45]. The receiver operating charac-
teristic (ROC) curve is the graph of sensitivity (true-positive rate) versus one minus
specicity (true-negative rate) evaluated at consecutive threshold values of the pre-
dicted probability. Briey, the sensitivity refers to the percentage of patients with an
event who are correctly identied as having the condition, and the specicity refers to
the percentage of patients without an event who are correctly identied as not having
the condition.
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The AUC measures the `concordance' of ranking between the predicted probabilities
of having the event for a random pair of subjects who had the event and who did not.
This represents the probability that the event subject has higher predicted probability
than the non-event subject. For a model with perfect discriminatory ability, the ROC
curve passes through the coordinate (0,1) of the ROC space, which corresponds to
sensitivity = 100% and specicity = 100% for each threshold value and AUC = 1. A
straight line from the bottom left (0,0) to the top right (1,1) corners corresponds to
the AUC = 0.5, which indicates a model with no discriminatory ability.
Applying ROC methodology to survival data is not straightforward. The AUC
assesses the discriminatory ability of the model at an arbitrary time point rather than
the entire time period, and it does not take into account the censoring pattern of the
subjects. To overcome these drawbacks, an extension of the C-index or AUC proposed
by Harrell et al. [8, 28, 46] for use with right censored survival data is commonly
known as Harrell's C-index. This is a rank-order statistic motivated by Kendall's 
[47] that measures the association between the ranked predicted and observed survival
times. Specically the C-index is based on the idea that, for a randomly selected pair
of subjects, the subject who fails rst has shorter predicted survival time. This is
described in detail in Chapter 3.
Gonen and Heller [48] discussed the possibility of bias in Harrell's C-index, induced
by censoring, and proposed a new measure of concordance probability, K(), for use
with the Cox proportional hazards model. K() is a model based estimator and is a
function of model parameters and the covariate distribution. This is explained in more
details in Chapter 3.
2.4.2.2 Measure based on prognostic separation
This measure quanties the separation between the observed risks across the range of
predicted risks. In survival analysis, the standard approach often used in the literature
is to generate a prognostic classication scheme comprising of two or more risk groups
and to plot the Kaplan-Meier survival curves for each group, which leads to the idea
of separation of survival curves as a measures of prognostic information. Based on this
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idea, Royston and Sauerbrei [49] proposed a measure of prognostic separation, called
separation statistic, D statistic. The D statistic can be calculated by rst transforming
the prognostic index derived from the model using the Blom's approximation [50] to
give a standard normal order rank statistic z; D is then the coecient of z in a model
tted with z as the only predictor. The D statistic can be interpreted as the log hazard
ratio (for survival outcomes) or log odds ratio (for binary outcomes) between low-and
high-risk patient-groups obtained by dichotomising the predicted prognostic index at
their median value.
2.4.3 Overall performance measures: R2 type measures
Measures in this category are equivalent to the R2 measures generally used in normal
linear regression and are also used to quantify the prognostic ability of the predictors
in the model. The main reason for the popularity of R2 in normal linear regression
is its interpretation as the proportion of variation in the outcome that is explained
by the predictors in the regression model. R2 measures in prediction research aim at
quantifying the increase in the amount of explained variation in the observed outcome
resulting from the addition of the predictor to the model. The value of R2 measures
range between 0 and 1 (or 0 - 100%). A maximum value of 1 indicates that the
predictors fully explain the variation in the outcome, whereas the minimum value 0
indicates that the predictors have failed to explain any of the outcome.
Extending the denition of R2 for linear regression, several measures have been
proposed for both binary and survival outcomes, exclusively for logistic and Cox models.
Such measures have been reviewed and compared by Mittlbock and Schemper [51] for
models with binary outcomes and by Choodari-Oskooei et al. [52] and Schemper and
Stare [53] for models with survival outcomes. As discussed by Mittlbock and Schemper
[51] and Choodari-Oskooei et al. [52], R2 measures are mainly dened based on either
a loss function (for example, squared error loss), or the model's log-likelihood function,
or the Kullback-Leibler distance [54].
Commonly used R2 type measures based on the loss function approach include those
proposed by Schemper and Henderson [23], Graf et al. [55], Schemper [56], Margolin
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and Light [57], Haberman [58], van Houwelingen and Le Cessie [59], and Schemper [60].
Measures based on the model's likelihood and the Kullback-Leibler distance include
those proposed by Kent and O'Quigley [61], Cox and Snell [62], Korn and Simon [63],
Magee [64], Nagelkerke [65] O'Quigley et al. [66], and Royston [67]. Among all types of
R2 measures, the measures based on the loss function approach have an interpretation
closely related to the measures of discrimination and calibration, and have also been
used in practice [37, 68]. In the following subsection, a brief discussion on the measures
based on the loss function approach are given.
2.4.3.1 Measures of explained variation: based on loss function approach
Measures in this category quantify the relative gain in predictive accuracy resulting from
the addition of predictors to the model. The predictive accuracy is usually obtained by
quantifying the distance between the observed and predicted outcome. For continuous
outcomes, the distance is usually Y   ^ Y , where ^ Y is the predicted value of the outcome
Y . For binary outcomes, ^ Y is equal to the predicted probability of the event occurring,
and for survival outcomes, it is the predicted survival probability at a given time or
as a function of time. A measure of predictive accuracy is then dened by applying a
loss function to the distance Y   ^ Y . The most commonly used loss functions include
the squared error loss, for example, (Y   ^ Y )2, and absolute error loss, for example,
jY   ^ Y j). A wide variety of loss functions, most of which are adapted from these two,
for binary and survival outcomes have been discussed in the paper of Mittlbock and
Schemper [51] and Korn and Simon [63], respectively.
The most commonly used measure of predictive accuracy for both binary and sur-
vival outcomes is the Brier score [55, 69], which was originally developed by Brier [70]
for assessing the inaccuracy of probabilistic weather forecasts. The Brier score is based
on the squared error loss function and assesses the predictive accuracy of individual
predictions. Schemper and Henderson [23] proposed another measure of predictive ac-
curacy, Dx, based on the absolute error loss function. The calculation of both the Brier
score and Dx for survival data require an additional weight factors to adjust for the
eects of censoring.
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The relative gain in predictive accuracy, which gives an R2 value, can be obtained
by comparing the prediction error PEx (for example, the Brier score) obtained for the
model with predictors X and the prediction error PE0 obtained for the null model.
Then a general measure of explained variation based on the loss function approach is
dened as
R2
PA = 1  
PEx
PE0
:
R2
PA ranges between 0 and 1; a maximum value of 1 indicates that the outcome is fully
explained by the predictors in the model while the minimum value 0 indicates that the
predictors have failed to explain the outcome at all.
2.5 Conclusion
This chapter has discussed motivation and a general procedure for validating a prog-
nostic model, particularly focusing on models with binary and survival outcomes. Val-
idation of a prognostic model is essential before using it in clinical practice. Generally,
validating a prognostic model implies achieving evidence regarding the accuracy of
predictions for new patients dierent from those used to developed the model. This
chapter has discussed the design of the validation process and key aspects of the model
that are evaluated when conducting a validation study. This chapter has also provided
a brief literature review of validation measures that have been proposed to assess the
predictive performance of models for binary or survival outcomes.
The next chapter reviews and evaluates some of the validation measures that have
been proposed for models with independent survival outcomes and makes practical
recommendations, starting with a motivation for this investigation.
20Chapter 3
Measures for independent
survival outcomes
3.1 Introduction
It is essential that prognostic models have good ability to make accurate predictions.
Therefore, there needs to be validation measures available to evaluate the predictive
ability of these models. Validation measures for models for binary outcomes are rea-
sonably well developed; see, for example, Omar et al. [10], Steyerberg et al. [24], and
Royston and Altman [25]. However, despite the proposal of several validation measures
for survival outcomes, it is still unclear which measures should be adopted for general
use. One common feature of survival data is that these are subject to censoring, and
therefore it is essential for a validation measure to be robust to the degree of censoring
[52, 53, 68]. The aim of this chapter is to review some of the validation measures pro-
posed for survival models, to evaluate their performance through simulation studies,
and to make recommendations regarding their use in practice.
Some authors have already investigated the performance of validation measures for
survival risk models [52, 53, 68]. However, these papers focussed only on measures
of explained variation. In addition, some of these papers did not consider the use
of validation data; they validated the model using the same data that were used to
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develop the model [52, 53]. However, assessing the performance of a prognostic model
on the data used to develop the model can lead to overoptimistic results regarding
its predictive performance [26]. This chapter will evaluate validation measures using
data that have not been used for model development. The performance of validation
measures for survival outcomes from all categories: discrimination, calibration and
predictive accuracy, and explained variation will be investigated.
The chapter is organised as follows. Section 2 describes two real clinical datasets
that are used to simulate the new data for this investigation. Section 3 describes the
validation measures that were assessed, focusing on the motivation for choosing these
measures, their estimation, and their properties. In Section 4, the criteria against which
the measures are assessed and the simulation design are discussed. Section 5 presents
and discusses the simulation results. Some recommendations are discussed in Section
6, and Section 7 ends the chapter with a general discussion.
3.2 Example data sets
3.2.1 Breast cancer data
This dataset contains information on patients with primary node positive breast cancer
from the German Breast Cancer Study [71]. The outcome of interest is recurrence-free
survival time and there are 686 patients, with 299 events; that is, the rest of the
patients (56%) were censored. The median follow-up time was 4.5 years. All these
patients had complete data for all predictors that include age, tumour size (tsize),
number of positive lymph nodes (lnod), progesterone status (progest), menopausal
status (menpst: pre/post), tumour grade (tgrad: 1-3), and hormone therapy (hormon:
yes/no). For simulation purposes, all the continuous predictors, except age, were log-
transformed. If the predictor contained zero values then a small scalar was added prior
to the transformation. Age was converted into three categories: below 45 years, 45-60
years, above 60 years. The risk model based on this dataset has already been published
[72]. The only focus here is to use this dataset for simulation purposes and to assess
the performance of the validation measures, rather than on the clinical motivation for
developing a risk model.
223.3 Validation measures for the Cox Proportional Hazards model
3.2.2 Sudden cardiac death data
This dataset contains information on a retrospective cohort of patients with hyper-
trophic cardiomyopathy from a single cardiac hospital in the UK. The outcome of in-
terest is sudden cardiac death (SCD). There are 1831 patients of which 79 had recorded
sudden cardiac death; the rest of the patients were censored. The median follow-up
time was approximately 5 years. The predictors of interest are age, number of runs
of ventricular tachycardia (runvent: 0-2 or 3+), obstruction to blood ow (BF), ab-
normal blood pressure response to exercise (BP: normal or abnormal), and maximum
thickness of heart muscle (HM). The dataset is used in this thesis only for simulation
purposes and to evaluate the performance of the validation measures. The risk model
based on this dataset is under development; the aim is to guide clinical management
of patients who have been suering from hypertrophic cardiomyopathy. I would like to
thank Drs Constantinos O'Mahony and Perry Elliott for allowing me to use their data
for simulation purposes.
3.3 Validation measures for the Cox Proportional Haz-
ards model
The Cox Proportional Hazards (PH) model [73] is the most commonly used regression
model for the analysis of right censored survival outcomes. Note that a subject is
right censored if it is known that the event of interest occurs some time after the
observed follow up period. Consequently, in health care research, prognostic models
for survival data are typically developed using the Cox PH model and hence validation
measures will be evaluated based on this model. For this investigation, we have selected
measures that can be interpreted and communicated easily for clinical purposes, have
been implemented or are easy to implement in commonly used statistical softwares,
and can be used routinely in practice.
Validation measures selected include the calibration slope [44] from the category of
calibration measures; Harrell's C-index [8], G onen and Heller's K() [48], and Roys-
ton and Sauerbrei's D [49] from the discrimination measures; Graf et al's integrated
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Brier score (IBS) from the category of predictive accuracy measures; and R2
IBS [55],
and Schemper and Henderson's V [23] from the explained variation category. Further
motivation for choosing these measures and their estimation for the Cox PH model are
given in the following sections, following a description of the Cox model and some basic
notation.
3.3.1 The Cox Proportional Hazards model
Suppose we have data on N subjects, where for the ith subject, ti is the observed
time, i is 1 if the event of interest is experienced at ti or 0 otherwise (right censoring),
and xi is a vector of p predictor values. The Cox model species the hazard, which
corresponds to the risk that the event will occur in an interval after time t given that
the subject had survived to time t, as
h(tjxi;) = h0(t)exp(i);
where h0(t) is the baseline hazard that describes how the hazard changes over time at
baseline levels of predictors, and i = 1xi1+:::+pxip = Txi is the prognostic index,
a linear combination of p predictor values weighted by regression coecients 1;:::;p.
The predictive form of this model can be written in terms of the survival function as
S(tjxi;) = S0(t)exp(i);
where S(tjxi) is the probability of surviving beyond time t given predictors xi, and
S0(t) is the baseline survivor function at time t, which corresponds to the baseline
hazard h0(t) as S0(t) = exp[ 
R t
0 h0(u)du]. To make predictions at time t, one uses
estimates ^ T and ^ S0(t) [37].
3.3.2 Measures of calibration
A calibration measure assesses whether the model makes reliable predictions by as-
sessing how closely the predicted probability of survival for a group of subjects at a
particular time point agrees with the actual outcome. When such an agreement is quan-
tied for an individual subject, this aspect leads to a measure of predictive accuracy
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(Section 3.3.4). The most commonly used calibration measure for survival models is the
calibration slope proposed by van Houwelingen [44], which was originally introduced
for binary outcomes by Cox [42] and was further considered by Miller et al. [74].
3.3.2.1 Calibration slope (CS)
The calibration slope (CS) assesses the degree of agreement between the observed and
predicted values using a regression model. The calibration slope for survival data is
obtained by tting a Cox Model to the validation data where the predicted prognostic
index ^ i = ^ Txi is included as the only predictor:
h(tj^ ;) = h0(t)exp(^ ):
If ^  is close to 1, it suggests that the predicted log hazard ratio is accurate. A value
far away from 1 indicates that some form of re-calibration of the risk model may be
necessary [44]. In particular, ^   1 suggests over-tting in the original data with the
spread of predictions being too large: the predictions are too low for low risk subjects
and too high for high risk subjects.
3.3.3 Measures of discrimination
Measures of discrimination assess how well a model can distinguish patients with high-
risk from those with low-risk. The discriminatory ability of a survival model is com-
monly quantied by a measure of concordance probability that quanties the correlation
between the predicted and observed survival times. The most frequently used concor-
dance measure is the C-index, which has been proposed by Harrell et al. [8]. However,
Gonen and Heller [48] reported possible censoring bias in the C-index and proposed
a new measure of concordance probability K() to overcome this problem. Another
measure of discrimination is the D statistic proposed by Royston and Sauerbrei [49].
This is based on the idea of prognostic separation which quanties the spread in the
observed risks between those patients predicted to be at low risk and those at high risk.
All these measures are discussed in detail in the next section.
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3.3.3.1 Harrell's C-index
The C-index [8] is a rank-correlation measure motivated by Kendall's  statistic [47]
which quanties the correlation between the ranked predicted and observed survival
times. For the Cox PH model, this is dened as the probability that of a randomly
selected pair of subjects, the subject who fails rst has the worse predicted prognosis.
The overall concordance probability, or the C-index, is calculated as the proportion of
all usable pairs in which the predictions and outcomes are concordant. For a randomly
selected pair of subjects (i;j) with observed survival times ti and tj respectively, the
pair is said to be usable or comparable if ti 6= tj. For censored data, a pair is usable if
the shorter time corresponds to an event. With the corresponding predicted survival
times ^ ti and ^ tj, a usable pair is said to be concordant if ti > tj and ^ ti > ^ tj or ti < tj and
^ ti < ^ tj. For a proportional hazards model, a `one-to-one' transformation holds between
the predicted survival time ^ ti and the predicted probability of survival S(tjxi) for every
t > 0 [75]. Therefore, ^ ti and S(tjxi) are interchangeable. A pair is then concordant
if ti > tj and S(tjxi) > S(tjxj) or ti < tj and S(tjxi) < S(tjxj). If the inequalities
go in the opposite direction, that is, ti > tj and S(tjxi) < S(tjxj) or ti < tj and
S(tjxi) > S(tjxj), then the pair is said to be discordant. In the presence of censoring,
not all pairs of subjects are observed to be usable. If there is high degree of censoring
then many subject pairs will be omitted from the calculation of the C-index.
Mathematically, the concordance probability under the Cox PH model can be de-
ned as
C = Pr
h
S(tijxi) < S(tjjxj)jti < tj
i
;
or equivalently
C = Pr
h
Txi > Txjjti < tj
i
:
Ties in the observed survival times and/or in the predicted survival probability are
ignored in above denition. Indeed, the distributions of survival times and the predicted
probability of survival are assumed to be continuous.
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Considering all possible pair of subjects (i;j), given that at least one of them had
an event, with their observed data f(ti;i;xi);(tj;j;xj)g the C-index for the Cox PH
model can be estimated using
^ C =
N X N X
i<j
h
I(^ Txi > ^ Txj & ti < tj & i = 1) + I(^ Txj > ^ Txi & tj < ti & j = 1)
i
N X N X
i<j
h
I(ti < tj & i = 1) + I(tj < ti & j = 1)
i
;
where I(:) is the indicator function and ^ T is the partial likelihood estimator of T.
The C-index typically ranges between 0.5 and 1, where a value of 0.5 indicates no
discriminatory ability of the model and 1 indicates perfect discrimination. Values
below 0.5 are possible, but rarely occur in practice. This scenario implies that the
model predicts better prognosis for the subject who fails rst.
3.3.3.2 G onen and Heller's K()
G onen and Heller's K() [48] is an alternative estimator of the concordance probability
under the Cox PH model. It is a function of the model parameters and the predictor
distribution only. Unlike Harrell's C-index, K() does not use the observed event and
censoring times directly. Since the eect of censoring on the partial likelihood estimator
of T is negligible, K() is reported to be asymptotically unbiased [48]. The K()
statistic has the same interpretation to the C-index.
Under the proportional hazards model, the ranking between the survival times,
denoted T(Txi) and T(Txj), of a randomly selected pair of subjects (i;j) can be
calculated by
Pr[T(Txj) > T(Txi)] =
Z 1
0
S(tjxj;T)dS(tjxi;T)
=
1
1 + expfT(xj   xi)g
;
where T(Txi) and T(Txj) corresponds to the prognostic index Txi and Txj,
respectively. Considering all pairs (i;j), the concordance probability
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K() = Pr(tj > tijTxi  Txj)
can be estimated using
K(^ ) =
2
N(N   1)
N X N X
i<j
h I(^ Txi > ^ Txj)
1 + expf^ T(xj   xi)g
+
I(^ Txj > ^ Txi)
1 + expf^ T(xi   xj)g
i
:
It seems that K() can be calculated knowing the regression coecients of the Cox
model and predictor values. Unlike C-index, all pairs of subjects are used in the
calculation of K(). The C-index uses all pairs only when there is no censoring.
Therefore, for the uncensored data, K() claims to be very close to the C-index [48].
3.3.3.3 Royston and Sauerbrei's D
The D-statistic [49] quanties the observed separation between subjects with low and
high predicted risk, as predicted by the model. It is calculated by rst transforming
each patient's predicted prognostic index ^ i = ^ Txi to give standard normal order rank
statistics (rankits-formed) using Blom's approximation [50]. These rank statistics are
then divided by a factor of
p
( 8
) to give zi as
zi = k 1 1
 i   3=8
N + 1=4

;
where i is the rank order based on the predicted prognostic index ^ (i), N is the number
of observations,  1(:) is the inverse standard Normal distribution function, and k =
p
8=  1:60. The scaled normalised predicted prognostic index zi is distributed as
N(0;=8). A Cox PH model is then tted using zi as the sole predictor, which takes
the following form:
h(tjz;z) = h0(t)exp(zz):
The estimated regression coecient for this predictor is the estimate of D statistic, ^ D.
Alternatively, suppose two equal-sized prognostic groups are determined by dichotomis-
ing zi at their median, then Cox regression on the group averaged zi provides the same
regression coecient as Cox regression on a dummy variable distinguishing the groups.
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Therefore, ^ D is interpreted as the log hazard ratio between the two patient groups;
these groups may be described as low and high risk, respectively. The null value for ^ D
is 0, with increasing values indicating greater separation.
3.3.4 Measures of predictive accuracy and explained variation
Measures of predictive accuracy quantify the squared (or absolute) distance between
the predicted survival probability and the actual outcome for an individual subject at
a particular time point. For example, the Brier score [55, 76] may be used to assess
predictive accuracy at a particular time point t. The integrated version of the Brier
score (integrated Brier score) assesses the overall predictive accuracy over the entire
study period. Schemper and Henderson [23] proposed a similar measure of predictive
accuracy, denoted by Dx, to the integrated Brier score (IBS).
A measure of predictive accuracy leads to a `relative measure of predictive accuracy'
or `measure of explained variation' that has the same interpretation to R2 measures
commonly used in normal linear regression [23, 55]. Several measures of explained vari-
ation have been proposed in the literature [52, 53]. Among them, the measures which
are based on the predictive accuracy approach, for example, V proposed by Schemper
and Henderson [23] and R2
IBS proposed by Graf et al. [55], have an interpretation closely
related to the measures of discrimination and calibration. In addition, these measures
have been used in practice [37, 68]. Therefore, these two measures have been chosen
from the category of explained variation. All these measures are discussed in detail in
the following sections.
3.3.4.1 Graf et al's Brier score
The Brier score can be calculated by comparing the predicted survival probability and
the observed survival status using a quadratic loss function, then taking a weighted
average over all subjects. The weights are used to compensate for the loss of information
due to censoring.
For data (ti;i;xi), the individual contribution to the Brier score (BS) at time t
can be split up into three categories: if
293.3 Validation measures for the Cox Proportional Hazards model
(i) ti  t and i = 1, d BS(tjxi) = (0   ^ S(tjxi))2
(ii) ti > t and i = 1 or i = 0, d BS(tjxi) = (1   ^ S(tjxi))2
(iii) ti  t and i = 0, the survival status is unknown and thus the contribution to
BS cannot be calculated.
The loss of information indicated in category (iii) is compensated by adding a weight
to d BS(tjxi) for subjects in categories (i)-(ii). These weights account for the inverse
probability of censoring [77]. The resulting weighted Brier score can be calculated as
d BSx(t) =
1
N
N X
i=1
h(0   ^ S(tjxi))2I(ti  t;i = 1)
^ G(ti)
+
(1   ^ S(tjxi))2I(ti > t)
^ G(t)
i
;
where ^ G(t) is the Kaplan-Meier estimate of the probability of being uncensored at time
t. The Brier score at time t can be interpreted as the mean squared error of prediction
for survival. Lower values of the Brier score indicate better predictive performance of
the model; 0 indicates perfect predictions, which is however very unlikely to occur in
practice.
The Brier score dened above is a function of time t. Therefore, to obtain a summary
measure of predictive accuracy over a range of time points, say 0 < t  , an integrated
version of the Brier score (IBS) can be estimated by integrating d BSx(t) for all t (0 <
t  ) with respect to some weight functions W(t). The IBS is given by
d IBSx() =
Z 
0
d BSx(t)d ^ W(t):
where ^ W(t) is a function to weight the contribution of the Brier score at individual time
points, and  should be chosen as any time less than or equal to the last observed failure
time. The weight ^ W(t) is implemented for d IBSx() as a straightforward trapezoidal
rule for integrating the area under the prediction curve. Following [55], we choose
^ W(t) = (1   ^ S(t))=(1   ^ S()), where ^ S(t) denotes the estimated marginal survival
function. The integrated Brier score was investigated in this study.
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3.3.4.2 Graf et al's R2
IBS
To quantify the relative gain in predictive accuracy resulting from the inclusion of
predictors in the model, Graf et al. [55] also proposed R2
IBS which can be estimated as
^ R2
IBS = 1   d IBSx()= d IBS0();
where d IBS0() and d IBSx() are the estimated integrated Brier scores obtained from
the null model and the model with predictors, respectively. R2
IBS ranges between 0
and 1. A maximum value of 1 indicates that the predictors fully explain the variation
in the outcome, whereas the minimum value 0 indicates that the predictors have failed
to explain any of the outcome.
3.3.4.3 Schemper and Henderson's V
Similar to R2
IBS, V [23] is a relative measure of prognostic accuracy and can be calcu-
lated as
^ V = 1   ^ Dx()= ^ D0();
where ^ D0() and ^ Dx() are the measures of predictive accuracy obtained for the null
model and the model including the predictors, respectively. In principle, Dx() is anal-
ogous to IBSx(). However, unlike IBSx() which is based on quadratic dierences,
Dx() quanties the absolute dierence between the predicted and observed survival
status (alive/died) at each event time and averages over all subjects and event times up
to the last event time . Additionally, subjects who are censored before the event time
are allocated to alive or dead categories according to their corresponding conditional
survival probability estimates at their censoring times.
Assuming that there are m distinct event times t(j) (t(1) < t(2) ::: < t(m)) in the ob-
served data (ti;i;xi) with dj events at t(j), the individual contribution to the absolute
distance, M(t(j)jxi), at each event time t(j) falls into one of three categories:
(i) ti  t(j) and i = 1, ^ M(t(j)jxi) = ^ S(t(j)jxi)
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(ii) ti > t(j) and i = 1 or i = 0, ^ M(t(j)jxi) = 1   ^ S(t(j)jxi)
(iii) ti  t(j) and i = 0, ^ M(t(j)jxi) =

1   ^ S(t(j)jxi)
 ^ S(t(j)jxi)
^ S(tijxi) + ^ S(t(j)jxi)

1  
^ S(t(j)jxi)
^ S(tijxi)

.
The rst category corresponds to the subjects who have died before or at t(j) and the
second to those who are alive at t(j). The last category relates to the subjects censored
before or at t(j) and amounts to an extrapolation, assuming that these subjects have
identical risk of death to those with known survival status at t(j). This assumption
is quite similar to that of random censoring and is required by the standard survival
methods [23]. Therefore, the estimate in the third category gives an average over alive
or dead categories weighted by the corresponding conditional probability estimates at
their censoring times: namely, ^ S(t(j)jxi)=^ S(tijxi) represents the probability of survival
beyond time t(j) given that the subject survived to at least time ti.
The overall estimator ^ Dx() of predictive accuracy can be obtained by taking a
weighted average of M(t(j)jxi) over failure times, with weights designed to compensate
for the reduction in observed deaths due to earlier censoring:
^ Dx() = w 1
m X
j=1
^ G(t(j)) 1dj
h 1
N
N X
i=1
^ M(t(j)jxi)
i
;
where w =
Pm
j=1 ^ G(t(j)) 1dj is the weighting factor and ^ G(t(j)) is the Kaplan-Meier
estimate of the censoring times. Similarly, ^ D0() can be computed for the null model
by replacing ^ S(t(j)jxi) with ^ S(t(j)).
Hielscher et al. [68] showed that IBSx() = Dx()=2, given that the model is
correctly specied and the same method of integrating over time is used. Similarly
IBS0() = D0()=2. Furthermore, since Dx() uses absolute distance between the ob-
served and predicted survival status as opposed to squared distance used by IBSx(),
Dx() is less aected than IBSx() by unstable survival probability estimate for the
largest survival time. Hence, Dx() has a smaller variance than IBSx(). A similar
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argument can be applied to IBS0() and D0() and hence to V and R2
IBS. As discussed
by Hielscher et al. [68], the dierence between squared distance and absolute distance
is particularly large in the context of survival data, because due to censoring the un-
certainty in the right tail of the survival distribution is large. This uncertainty may
have inuence on the quantity we use to evaluate the prediction accuracy. Therefore,
a measure of predictive accuracy that is based on absolute distance might be preferred
in this context.
3.4 Evaluation of the measures
Using a simulation study the validation measures are evaluated against a set of criteria
that a suitable validation measure should have in the context of survival analysis. This
section discusses the criteria, the simulation design, and strategies for assessing the
measures against the proposed criteria.
3.4.1 Criteria for evaluation
To evaluate the suitability of the validation measures for use in practice with survival
data, three aspects were considered:
(i) Robustness to censoring: Censoring is common for survival data. For example,
in the example datasets in Section 3.2, there are 56% censoring in the breast
cancer data while it is 95% in the sudden death data. An essential property for a
validation measure is that it should be robust to censoring or at least not aected
much by the presence of censoring.
(ii) Sensitivity to the exclusion of important predictors: If an important predictor is
excluded from the model then the validation measures, except perhaps for the
calibration slope, should demonstrate sensitivity to the exclusion. The validation
measures are generally expected to move closer to their null value as important
predictors are omitted from the model. However, the calibration slope may not
react to this exclusion if the distribution of the predictors in the development and
validation data are similar [40, 44]. For more details see Section 3.5.1.2.
(iii) Interpretability: The measure should be intuitive and clearly interpretable.
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Each validation measure under study has already been discussed with respect to
criteria (iii) in Section 3.3. In the simulation study, the measures are investigated with
respect to criteria (i) and (ii).
3.4.2 Simulation design
3.4.2.1 Simulation scenarios
The simulation study was based on the two clinical datasets described in Section 2. Val-
idation datasets were generated by simulating new outcomes for each of these datasets
based on a true model and combining these with the original predictors. The validation
measures were investigated over a range of scenarios to mimic real situations. For all
simulations, three dierent risk proles (low, medium, and high) were constructed for
the patients in the validation data to reect the fact that, in practice, the characteristics
of the patients in the development and validation data may dier.
For the investigation into the eect of censoring, two types of censoring mechanism
were considered, random and administrative. Random censoring is more common in
clinical studies where patients are lost to follow-up throughout the course of the study,
and administrative censoring is more common in population-based studies where birth
cohorts are followed up until a xed time point. The levels of censoring considered were
0%, 20%, 50%, and 80%, which combined with the risk proles, results in a total of
24 validation scenarios for each clinical dataset. No development data were simulated
for this investigation. It was assumed that the risk model had been correctly specied
and perfectly estimated in order to assess the eect of censoring, rather than model
development.
Censoring was not introduced into the simulations that investigated the eect of
the omission of predictors, so as not to confound the results. Again, no development
data were simulated for this investigation although incorrectly specied risk models
were considered.
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3.4.2.2 Generating new survival and censoring times
To simulate validation data, new survival outcomes were generated from a true model
based on each of the real data sets. The true model was derived by tting a Weibull
proportional hazards model to each dataset including all available predictors. The
estimates of the model parameters from these tted models were then set as the \true"
values to simulate new outcomes using the Weibull distribution. The Weibull survival
times were simulated from the true model as
ti =
 
 log(ui)
exp(Txi)
!1=
(i = 1;:::;N);
where Txi is the true prognostic index (PI) with observed predictor vector x,  is the
true value of the shape parameter, and ui has a pseudo-random uniform distribution
on (0, 1).
To introduce random censoring, an additional Weibull distributed censoring time
was simulated with the same shape parameter as before but with the log hazard ratio
Txi replaced by a scalar . Dierent choices of  were used to give dierent propor-
tions of censoring. To generate administratively censored data, it was assumed that
individuals were recruited uniformly over the period from 0 to T and were censored at
the study end date T, which was xed in advance. The censoring times were simulated
from a uniform distribution on (0, T) with dierent choices of T giving dierent pro-
portions of censoring. The observed times under both types of censoring mechanism
were obtained by taking the minimum of the survival and censoring times.
3.4.2.3 Generating validation data with dierent risk proles
For each of the example datasets, validation data with three dierent risk proles were
created. To create these validation datasets, patients were split into three tertile groups
based on their prognostic index PI=Txi derived from the true model. These groups
may be viewed as low, medium, and high risk patients. Based on these risk groups, three
dierent validation datasets were created by sampling patients (without replacement)
in the following way:
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(a) low risk prole: 80% of the patients were sampled from the lowest tertile, 50%
from the middle tertile, and 20% from the highest tertile;
(b) medium risk prole: all patients from the 3 risk groups were used, which formed
a validation sample with a mix of high and low risk patients. By denition, this
dataset has the same risk prole as the observed (development) data;
(c) high risk prole: 20% of the patients were sampled from the lowest tertile, 50%
from the middle tertile, and 80% from the highest tertile.
The whole procedure was done once before simulating the outcome data. Due to the
sampling scheme considered, the sample sizes for the low and high risk proles were
half that of the medium risk prole. To achieve equal sample sizes we doubled the size
of the low and high risk prole datasets by creating two \patients" based on each set
of the observed predictor values. However, the survival and censoring times were not
duplicated and were generated separately for each \patient".
Table 3.1 summarises the risk prole of the patients in the above validation scenarios
in terms of the failure probability (1   S(tjx)) estimated at a single time-point t. In
the breast cancer simulations, the overall risk of failure was 27%, 34%, and 42% at 3
years for the patients from the low, medium, and high risk prole, respectively. The
dierence between the 1st and 3rd tertiles of the failure probability (1 S(tjx)) for the
patients from the low risk prole was 32%, which was smaller than 42% and 43% for
the patients from the medium and high risk proles, respectively. A similar pattern of
results was observed for the sudden cardiac death simulation, with an estimate of the
overall risk of death of 7%, 10%, and 13% by 15 years for the patients from the low,
medium, and high risk proles, respectively.
For both datasets, the standard deviation of the true prognostic index (PI) for the
patients from the medium risk prole was the largest, compared to those for the pa-
tients from the low and high risk proles, suggesting greater separation (discrimination)
between low-and high-risk patients. The distribution of the PI for the breast cancer
patients from the medium risk prole was approximately symmetric (normal) while it
was asymmetric for all other validation scenarios.
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Table 3.1: Risk prole of patients in validation scenarios, described by the failure prob-
ability (1   ^ S(tjx)) estimated at a single time point t: the overall probability and ter-
tiles (mean over 500 simulations of uncensored data, maximum Monte Carlo standard
error=0.0007). The distribution of the true prognostic index is also discussed.
Failure Probability Prognostic index
Data Risk proles Overall tertile 1 tertile 2 tertile 3 Std. Skew. Kurt.
low risk 0.27 0.13 0.22 0.45 0.67 0.45 3.13
Breast cancer medium risk 0.34 0.15 0.30 0.57 0.75 0.06 2.55
high risk 0.42 0.22 0.40 0.65 0.68 -0.20 3.17
low risk 0.07 0.04 0.06 0.12 0.51 1.22 4.63
Sudden death medium risk 0.10 0.04 0.08 0.17 0.61 0.70 3.19
high risk 0.13 0.06 0.10 0.21 0.58 0.45 3.28
For breast cancer t = 3 years and sudden death t = 15 years. Std=Standard deviation, Skew=Skewness, and Kurt=Kurtosis
3.4.3 Assessing the eect of censoring
The aim was to investigate the eect of censoring on the performance of the validation
measures, and not the eect of model development. Therefore, all validation measures
were calculated for the true model, rather than for a model developed using development
data. Calculation of the calibration slope and Harrell's C-index was performed using
Stata packages stcox and estat concordance respectively while user written Stata
codes were used for the other measures (Appendix B: Figure B.1). The results based on
these codes were consistent with those with the corresponding R-packages such as CPE
for K(), pec for IBS, and f.surev for V and Stata package str2d for D statistic. A
reference value (or true value) was calculated for each validation measure by calculating
its average over a large number of uncensored survival simulations (10,000), for each of
the low, medium, and high risk populations. The eect of censoring was investigated by
calculating bias (referred to as `censoring bias') as the mean of the dierence between
the estimate of the measure and the reference value, over 500 simulations. The number
of simulations required (500) was determined using the formula provided by Burton
et al. [78], which is based on the true value of the measure of interest, the variability of
the measure, the level of accuracy of the measure we are willing to accept (within 2%
of the true value), and the normality of the estimated measure. This specication (500
simulations) provided reasonably low Monte Carlo standard error for the estimates of
the measures, which was the case for each of the scenarios.
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However, it is dicult to compare the dierent validation measures with each other
due to their diering scales. Therefore, a standardised bias was calculated as follows.
Let ^ mg (g = 1;:::;G) be the estimate of a measure for the gth simulation, m be the
corresponding reference value, and m0 be the null value that is obtained for the null
model, then the standardised bias contribution is
Bg =
^ mg   m
jm   m0j
 100:
The standardised bias estimate Bg can be regarded as a random variable that follows
a Normal distribution according to the central limit theorem. A condence interval for
standardised bias can be calculated assuming normality and using the empirical stan-
dard deviation of the estimated standardised bias. The empirical condence intervals
are used to make conclusions on whether the bias for a validation measure is signi-
cantly dierent from zero or whether the bias between two measures are signicantly
dierent.
3.4.4 Assessing sensitivity to the exclusion of important predictors
The sensitivity of the validation measures to the exclusion of important predictors from
the model were also assessed. In this part, models with strong and weak predictors were
specied to examine whether the validation measures are able to distinguish between
the predictive ability of these models. To assess the sensitivity of the measures, rst,
the most important predictors were identied by tting multivariable Cox PH models
in the observed data and using the P-values calculated from likelihood ratio tests. The
most important predictor identied was excluded from the full model (say Model 1 that
contains all available predictors in the data), resulting in a reduced model (Model 2).
The validation measures were then used to validate Model 2. Further reduced models
were specied by omitting the next most important predictor, along with any others
already omitted. The validation measures were calculated for each of these reduced
models. All models were developed using the observed (original) data and validated by
calculating validation measures using the simulated validation data. In addition, the
model 2 values for each of the tted models was calculated in the validation data to
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assess how changes in the value of the validation measures were related to changes in
the model 2 values.
To ensure that the results across the validation measures were comparable, the
estimates (average values over 500 simulations) were re-scaled with the full model set
at 100% and the null model at 0%. Furthermore, to examine how weak the reduced
models were (in terms of predictive ability) relative to the full model, the R2 values
were calculated by regressing the PI derived from the full model on the PIs derived
from the reduced models. This procedure is similar in idea to the `step-down' approach
proposed by Harrell [40], where a full model is approximated to a reduced model.
3.5 Results and discussion
3.5.1 Results
3.5.1.1 Eect of censoring
Figure 3.1 shows the distribution of the validation measures, over 500 simulations,
for various degrees of censoring. Only the results for the medium risk prole breast
cancer patients with randomly censored survival times are presented. The horizontal
dashed line shows the reference value for each validation measure. The median val-
ues of C-index and IBS increased with the degree of censoring whereas the median
values of R2
IBS and V decreased with increased censoring. This suggests that mislead-
ing conclusions may be drawn regarding a model's predictive performance when using
these measures in the presence of censoring. In particular, C-index may give an over-
optimistic estimate of model discrimination in the presence of censoring, whereas IBS,
R2
IBS and V are likely to be conservative. The median values for the other measures
were little aected by censoring. The inter-quartile range for the validation measures
generally increased with increased level of censoring. This was perhaps most noticeable
for IBS and R2
IBS. Similar results were obtained in the other simulation scenarios (not
shown).
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Figure 3.1: Empirical distribution of the validation measures by degree of censoring was summarised using box plots. The results
are from the medium risk breast cancer simulations under the random censoring mechanism. The horizontal dashed line indicates
the true/reference value of the respective measure.
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Figure 3.2: Relative bias (%) with 95% condence intervals for the C-index, K(), D statistic, Calibration slope, and Integrated
Brier score (IBS). The rst and second rows show the results for the breast cancer and sudden cardiac death simulations with
dierent risks prole (low, medium, and high), respectively. All simulations were under the random censoring mechanism.
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Figure 3.3: Relative bias (%) with 95% condence intervals for R2
IBS and V . The rst and second rows show the results for the
breast cancer and sudden cardiac death simulations with dierent risks prole (low, medium, and high), respectively. All simulations
were under the random censoring mechanism.
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n Figure 3.4: Distribution of the prognostic index derived from the true model for the breast cancer and sudden cardiac death
patients with dierent risk proles.
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Figure 3.2 shows the standardised bias for the C-index, K(), D statistic, calibra-
tion slope (CS) and IBS, and Figure 3.3 shows bias for R2
IBS and V measures. The
results are from both the breast cancer and sudden cardiac death (SCD) simulations
when the censoring is random. The bias in CS and K() was negligible which is to
be expected since both are derived from the Cox model. The other measure, derived
from this model, the D statistic was biased in some scenarios. For example, the bias
was negligible in the medium risk breast cancer scenario, whereas the bias was often
high in the SCD scenarios. Further investigation suggests that the level of bias in D
corresponds to the level of skewness in the distribution of the prognostic indices (Fig-
ure 3.4). Royston and Sauerbrei [49] note that the D statistic is most accurate when
the prognostic index is normally distributed. The C-index, one of most widely used
measures in practice, showed increasing bias as the level of censoring increased, which
may be expected since it depends on the censoring mechanism. In addition, when there
are high levels of censoring, the proportion of patient pairs used in the calculation of
C-index is relatively small and may not be representative of the patient pairs in the
population [37, 48]. Further investigation suggests that the bias in C-index may be
acceptable for censoring up to 30% (additional results not shown). The measures of
predictive accuracy and explained variation were most aected by censoring, even at
low levels, despite their use of weighting to alleviate the eect of censoring. Similar
results were observed for the administrative censoring scenarios (Appendix A: Table
A.1).
3.5.1.2 Sensitivity to the exclusion of important predictors
In the breast cancer data, the Cox PH analysis identied number of lymph nodes
(lnod), progesterone status (progest), hormone therapy (hormon), and menopausal
status (menpst) as strong predictors and tumour grade (tgrad), age as moderate pre-
dictor, and tumour size (tsize) as weak predictor (Appendix A: Table A.2). In the
sudden cardiac death data, the analysis identied number of runs of ventricular tachy-
cardia (runvent), obstruction to blood ow (BF), and abnormal blood pressure response
to exercise (BP) as strong predictors while age and maximum thickness of heart muscle
(HM) as weak predictors (Appendix A: Table A.3).
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Following the procedures described in Section 3.4.4, rst, a full model that included
all available predictors (both strong and weak predictors) was developed using the
observed data, then reduced models were tted to the same data by excluding important
(strong) predictors. For each of these models, the value of the validation measures and
the model 2 value were calculated in the simulated validation data. The predictive
ability of each of these models developed using the breast cancer data (5 in total
including the full model) are summarised in Table 3.2 in terms of R2 as discussed in
Section 3.4.4. It appears that the Model 5 was the weakest model, relative to the
full model. The reduction in the R2 values from the value for the full model to that
obtained for the Model 5 was relatively sharp for the high risk validation data than
those for the low and medium risk validation data.
Table 3.2: Models with dierent predictive abilities, relative to the full model, are sum-
marised in terms of R2 values. The results are from the breast cancer simulations with
dierent risk proles. No censoring was considered.
Predictors Dropped R2
Models in the model predictor LowMedHigh
Full Model lnod+progest+hormon+menpst+age+tgrad+tsize - 1.00 1.00 1.00
Model 2 progest+hormon+menpst+age+tgrad+tsize lnod 0.61 0.64 0.57
Model 3 hormon+menpst+age+tgrad+tsize progest 0.47 0.44 0.30
Model 4 menpst+age+tgrad+tsize hormon 0.39 0.38 0.25
Model 5 age+tgrad+tsize menpst 0.37 0.35 0.23
Low=Low risk, Med=Medium risk, and High=High risk
Figure 3.5 shows the results of sensitivity of the measures for the breast cancer sim-
ulations. All the validation measures, except the calibration slope, showed monotonic
sensitivity to the omission of important predictors, although none were as sensitive as
model 2 in the low and medium risk scenarios. The measures belonging to the cate-
gory of predictive accuracy and explained variation (V , IBS and R2
IBS) were the most
sensitive, with V closely following the model 2 value in the high risk scenarios. This
may be because these measures are calculated using the individual predictions directly
and thus are more sensitive to changes in the prognostic strength of the model. The
least sensitive measures were C-index which may be expected since they are both pure
rank based measures and do not incorporate the actual dierence between predictions.
It is worth noting that there was less variation across the measures in the high risk
scenarios.
453
.
5
R
e
s
u
l
t
s
a
n
d
d
i
s
c
u
s
s
i
o
n Figure 3.5: Sensitivity of the measures to the exclusion of important predictors, described as the percentage of reduction in a
measure's value relative to that for the full model. The results are from the breast cancer simulations with dierent risk proles.
No censoring was considered.
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The value of the calibration slope was little aected by the omission of important
predictors when the risk prole of the validation data matched that of the develop-
ment data (Figures 3.5: Medium risk). In this situation, the relationship between the
outcome and the remaining predictors should be similar in both the development and
validation data, and hence the calibration slope should indicate good calibration (values
close to 1). If the risk proles are dierent, then the relationship between the outcome
and the included predictors may be dierent in the development and validation data
due to the correlation between these predictors and the omitted predictors, and hence
some sensitivity may be observed. The level of sensitivity may be dicult to predict
since it depends on the strength of the predictors and the correlation between them.
Similar results were seen for the sudden cardiac death simulations (not shown).
3.5.1.3 Relationship between the validation measures
The relationships between the various measures, excluding CS, are shown in Figure 3.6
for the medium risk breast cancer scenario. There was very good agreement between
C-index, IBS, R2
IBS and V when there was no censoring, although these relationships
weakened considerably as censoring increased. Similar relationships were seen for the
low and high risk breast cancer scenarios (results not shown). Generally, these relation-
ships were weaker in the sudden cardiac death (SCD) scenarios (results not shown),
perhaps reecting the lower amount of prognostic information available. However, there
was excellent agreement between K() and D in the breast cancer scenarios and this
relationship was robust to censoring. This relationship was weaker in the SCD scenarios
which may be due to non-normality of the prognostic indices.
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Figure 3.6: Empirical agreement between the measures by degrees of censoring. The results are from the medium risk breast
cancer simulation under the random censoring mechanism.
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3.5.2 Discussion and recommendations
When developing a risk prediction model for survival data it is essential that the per-
formance of the model is evaluated using appropriate validation measures. Although
a number of measures have been proposed, there is only limited guidance regarding
their use in practice. The aim of this research was to perform a simulation study based
on two clinical datasets with contrasting characteristics to investigate a wide range of
validation measures in order to make practical recommendations regarding their use.
Based on the simulation study, the measures of predictive accuracy (IBS) and
explained variation (V and R2
IBS) cannot be recommended for use with survival risk
models due to their poor performance in the presence of censored data. However, these
measures were all conservative with censored data so that high (or low for IBS) values
would still be indicative of a good risk model. Of the discrimination measures, K()
was not biased in the presence of censoring. The performance of D in the presence
of censoring depended on the distribution of the prognostic index. Provided that the
prognostic index was approximately normally distributed, the eect of censoring on
the bias in D was negligible. The C-index was aected by censoring and cannot be
recommended for use with data with more than 30% censoring. The sole calibration
measure under investigation, CS, was unbiased in the presence of censoring.
All the measures of discrimination, predicted accuracy and explained variation
showed sensitivity to the omission of important predictors from a model. However,
the ranked-based measure C-index was less sensitive than the other measures. The cal-
ibration slope showed only limited sensitivity to predictor omission since the developed
risk model eectively re-calibrates itself to compensate for the omitted predictors.
The validation measures dier in their exibility regarding their assumptions and
the form of the risk model. The concordance measure C-index only require that the
risk model is able to rank the patients. In contrast, K() requires that the risk model
was tted using the Cox proportional hazards model. The D statistic assumes that
proportional hazards holds and that the prognostic index is normally distributed. The
calibration slope measure, as described, also assumes proportional hazards although
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more general approaches are described by van Houwelingen [44]. The measures based
on predictive accuracy, IBS, R2
IBS, and V , only require that a survival function can
be calculated for all patients.
With respect to clinical interpretation, all of the measures considered in this paper
can be easily communicated to a non-statistical health researcher, except perhaps for
the calibration slope and IBS. The concordance measures can be readily communi-
cated in terms of correctly ranking patient pairs, and explained variation measures are
intuitive with their percentage scale. The D statistic also has a nice interpretation as
it can be communicated as a (log) relative risk between low and high risk groups of
patients.
In summary, based on the ndings of this simulation study, K() can be recom-
mended for validating a risk model developed using the Cox proportional hazards model,
since it is both robust to censoring and reasonably sensitive to the omission of impor-
tant predictors. D can also be recommended provided that the distribution of the
prognostic index is approximately normal. It is more sensitive to predictor omission
than K() and can be calculated for models other than those tted using the Cox
model. The calibration slope can be recommended as a measure of calibration since
it is not aected by censoring although it is less sensitive than the other measures to
the omission of important predictors. In practice, one might additionally investigate
calibration graphically by comparing observed and predicted survival curves for groups
of patients. This approach also has the benet of being easy to communicate.
An important point to note is that the characteristics of the validation data should
be investigated before choosing the validation measures. In particular, the level of
censoring and the distribution of the prognostic index need to be checked, assuming
that the standard model assumptions such as proportional hazards hold. It is not clear
that this is routinely done in practice.
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3.6 Conclusion
This chapter investigated some of the validation measures that have been used for
independent survival outcomes. By means of a simulation study based on two real
datasets, this investigation compared their performance against criteria for a suitable
validation measure for a survival model. The results in the simulation study provided
guidelines for using these measures in practice, particularly when data have censoring.
The next chapter discusses the possible extensions of validation measures that have
been used for independent binary outcomes for use with correlated/clustered binary
outcomes.
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Measures for clustered binary
outcomes
4.1 Introduction
Clustered binary outcomes occur frequently in health care research. For example,
subjects could be nested in larger units such as hospitals, doctors, family, or geographic
regions. Due to clustering within larger units, outcomes in the same cluster often share
some common cluster level characteristics and thus tend to be correlated. Various
statistical models have been proposed in the last two decades to model the relationship
between predictors and outcomes in the presence of clustering, particularly focusing on
how to account for the eect of clustering. These models are typically grouped into
two broad classes: cluster-specic and population-averaged approaches [79, 80].
In the cluster-specic approach, the probability distribution of the outcomes is mod-
elled as a function of xed predictors and one or more random terms. The random term
represents the eect of unobserved cluster-specic characteristics, which varies across
clusters following a specic distribution. This modelling approach is known as the
random eects model, for example, random eects logistic model for clustered binary
outcomes [81, 82]. In the population-averaged approach, the marginal or population
averaged expectation is modelled as a function of predictors, treating the correlation be-
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tween the outcomes within the same cluster as a nuisance parameter. Marginal logistic
models, with generalized estimating equations [83] for the estimation of the model pa-
rameters, are often used for modelling clustered binary outcomes. The estimates from
the random eects models have a conditional interpretation, given the cluster-specic
random eect, while the estimates from the marginal models have population-averaged
interpretation. The conditional estimates from a logistic model can be interpreted as
the eect of a unit change in the predictors for subjects belonging to the same clus-
ter, whereas the marginal estimates can be interpreted as the averaged eect of a unit
change in the predictors for all subjects in the population. Generally, the preference for
using one of these two classes of models depends on what type of inference a researcher
would like to draw in practice: conditional or marginal [84]. Lee and Nelder [85] and
Skrondal and Rabe-Hesketh [86] considered the random eects models as more general
form of models for analysing clustered binary data, from which the marginal models
can be derived by integrating out the random eects. It is thus possible to obtain both
conditional and marginal predictions from the random eects models.
Although the clustering of data within larger units is usually taken into account
in explanatory models in aetiological research, it is often ignored in risk prediction
research, both in the process of model development and the validation of the model's
performance [87]. This work focuses on the use of random eects logistic models in risk
prediction for clustered binary outcomes. To understand the predictive ability of such
a model, it is essential to validate its predictive performance. Validation measures for
assessing the predictive ability of models for independent binary outcomes are reason-
ably well developed; see, for example, Omar et al. [10], Steyerberg et al. [24], Royston
and Altman [25], and Harrell et al. [40]. However, very limited research has been
conducted to develop validation measures for models with clustered binary outcomes.
This chapter discusses possible extensions of some of the existing validation measures
that could be used to assess the predictive ability of prognostic models based on the
random eects logistic models.
The C-index [45], and the D-statistic [49] are commonly used validation measures
to assess the discriminatory ability of prognostic models for independent binary out-
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comes. The calibration slope [39, 42] is commonly used to assess whether the model
predicts accurately for a group of subjects (calibration), and the Brier score [55] is often
used to assess accuracy for individual predictions (predictive accuracy). In this chapter,
these validation measures are extended for use with models for clustered binary out-
comes. The Hosmer-Lemeshow Chi-squared test statistic [41] is also used frequently to
assess a model's calibration. This test assesses whether or not the observed event rates
match the expected event rates in subgroups of model population, where the groups
are identied from the deciles of the predicted risk of having the event. However, it is
not straightforward to evaluate this measure using a simulation study. Therefore, this
measure is not investigated for the models with clustered binary outcomes.
The chapter begins with a brief description of the proposed validation measures
for independent binary outcomes, then discusses the estimation of these measures for
clustered data. The methods are illustrated using data on patients who had undergone
heart valve surgery. A simulation study is conducted to evaluate the performance of
the validation measures under various clustered data scenarios.
4.2 Validation measures for independent binary outcomes
This section briey describes some of the commonly used validation measures for inde-
pendent binary outcomes, starting with a description of notation based on the logistic
regression model.
4.2.1 Logistic regression model
Let Yi (i = 1;:::;N) be a binary outcome (0/1) for the ith subject which follows
Bernoulli distribution with the probability i = Pr(Yi = 1). The logistic regression
model can be used to model the relationship between the outcome and predictors and
is dened as
logit[Pr(Yi = 1jxi)] = log
 i
1   i

= Txi;
544.2 Validation measures for independent binary outcomes
where T is a vector of regression coecients of length (p + 1), and xi is the ith row
vector of the predictor matrix X which has order N  (p + 1). The term i = Txi
is known as the `prognostic index'. The predictive form of this model, used to predict
the probability of the event of interest, can be written as
(jxi) =
1
1 + exp[ Txi]
:
Predictions from the model depend on the estimate of T, which is typically obtained
by the method of maximum likelihood [88].
4.2.2 The C-index: denition
The C-index is a measure of concordance probability and is numerically identical to the
area under the receiver operating characteristic curve (AUC) [45], a graph of sensitivity
(true positive rate) against 1-specicity (false positive rate). The C-index is widely used
as a tool for assessing the discriminatory ability of standard logistic models because
of its straightforward clinical interpretation. The C-index equals to the proportion of
pairs in which the predicted event probability is higher for the subject who experienced
the event of interest than that of the subject who did not experience the event. For
a pair of subjects (i;j), where i and j correspond to those who experienced the event
and those who did not respectively, with event probabilities f(jxi);(jxj)g, the
C-index can be dened as
C = Pr[(jxi) > (jxj)jYi = 1 & Yj = 0]:
Since there exists a one-to-one transformation between  and Tx, the above proba-
bility expression can be written as
C = Pr[Txi > TxjjYi = 1 & Yj = 0]:
The C-index from standard logistic regression models can be estimated using both
parametric and nonparametric approaches. Generally, under the parametric approach,
a distributional assumption is required for the prognostic index for the population who
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had experienced the event and for those who did not. Under the assumption of normal
distribution, the method of maximum likelihood may be used to estimate the C-index
[89, 90].
The widely used non-parametric approach to estimate the C-index is based on the
Mann-Whitney U statistic [91] and does not require any distributional assumptions
regarding the prognostic index. The C-index or AUC has been shown to be equal to
the U statistic when it (the area) is calculated using the trapezoidal rule [45, 92]. The
U statistic is usually computed to test whether the levels of a quantitative variable in
one population tend to be greater than those in a second population, without making
any distributional assumptions for the variable. In this chapter, both the parametric
and nonparametric approaches for estimating the C-index are discussed.
4.2.3 Non-parametric estimation of the C-index
Let 
(1)
i = TxijYi = 1 and 
(0)
j = TxjjYj = 0 be the prognostic index derived
by the model for subject i who had experienced the event and for subject j who did
not, respectively. Further, let N1 and N0 be the number of events and non-events,
respectively. Considering all pairs (i;j), the C-index can be estimated by analogy to
the U statistic formulation [45, 91, 92] as
Cnp =
1
N1N0
N1 X
i=1
N0 X
j=1
I
 

(1)
i ;
(0)
j

; (4.1)
where
I
 
(1);(0)
=
8
<
:
1 if (1) > (0)
0:5 if (1) = (0)
0 if (1) < (0)
:
The value of Cnp ranges between 0.5 and 1: a value of 0.5 indicates that the model
has no ability to discriminate between low and high risk subjects, whereas a value of 1
indicates that the model can perfectly discriminate between these two groups.
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4.2.4 Parametric estimation of the C-index
Based on the central limit theorem, the prognostic index is likely to follow normal
distribution as the dimension of the parameter vector  increases [52]. The estimation
of the parametric C-index is as follows.
Let us assume that 
(1)
i = TxijYi = 1  N(1;2) and 
(0)
j = TxjjYj = 0 
N(0;2). Therefore, 
(1)
i   
(0)
j  N(1   0;22). By denition, the parametric
C-index is
Cp = Pr[
(1)
i > 
(0)
j ]
= Pr[(
(1)
i   
(0)
j ) > 0]:
After standardising the term 
(1)
i   
(0)
j , Cp can be obtained as
Cp = Pr
h
Z <
1   0 p
22
i
; Z  N(0;1)
= 
 
1   0 p
22
!
; (4.2)
where  denotes the standard normal cumulative distribution function. The estimate
of Cp can be obtained by replacing 1, 0, and 2 by their sample estimates  x1,  x0,
and S2, respectively.
4.2.5 D statistic
The D statistic [49] is a measure of prognostic separation and quanties the separation
between two equal-sized prognostic groups obtained by dichotomising the predicted
prognostic indices at their median value. The D statistic for the logistic regression
model can be calculated by transforming the predicted prognostic index ^ i = Txi to
a standard normal order statistic zi, in a manner similar to that for the Cox PH model.
A logistic model is then tted to the validation data with z as the sole predictor:
logit(Yi = 1jzi) = zzi:
574.2 Validation measures for independent binary outcomes
The estimated coecient of z is an estimate of the D statistic, ^ D, and the correspond-
ing estimated standard error of z is the standard error of ^ D. ^ D is interpreted as the log
odds ratio of having the event of interest between low-and high-risk groups, where the
groups represent the lower and upper half of the predicted prognostic index, respec-
tively. The null value for D is 0, with increasing values indicating greater separation
(discrimination) between these two groups.
4.2.6 Relationship between the C-index and D statistic
The C-index and D statistic are closely related under the assumption of normality of
the prognostic index i = Txi. Based on this assumption, an analytical relationship
between the parametric C-index and D-statistic is derived as follows.
Let us assume that

(1)
i = TxijYi = 1  N(1;2) with Pr(Yi = 1) = 1
and

(0)
j = TxjjYj = 0)  N(0;2) with Pr(Yj = 0) = 0.
Further, suppose that the conditional distribution of  given Y = y is
jY = y  N

y;22

.
The above formulation corresponds to linear discriminant analysis (LDA) [93], which is
equivalent to logistic regression model [94]. In LDA, we assign subject i with prognostic
score i = Txi to the population who had experienced the event with probability
Pr(Yi = 1ji). This probability can be expressed in terms of a logistic model as
Pr(Yi = 1ji) =
1
1 + exp[ (0 + i)]
; (4.3)
where 0 =  log
1
0
+
1
2
(2
1   2
0)
22 and  =
(1   0)
22 .
Standardising the prognostic index  and then multiplying it by
p
=8 gives the
term Z0 (say), which is distributed as N(0;=8). This standardised statistic is ap-
proximately equivalent to the standard normal order statistic Z which we obtained
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from  through a transformation when calculating the D statistic (see Section 4.2.5).
Therefore, the standardised versions of (1) and (0) can be written as
Z0(1)  N
 
1   E()
p
var()
;
22
var()
=8
!
= N
 
1   E()
p
22 ;=8
!
and
Z0(0)  N
 
0   E()
p
var()
;
22
var()
=8
!
= N
 
0   E()
p
22 ;=8
!
,
respectively. This formulation also corresponds to the LDA with the transformed vari-
able Z0 and can be expressed in terms of a logistic regression model for the binary
outcome Y with Z0 as a predictor:
Pr(Yi = 1jZ0
i = z0
i) =
1
1 + exp[ (0 + z0z0
i)]
:
Therefore, the D statistic is the coecient of Z0, z0, in the above model and can be
estimated approximately by analogy to  in equation (4.3) as
D 
E[Z0(1)]   E[Z0(0)]
var(Z0)
=
1 E() p
22  
0 E() p
22
=8
= (8=)
 
1   0 p
22
!
: (4.4)
By using equation (4.2), equation (4.4) can be written as
D  (8=) 1(Cp); (4.5)
where  1(:) is the inverse standard normal distribution function. An illustration of
the above relationship is as follows. Under the null situation, if Cp = 0:5 indicating
no ability of the model (possibly the null model) to discriminate between the low and
high risk subjects, then D from equation (4.5) is equal to 0, indicating no separation
(discrimination) between those two groups. Similarly, if Cp = 0:75, the approximate
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equivalent value of D is 1.72, indicating reasonably good separation. Both the C-
index and D statistic have their own clinical interpretations: the former can be readily
communicated in terms of correctly ranking patient pairs and the latter can be commu-
nicated as a (log) relative risk between low and high risk groups of patients. Therefore,
to have dierent clinical interpretation in practice, one can quickly obtain the value of
the D statistic knowing the value the C-index and vice-versa, rather than calculating
from the model.
4.2.7 Calibration slope
The calibration slope (CS) assesses the calibration of the model by quantifying the
agreement between the observed outcome and prediction for a group of subjects. The
calibration slope can be obtained by tting a logistic model with the prognostic index
^ i = ^ Txi, calculated from the validation sample, as the only predictor in the model
[39, 42]:
logit[Pr(Yi = 1j^ i)] = 0 + ^ i; (4.6)
where d CS is equal to ^ . If ^  is close to 1 then it suggests that the prognostic indices
(log odds) derived from the model are accurate. If ^  is somewhat dierent from 1, it
suggests that some form of re-calibration is necessary [24, 38, 40, 59, 95]. In particular,
a value much smaller than 1 indicates over-tting, where risk estimates are too low for
low risk subjects and too high for high risk subjects (for more details, see Chapter 2).
4.2.8 Brier score
The Brier score (BS) assesses whether the predictions of the model for each subject are
accurate, by quantifying the averaged squared dierence between the predicted event
probability and the actual outcome [55, 69]. For the logistic model with predicted
probability ^ (^ jxi) for subject i, the Brier score is dened as
BS =
1
N
N X
i=1
(yi   ^ (^ jxi))2: (4.7)
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If the model is predicting perfectly then BS = 0, which is however unlikely to occur
in practice. Inaccuracy in predictions is indicated by positive value of the BS, and
higher values indicate greater inaccuracy. A Brier score value of about 0.33 indicates
that predictive ability of the model is not better than random guessing [55, 69].
4.3 Extension of the validation measures for clustered
data
This section discusses possible approaches to extend the validation measures discussed
above for use with models for clustered binary data. Here a random eects logistic
model is considered, where the intercept is the only random parameter. This type
of model is usually referred to as a `random-intercept logistic model', which assumes
equal correlation between pairs of subjects in the same cluster. The section begins with
describing a random-intercept logistic model and approaches to make predictions using
this model, and then discusses how to obtain the validation measures for this model.
4.3.1 Random-intercept logistic model
Let Yij be a binary outcome variable (1/0) for the ith subject in the jth cluster of size nj
(i = 1;:::;nj;j = 1;:::;J) and
PJ
j=1 nj = N. It is assumed that Yij  Bernoulli(ij),
where ij = Pr(Yij = 1) is the probability of having the event of interest. The random-
intercept logistic model is an extension of the standard logistic model with an additional
cluster-specic random eect uj, where uj acts as an additive component with the
intercept of the model and varies randomly between clusters. The random eects
ujs represent the eects of cluster-specic unobserved predictor information and are
independent and identically distributed random variables. Typically ujs are normal
with mean 0 and variance 2
u. The variance parameter 2
u is interpreted as the variation
in the log-odds of having the event of interest between clusters. The random-intercept
logistic regression model is given by:
logit[Pr(Yij = 1juj;xij)] = log
 ij
1   ij

= Txij + uj;
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where T is the vector of regression coecients of length (p+1), and xij is the ith row
vector of the p-predictors.
4.3.2 Predictions from the model
The predictive form of the random eect logistic model, to predict the probability of
having the event, for subject i in cluster j is given by
(juj;xij) =
exp[(;xij;uj)]
1 + exp[(;xij;uj)]
; (4.8)
where (;xij;uj)=Txij +uj is referred to as the prognostic index. Predictions from
the model depend on the estimates of the model parameters (T;2
u) and the random
eect uj.
The model parameters can be estimated using adaptive Gaussian quadrature (AGQ)
[96{99] or penalized quasi-likelihood (PQL) [100{102]. Using the estimates of the model
parameters, the random eect uj for the jth cluster can be obtained by empirical
Bayes approach [86, 103{105], which is the most commonly used method for estimating
random eects. The empirical Bayes estimates are the means of the empirical posterior
distribution of uj, p(ujjyij;xij; ^ T; ^ 2
u) with the parameters estimates ( ^ T; ^ 2
u) plugged
in, and are given by:
^ uj = E(ujjyij;xij; ^ T; ^ 2
u) =
Z
ujp(ujjyij;xij; ^ T; ^ 2
u)duj; (4.9)
where p(ujjyij;xij; ^ T; ^ 2
u) can be derived using Bayes theorem. The Bayes theo-
rem combines the prior distribution of uj, which is essentially N(0;2
u), and the data
(yij;xij). The above integrals do not have analytical solution and need to be solved
numerically. The estimated random eects may be useful to make inferences about
particular clusters and to identify outlying clusters [106, 107].
The random eects logistic model formulated in the above way can be used to make
both conditional (cluster-specic) and marginal (population-averaged) predictions. The
conditional predictions can be made either by using ^ T and plugging in the estimated
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random eects ^ u or by using ^ T and setting the random eects at their mean value zero
(u = 0). Marginal predictions can be made by integrating the conditional prediction
(ju;x) given in equation (4.8) over the (prior) random eects distribution. For
convenience, these three forms of model prediction are denoted as ij(u), ij(0), and
ij(pa), respectively. Similarly, the prognostic indices derived from these predictive
functions are denoted by ij(u), ij(0), and ij(pa), respectively. Note that ij(0) 6=
ij(pa), which holds for most models with non-linear link function.
As an alternative to ij(u), a clustered-averaged or posterior mean probability  ij(u)
can be obtained by integrating (ju;x) given in equation (4.8) over the posterior
distribution of the random eects for cluster j [86]. However, Skrondal and Rabe-
Hesketh [86] showed via simulation studies that both ij(u) and  ij(u) perform equally
and have equal mean squared error of predictions for a range of conditions in a clustered
data setting. This research considers ij(u) instead of  ij(u) as it can be obtained from
most standard softwares.
The decision to make either cluster-specic or population-averaged predictions should
depend on the research question. Some examples of cluster-specic predictions can be
found in [108{110] and population-averaged predictions in [111]. Generally, the use of
the above three approaches to prediction may also depend on whether the subjects for
whom predictions will be made belong to an existing cluster or to a new cluster. Skron-
dal and Rabe-Hesketh [86] and Oirbeek and Lesare [112] suggested that if subjects are
from an existing cluster, ij(u) is preferred as the eect of clustering (random eect)
for that cluster is known. If subjects are from a new cluster on which information is
usually unknown, either ij(0) or ij(pa) should be used, assuming that the new cluster
is sampled randomly.
This research discusses possible extensions of the standard validation measures de-
scribed in Section 4.2 for use with each of the above three dierent approaches to
prediction. The following sections discuss the calculation of these validation measures,
starting with an overview of the approaches proposed to calculate the measures for
clustered data.
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4.3.3 Approaches for the calculation of the validation measures for
clustered data
For clustered data, the na ve use of the existing validation measures for independent
outcomes may lead to misleading conclusions regarding the model's predictive perfor-
mance. The na ve approach assesses the eects of the xed predictors only, and the
predictive performance may change if clustering eects are considered in addition to the
eects of the xed predictors. Furthermore, assessing the model's performance within
each cluster may be of interest, particularly to identify outlying clusters, where, for
example, a cluster might represent a hospital.
Only limited research has been carried out to date to address these issues. One
approach suggested by Oirbeek and Lesare [112] is an adaptation of the concordance
measure for clustered survival outcomes (Harrell's C-index [8] Chapter 3). Their ap-
proach results in three concordance measures each with its own interpretation. In turn,
these measures are based on a comparison of subjects: between clusters (`between clus-
ter concordance' or QB); within clusters (`within cluster concordance' or QW); and
both between and within clusters (`overall concordance' or QO). QO is calculated as a
weighted sum of QB and QW, with weightings given by the proportion of between-and
within-cluster usable pairs, denoted by B and W respectively. Between-cluster pairs
consist of pair of subjects from dierent clusters only, whereas within-cluster pairs con-
sist of pair of subjects from the same cluster only. The `overall weighted concordance
measure', QO, is given by:
QO = BQB + WQW; (4.10)
where
B =
NB;usbl
NT;usbl
, W =
NW;usbl
NT;usbl
,
QB =
NB;conc
NB;usbl
; QW =
1
J
J X
j=1
QW;j =
1
J
J X
j=1
nW;conc;j
nW;usbl;j
; (4.11)
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NT;usbl is the total number of usable pairs in the data, NB;usbl and NW;usbl are the
number of between-and within-cluster usable pairs respectively, NB;conc and NW;conc
are the number of between-and within-cluster concordance pairs respectively, and QW;j
is the `within-cluster concordance measure' for cluster j. As discussed by Oirbeek
and Lesare [112] and Chebon [87], the `overall weighted measure' QO depends on the
number and size of the clusters. Therefore, its value is dicult to compare across studies
with dierent clustering designs. The `within-cluster concordance measure' QW is the
simple arithmetic mean of the cluster-specic concordance measure QW;j and hence
may be aected by the precision of the cluster-specic estimates of the measure.
This research proposes two approaches to calculate validation measures in the clus-
tered data setting, which results in an `overall' and a `pooled cluster-specic' measure.
In the `overall' approach, one calculates the validation measure from a comparison of
subjects within and between clusters, and the resulting measure assesses the overall
predictive ability of the model. For example, the `overall C-index' for clustered data
can be calculated by comparing all possible pairs of subjects in the data, where subjects
in a pair may come from the same cluster or from dierent clusters. Using the above
notation, the `overall C-index', CO, can be written as:
CO =
NB;conc + NW;conc
NT;usbl
: (4.12)
CO has the same interpretation as the `overall weighted measure' of Oirbeek and Lesare
QO in that it assesses the overall discriminatory ability of the model. In the rest of
the chapter, the notation CO will be replaced by Cre(u), Cre(0), and Cpa based on the
model predictions ij(u), ij(0), and (pa), respectively.
In the `pooled cluster-specic' approach, one calculates the validation measure for
each cluster based on its original denition for standard logistic model along with a
measure of precision. These measures are then pooled across clusters using the random-
eects summary statistic method often used in meta analysis [113] (for more details, see
Section 4.3.5). This approach yields a weighted average of the cluster-specic values,
referred to as a `pooled estimate'. The `pooled cluster-specic' measure assesses the
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predictive ability of the predictors whose values vary within clusters. For example, a
`pooled estimate' of the cluster-specic C-indices of 0.75 can be interpreted as that the
ability of the model to discriminate between low-and high risk subjects is reasonable,
given that the subject-pairs are drawn from the same cluster. This `pooled' measure
is similar to the `within cluster measure' of Oirbeek and Lesare. However, unlike
Oirbeek and Lesare's approach, this approach provides a weighted estimate, weighted
by the precision of the cluster-specic estimates of the validation measure. Therefore,
the `pooled estimate' of the cluster-specic measures is less aected by clusters which
produce extreme estimates.
The calculations of the validation measures for each of these approaches are dis-
cussed in the following sections.
4.3.4 Estimation: Overall measure
4.3.4.1 The C-index for clustered data: denition
Based on the model's three dierent approaches to prediction, three dierent denitions
of the C-index can be obtained as follows. For a pair of subjects (i;k) from clusters (j;l)
respectively, where i and k correspond to subject who had an event and those who did
not respectively, with event probability fij(u);kl(u)g, the concordance probability or
C-index for the random-intercept logistic model can be dened as
Cre(u) = Pr[ij(u) > kl(u)] , Pr[ij(u) > kl(u)]:
This applies to all possible pairs (i;k) in the data, where a pair may consist of subjects
from the same cluster or from dierent clusters. If subjects are from dierent clusters,
the cluster-specic random eect u values contribute in determining whether a pair is
concordant and in Cre(u), even if both subjects have the same predictor values. The
random eects u however do not contribute in determining a concordant pair if both
subjects are from the same cluster, as they share the same value of the random eect.
Based on the conditional event probabilities fij(0);kl(0)g (where the random
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eects u are set to zero), the above probability become
Cre(0) = Pr[ij(0) > kl(0)] , Pr[ij(0) > kl(0)]:
Similarly, based on population average probabilities fij(pa);kl(pa)g, the C-index can
be dened as
Cpa = Pr[ij(pa) > kl(pa)] , Pr[ij(pa) > kl(pa)]:
Note that ij(pa) is simply a transformed or re-scaled value of ij(0), re-scaled by
integrating out the random eect u in ij(u) to obtain population-averaged probability.
This has a one-to-one relationship with ij(0), and hence the rank orders based on both
ij(pa) and ij(0) will be identical. Therefore, Cpa is equal to Cre(0).
4.3.4.2 Nonparametric estimation of the C-index
Let 
(1)
ij (u) = ij(u)jYij = 1 be the prognostic index for the ith subject with an event
in the jth cluster, derived from ij(u). Similarly, let 
(0)
kj (u) = kj(u)jYkj = 0 be the
prognostic index for the kth subject without an event in the jth cluster. Let n1j and
n0j be the number of subjects with an event and without an event respectively in the
jth cluster. The total number of subjects with an event is N1 =
P
j n1j, and the total
number of subjects without an event is N0 =
P
j n0j. Further, let J1 and J0 be the
total number of clusters with at least one subject with an event and one without an
event, respectively. Note that J  (J1 + J0)  2J.
Extending equation (4.1), the non-parametric C-index for clustered binary outcomes
can be dened as
C
np
re(u) =
1
N1N0
J X
j=1
J X
l=1
nj X
i=1
nl X
k=1
I


(1)
ij (u);
(0)
kl (u)

; (4.13)
where I(:) can be dened similarly as in Section 4.2.3. C
np
re(u) is analogous to the U
statistic derived by Obuchowski [114] for clustered data. The use of the U statistic
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in the context of clustered data has been further discussed in other studies; see, for
example, Rosner and Grove [115], Lee and Rosner [116], and Lee and Dehling [117].
The C-index based on ij(0) and ij(pa) can be obtained using the same approach
to that described in equation (4.13) but by replacing 
(1)
ij (u) and 
(0)
kl (u) by the corre-
sponding prognostic indices derived from ij(0) and ij(pa). The resulting C-indices
are denoted by C
np
re(0) and C
np
pa, respectively. Since the rank orders based on ij(pa)
and ij(0) are identical, C
np
pa = C
np
re(0).
The indices C
np
re(u) and C
np
re(0) are referred to as `conditional indices', conditioned
on the random eect u, and assess the predictive ability of predictor eects  and the
random eects u, although C
np
re(0) is based on the mean value of the random eects at
zero. The C
np
pa does not include the contribution of the random eects u, assesses the
predictive ability of the predictor eects  only, and has a marginal interpretation.
Note that C
np
re(u) > C
np
pa if clustering exists in the data. If there is no clustering,
C
np
re(u) = C
np
pa. This relationship is analogous to those derived by Oirbeek and Lesare
[112] for a concordance measure for clustered survival data. The relationship could be
explained using the following arguments. Let us consider a model with p predictors,
where its discriminatory ability is quantied by C
np
pa. Let this model be extended by
adding at least one predictor (hence p+1 predictors altogether in the new model) and
the discriminatory ability of the extended model is quantied by C
np
re(u). For example,
if there is p xed predictors in the model and an additional predictor represents the
the eect of clustering then C
np
re(u) is based on a model of p + 1 predictors. If the
additional predictor (that is, clustering) adds discriminative ability, then C
np
re(u) based
on the p+1 predictor model is greater than C
np
pa obtained from the p predictor model.
If the additional predictor has no discriminative ability, both indices will be equal. In
the random-intercept logistic model, the random eects u estimate the clustering eect,
that is, the eect of unmeasured cluster level predictors that have not been included in
the model. C
np
re(u) is the result of combining both the random eects u and the predictor
eects , whereas C
np
pa is the result of the predictor eects  only. This implies that
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C
np
re(u) is expected to be greater than or equal to C
np
pa, depending on whether clustering
exists or not. Similarly, C
np
re(u) > C
np
re(0) as C
np
pa = C
np
re(0).
Condence interval for C
np
re(u)
Several approaches have been proposed to estimate the variance of the area under
ROC curve in the absence of clustering [45, 118, 119]. However, Rockette et al. [120]
showed that all these approaches are approximately equivalent when sample size is
large. Obuchowski [114] extended the method of DeLong et al. [118] for use with
clustered data, following the concept of the design eect and eective sample size for
the clustered design proposed by Rao and Scott [121]. In this research, the method of
Obuchowski [114] is adapted to derive the variance expression for C
np
re(u).
Let us dene following two components as
V1[
(1)
ij (u)] =
1
N0
J0 X
l=1
nl X
k=1
I


(1)
ij (u);
(0)
kl (u)

(4.14)
for all 
(1)
ij (u), and
V0[
(0)
kl (u)] =
1
N1
J1 X
j=1
nj X
i=1
I


(1)
ij (u);
(0)
kl (u)

(4.15)
for all 
(0)
kl (u), where V1[
(1)
ij (u)] is the proportion of subjects without an event who had
prognostic index smaller than that of each subject with an event, and V0[
(0)
kl (u)] is the
proportion of subjects with an event who had prognostic indices larger than that of
each subject without an event. It is obvious that
PJ1
j=1
Pnj
i=1 V1[
(1)
ij (u)]=N1 = C
np
re(u)
and similarly,
PJ0
l=1
Pnl
k=1 V0[
(0)
kl (u)]=N0 = C
np
re(u).
Following Obuchowski [114] and Rao and Scott [121], the sum of squares of the
proportions dened in equations (4.14)-(4.15) are computed as follows. Let V1[
(1)
:j (u)]
and V0[
(0)
:j (u)] be the sums of the components dened in (4.14) and (4.15), respectively.
Note that V1[
(1)
:j (u)] is equal to zero if n1j = 0, and similarly, V0[
(0)
:j (u)] is equal to
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zero if n0j = 0. Using the notations of Obuchowski [114] and DeLong et al. [118], the
sum of squares of the components in (4.14) and (4.15) can be dened as
S1 =
J1
(J1   1)N1
J1 X
j=1
h
V1[
(1)
:j (u)]   n1j ^ C
np
re(u)
i2
(4.16)
and
S0 =
J0
(J0   1)N0
J0 X
j=1
h
V0[
(0)
:j (u)]   n0j ^ C
np
re(u)
i2
; (4.17)
respectively, where n1j ^ C
np
re(u) and n0j ^ C
np
re(u) are the mean sum of the components dened
in (4.14) and (4.15), respectively. Further, let us dene the following cross-product of
these two components as
S10 =
J
(J   1)
=
J X
j=1
h
V1[
(1)
:j (u)]   n1j ^ C
np
re(u)
	
V0[
(0)
:j (u)]   n0j ^ C
np
re(u)
	i
;
which takes into account the correlation between subjects with an event and those
without an event within the same cluster [114]. Finally, the variance of ^ C
np
re(u) can be
estimated as
c var[ ^ C
np
re(u)] =
1
N1
S1 +
1
N0
S0 +
2
N1N0
S10: (4.18)
As discussed by DeLong et al. [118], it can be shown by the central limit theorem that
  ^ C
np
re(u)   C
np
re(u)

=
q
c var[ ^ C
np
re(u)] is asymptotically N(0;1) if limJ!1 J1=J0 is bounded
and nonzero. The (1   )% condence interval for C
np
re(u) can be obtained as ^ C
np
re(u) 
Z=2
q
c var[ ^ C
np
re(u)], where Z=2 is the =2 percentile of standard normal distribution.
The condence interval for C
np
pa and C
np
re(0) can be obtained using the same approach as
described above.
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4.3.4.3 Parametric estimation of the C-index
Similar to those for the standard logistic model, the parametric C-index for the ran-
dom eects logistic model can be estimated under the assumption of normality of the
prognostic index, ij(u) = Txij + uj, for the population who had experienced the
event and for those who did not.
For the xed eects component of ij(u), let us assume that xijjYij = 1 
N(1;2) and xkljYkl = 0  N(0;2). Since the random eects ujs are assumed
to vary across clusters following a normal distribution with mean zero and variance 2
u,
the outcome prevalence (number of events) is expected to vary across clusters. The
greater the level of clustering greater the variation in the prevalence is expected across
clusters. This could lead to a scenario where some of the clusters may appear with a
prevalence close to 100% while others with a prevalence close to 0%. For simplicity,
let us assume that there is one subject in a cluster. Further consider the notation uij
instead of uj and dene u
(1)
ij and u
(0)
kl as the random eects for the cluster with a subject
who had experienced the event and one who did not, respectively. If one sketches the
distribution of u
(0)
kl and u
(1)
ij , their location parameters are expected to shift to some ex-
tent from zero towards  1 and +1 respectively, depending on the level of clustering.
Based on this premise, assume that u
(1)
ij  N(1;2
u) and u
(0)
kl  N(0;2
u).
Therefore,

(1)
ij (u)jYij = 1  N(1 + 1;2 + 2
u)
and

(0)
kl (u)jYkl = 0  N(0 + 0;2 + 2
u).
The C-index based on ij(u) can be dened as
C
p
re(u) = Pr[
(1)
ij (u) > 
(0)
kl (u)]
= Pr[(
(1)
ij (u)   
(0)
kl (u)) > 0]: (4.19)
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After standardising the term 
(1)
ij (u)   
(0)
kl (u), C
p
re(u) can be obtained as
C
p
re(u) = Pr
h
Z <
(1 + 1)   (0 + 0)
p
22 + 22
u
i
; Z  N(0;1)
= 
 
(1   0) + (1   0)
p
22 + 22
u
!
;
where  denotes the standard normal cumulative distribution function. Replacing the
parameters (1;0;1;0;2;2
u) by the corresponding sample estimates ( x1;  x0;  u1;  u0;S2; ^ 2
u),
C
p
re(u) can be estimated as
^ C
p
re(u) = 
 
 x1    x0 +  u1    u0 p
2S2 + 2^ 2
u
!
; (4.20)
The indices C
p
re(0) and C
p
pa for ij(0) and ij(pa) respectively can be derived using
a similar approach to that discussed above, but replacing ij(u) by the corresponding
prognostic indices ij(0) and ij(pa). All these versions of parametric C-indices have
the same interpretation to those with the non-parametric indices.
Condence interval for C
p
re(u)
Let us dene ^  =
 x1    x0 +  u1    u0 p
2S2 + 2^ 2
u
so that ^ C
p
re(u) = (^ ). Since  is a monotoni-
cally increasing function of ^ , nding the variance for ^ C
p
re(u) using the Delta method
[122, 123] is equivalent to nding one for ^  [124].
According to the properties of normal distribution,  x1,  x0,  u1, and  u0 are indepen-
dent normal random variables with means and variances 1 and 2=N, 0 and 2=N,
1 and 2
u=J, and 0 and 2
u=J, respectively. Therefore,
^  = ( x1    x0) + ( u1    u0)  N

1   0 + 1   0;
22
N
+
22
u
J

; (4.21)
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and
(N   1)S2
2  2
N 1 and
(J   1)^ 2
u
2
u
 2
J 1 (4.22)
are mutually independent. Let ^ 2
p = 2S2 + 2^ 2
u so that ^  =
^ 
^ p
. Assuming ^ 2
p and ^  to
be independent, the Delta method yields the following approximate variance expression
for ^ :
var(^ ) 
 
@^ 
@^ 
!2
var(^ ) +
 
@^ 
@^ p
!2
var(^ p) =
1
^ 2
p
var(^ ) +
^ 2
^ 4
p
var(^ p): (4.23)
Var(^ ) is given in equation (4.21), whereas the Delta method is applied again to obtain
var(^ p) as:
var(^ p) = var(^ 2
p)
1
2 
 
@(^ 2
p)
1
2
@^ 2
p
!2
var(^ 2
p) =
1
4^ 2
p
var(^ 2
p)
=
1
4^ 2
p
h
4var(S2) + 4var(^ 2
u)
i
=
1
4^ 2
p
h8(2)2
N   1
+
8(2
u)2
J   1
i
; [using equation (4.22)]: (4.24)
Using equation (4.21) and (4.24) in equation (4.23) yields,
var(^ ) 
1
^ 2
p
h22
N
+
22
u
J
i
+
^ 2
4(^ 2
p)3
h8(2)2
N   1
+
8(2
u)2
J   1
i
: (4.25)
Substituting the estimates for the unknown parameters in equation (4.25) results in
c var(^ ) 
h2S2
N
+
2^ 2
u
J
i
(2S2 + 2^ 2
u) 1
+
( x1    x0 +  u1    u0)2
4(2S2 + 2^ 2
u)3
h 8S4
N   1
+
8^ 4
u
J   1
i
: (4.26)
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The (1   )% CI for ^ C
p
re(u) is then given by


^   Z=2
q
c var(^ )

; (4.27)
where Z=2 is the =2 percentile of the standard normal distribution. The condence
interval for C
p
re(0) and C
p
pa can be obtained using a similar approach to that discussed
above.
4.3.4.4 D statistic
The D statistic for the random eects logistic model can be obtained by transforming
the prognostic index ^ ij(u) to zij using the same approach as described for the standard
Cox model and then tting a random-intercept logistic model to the validation sample
with zij as the only predictor. The model takes the following form:
logit(Yij = 1juj;zij) = zzij + uj; (4.28)
where ^ Dre(u) is equal to the coecient of z and the standard error of ^ Dre(u) is equal to
standard error of ^ z. It is also equivalent to obtain ^ Dre(u) by tting a standard logistic
model with zij as the only predictor, because the random eects are already included
in zij.
For ij(0) and ij(pa), ^ Dre(0) and ^ Dpa respectively can be obtained in a similar
manner to that described above by transforming the corresponding prognostic index to
zij. All these versions of D statistic have the same interpretation to those for C-index.
4.3.4.5 Calibration slope
The calibration slope (CS) for clustered binary outcomes can be obtained using the
same way to the standard logistic model but by tting a random-intercept logistic
model with the prognostic index ^ ij(u), derived from ij(u), as the only predictor. The
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resulting model takes the following form:
logit(Yij = 1juj; ^ ij(u)) = u^ ij(u) + uj: (4.29)
The estimated calibration slope, d CSre(u), is equal to the estimate of u. Similar to
^ Dre(u), one can also obtain d CSre(u) by tting a standard logistic model.
The calibration slope d CSre(0) and d CSpa based on ij(0) and ij(pa) respectively
can be obtained using the same approach to that discussed above but by replacing
^ ij(u) by the corresponding prognostic indices. All these versions of calibration slope
have the same interpretation to the standard calibration slope, based on the reference
value of one (see, Section 4.2.7).
4.3.4.6 Brier score
The Brier score (BS) for the random-intercept logistic model can be obtained by averag-
ing the squared dierences between the predicted probabilities ij(u) and the observed
outcomes y. Extending equation (4.7), the Brier score for ij(u) can be obtained as
BSre(u) =
1
N
J X
j=1
nj X
i=1

yij   ^ ij(u)
2
: (4.30)
Similarly, for ij(0) and ij(pa), the Brier score can be obtained by replacing ^ ij(u)
by their corresponding predicted probabilities ^ ij(0) and ^ ij(pa), respectively. The
resulting Brier scores are denoted by BSre(0) and BSpa, respectively. Unlike the same
versions of the rank-based validation measures, BSre(0) 6= BSpa as (0) 6= (pa).
In addition, it can be shown that BSre(u)  BSpa using the same explanation as
discussed for showing that C
np
re(u)  C
np
pa, keeping in mind that the Brier score has an
inverse relationship with the C-index. For example, the Brier score for a model with
p predictors can decrease to some extent towards its minimum value of zero with the
inclusion of a predictor that adds predictive strength in the model, whereas the C-index
can increase to some extent towards it maximum value of one due to a similar inclusion.
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4.3.5 Estimation: Pooled cluster-specic measure
The `pooled cluster-specic' measure involves estimation of validation measures for
each cluster and then pooling of these across clusters to obtain a weighted average.
The weights can be calculated based on the inverse of both the within cluster-and
between-cluster variances of the cluster-specic validation measures. The within clus-
ter variance is simply the estimated variance of the cluster-specic estimates of the
validation measures. For the between cluster variance, several estimation techniques
have been proposed in the literature of meta-analysis including the method of moments
[113] and maximum likelihood [125, 126]. In this thesis, the method of moment has been
used to estimate the between cluster variance, because of its simplicity. The estimated
between cluster variance is incorporated in the calculation of the pooled estimate of the
cluster-specic validation measures to take into account for the heterogeneity between
the clusters. This approach is commonly used in meta analysis to combine the results
of several studies. The detailed calculation of the pooled estimate of the cluster-specic
validation measures is described as follow.
Let ^ j (j = 1;:::;J) be the estimate of a validation measure for the jth cluster, and
^ 2
j be the corresponding estimated variance. The weighted average (pooled estimate)
of the cluster specic estimates can be calculated as
^ w =  w 1
J X
j=1
^ j ^ wj; (4.31)
where ^ wj = 1=(^ 2
j + ^ 2),  w =
PJ
j=1 ^ wj, and ^ 2 is the estimate of the between cluster
variance and can be obtained as
^ 2 = max
(
0;
hPJ
j=1 ^ aj(^ j    )2
i
  (J   1)
PJ
j=1 ^ aj  
PJ
j=1 ^ a2
j=
PJ
j=1 ^ aj
)
;
where ^ aj = 1=^ 2
j and   =
PJ
j=1 ^ aj^ j=
PJ
j=1 ^ aj.
Assuming that the clusters are suciently large and there is at least a moderate
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number of clusters, condence intervals can be obtained by using the following approx-
imation:
^ w  N

w;1=
PJ
j=1 wj

.
The 100(1   )% condence intervals for w can be obtained as
^ w  Z=2
 J X
j=1
^ wj
 1=2
; (4.32)
where Z=2 is the =2 percentile of the standard normal distribution.
Using the above approach, the `pooled estimate' of each of the validation measures
can be obtained. Similar to the `overall measure', three dierent denitions for each of
the `pooled cluster-specic' measures can be obtained based on the model predictions
ij(u), ij(0), and ij(pa). The resulting nonparametric C-indices, for example, are de-
noted by C
np
w;re(u), C
np
w;re(0), and C
np
w;pa, respectively. However, C
np
w;re(u)=C
np
w;re(0)=C
np
w;pa=C
np
w
(say). This is because the C-index is a rank-based statistic, and that the rank orders
between the subjects within a cluster for these three types of prediction are identical as
subjects from the same cluster share the same random eect u. This argument holds
for the parametric C-index and also for any other rank-based statistic, for example,
the D statistic. The resulting parametric C-index and D statistic are denoted by C
p
w
and Dw, respectively.
Although the calibration slope is not a rank-based statistic, the `pooled estimate'
of the cluster-specic calibration slopes for all the three approaches to prediction are
also equal. The reason is as follows. Among these approaches, only ij(u) uses the
random eect u values. When calculating the calibration slope for a cluster j by tting
a standard logistic model, ^ uj for that cluster is treated as a constant as all subjects
in a cluster have the same ^ uj. Therefore, the slope (calibration slope) of that logistic
model is not aected by ^ uj, except for the intercept which is essentially equal to ^ uj.
Therefore, the `pooled cluster-specic' calibration slope, say CSw, for ij(u) is equal
to those for ij(0) and ij(pa).
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Similarly, the `pooled estimate' of the cluster-specic Brier score can be obtained
for each of these predictions ij(u), ij(0), and ij(pa). The resulting measures are
denoted by BSw;re(u), BSw;re(0), and BSw;pa, respectively. Unlike the other measures,
these are not equal. This is because the Brier score quanties the accuracy of individual
predictions, but the predictions from these three approaches are not equal. However,
these three `pooled' Brier scores have their own interpretation based on ij(u), ij(0),
and ij(pa). Note that the analytical expression for the variance of the Brier score is
not available, and therefore bootstrap-based standard errors can be used to obtain the
`pooled estimate' of the cluster-specic Brier score.
4.4 Application to clustered binary data
In this section, an application of the above methods is illustrated using a real dataset
of patients undergoing heart valve surgery at dierent hospitals in the UK. The section
starts with a description of the data, which is followed by the analysis and results.
4.4.1 Heart valve surgery data
This dataset was based on patients who underwent aortic and/or mitral heart valve
surgery at 30 dierent hospitals in the UK. The clinical outcome of interest was in-
hospital mortality (alive/dead). The dataset consists of 32,839 patients, with a total
of 2,089 (6.3 percent) in-hospital deaths. The predictors of interest were age, gender,
body mass index (BMI), hypertension (no/yes), diabetes (no/yes), renal failure (none
or functioning transplant/ creatinine > 200 moL/ dialysis dependency), concomitant
CABG surgery (no/yes), concomitant tricuspid surgery (no/yes), preoperative arrhyth-
mias (no/atrial brillation or heart block/ventricular tachycardia or brillation), ejec-
tion fraction (<30%/30%-50%/>50%), operative priority (elective/urgent/emergency),
operation sequence (previous sternotomy; rst/second/third or more), and the year of
surgery. The median cluster size was 1517 with an interquartile range (IQR): 1168
to 2098. The intra-cluster correlation (ICC) calculated using the method of analysis
of variance (ANOVA) [127, 128] was 0.06. The risk model based on this dataset has
already been developed by Ambler et al. [1]. The main focus here is to illustrate the
validation measures for clustered binary data.
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4.4.2 Analysis and results
4.4.2.1 Model development
The dataset was split into two parts: one part was used to develop the model and the
other to validate the model. The development data included all patients who underwent
surgery during the rst ve years, and a temporal validation was conducted by including
patients who underwent surgery in the subsequent three years. In this validation exer-
cise, both the development and validation datasets consisted of the same hospitals but
dierent patients. A prognostic model was developed based on the random-intercept
logistic regression model with normally distributed random eects and all available
predictors. Maximum likelihood estimation of the model parameters was performed
using adaptive Gaussian quadrature [97, 99] with 20 quadrature points per level. The
gllamm package in Stata version 11 [129] was used to t the model. Inspection of the
residual plots suggested that the assumption of normality regarding the random eects
was reasonably satised.
The estimated model parameters are not reported here, except for the variance
parameter of the random eects, 2
u, which was estimated as 0.18. This corresponds to
an ICC = 2
u=(2
u + 2=3) = 0:05, indicating weak correlation between patients within
a hospital, after accounting for the xed predictors.
4.4.2.2 Model validation
The model was used to predict the probability of in-hospital mortality using three
dierent approaches ij(u), ij(0), and ij(pa) in the validation data. These predicted
probabilities are plotted in Figure 4.1 to observe the spread in predictions and to
see whether there are any dierences between them. All three approaches showed
reasonable spread in predictions, with relatively high proportion of patients predicted to
have a low risk of in-hospital mortality and low proportion of patients predicted as high
risk. This reects the observed risk, that is, about 6 percent of patients had experienced
in-hospital mortality following a heart valve surgery. The spread in predictions for all
the three approaches were similar; however, slightly a greater spread was observed for
predictions based on ij(u).
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Figure 4.1: Distribution of the predicted probability, Pr(Y = 1), by types of prediction
such as ij(u), ij(0), and ij(pa).
The predictive performance of the model in the validation data was evaluated by
using the validation measures described in Section 4.3. To calculate the validation
measures, the prognostic index ij(u), ij(0), and ij(pa) based on the model's three
dierent approaches to prediction were derived in the validation data. Some of the
validation measures, for example, the D statistic and the parametric C-index are based
on the assumption of normality of the prognostic index (PI). Therefore, the distributions
of the predicted PI for the patients who survived and those who died are presented
graphically in Figure 4.2, by types of prediction. It appears that the distributions of
the PI for the two groups of patients are approximately normal, which holds for all
types of prediction. Furthermore, there is a reasonable discrimination (or separation)
between these two groups of patients. The discriminatory ability for ij(u) appeared to
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Figure 4.2: Distribution of the predicted prognostic index (PI) or log odds for the popu-
lation who survived and those who died by types of prediction: (a) ij(0), (b) ij(u), and
(c) ij(pa).
be approximately equal to those for ij(0) and ij(pa). This is because the clustering
eect in these data is not strong.
Calculation of the validation measures was performed using user written Stata code
(Appendix B: Figure B.2), and the results are presented in Table 4.1. The `overall
estimates' for all types of non-parametric C-index C
np
re(u), C
np
re(0), and C
np
pa suggest rea-
sonably good discrimination between the high and low risk patients. The point estimate
C
np
re(u) was slightly greater than that of C
np
re(0) and C
np
pa, although the 95% CIs of the
indices overlap each other. This is because the eect of clustering in these data was
weak. In addition, the estimates of C
np
pa and C
np
re(0) were equal, indicating identical
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discrimination for both ^ ij(0) and ^ ij(pa). Similar ndings were observed for the D
statistics and the parametric C-indices. The non-parametric C-index was also calcu-
lated based on Oirbeek and Lesare's QO approach. The estimate was 0.784, which is
very close to that obtained for the analogous version C
np
re(u).
Table 4.1: Estimates of the validation measures for the model predicting in-hospital
mortality following heart valve surgery in the validation sample.
Overall Measures
Standard measures Adapted measures Estimates 95% CIs
C
np
re(u) 0.785 [0.776, 0.793]
Non Parametric C-index C
np
re(0) 0.774 [0.759, 0.789]
C
np
pa 0.774 [0.759, 0.789]
C
p
re(u) 0.785 [0.775, 0.794]
Parametric C-index C
p
re(0) 0.775 [0.758, 0.790]
C
p
pa 0.775 [0.758, 0.790]
Dre(u) 1.85 [1.78, 1.92]
D statistic Dre(0) 1.76 [1.63, 1.87]
Dpa 1.76 [1.63, 1.87]
CSre(u) 1.01 [0.94, 1.08]
Calibration slope CSre(0) 0.98 [0.91, 1.06]
CSpa 0.99 [0.93, 1.07]
BSre(u) 0.049 -
Brier score BSre(0) 0.052 -
BSpa 0.051 -
Pooled Measures
Non-parametric C-index C
np
w 0.775 [0.757, 0.791]
Parametric C-index C
p
w 0.774 [0.756, 0.790]
D statistic Dw 1.77 [1.63, 1.89]
Calibration slope CSw 0.99 [0.92, 1.07]
BSw;re(u) 0.051 [0.046, 0.056]
Brier score BSw;re(0) 0.053 [0.047, 0.059]
BSw;pa 0.052 [0.046, 0.058]
The `overall' calibration slope CSre(u) was estimated to be 1.01 (95% CI : 0.94 to
1.08), which suggests that overall calibration for ^ ij(u) was reasonably good. Similar
results were observed for ^ ij(0) and ^ ij(pa). The estimates of BSre(u), BSre(0), and
BSpa suggest that all the approaches showed reasonably good accuracy in predicting
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in-hospital mortality. The estimate of BSre(u) for ^ ij(u) was slightly smaller than those
for ^ ij(pa) and ^ ij(0), again suggesting weak clustering in these data.
The `pooled estimates' of the cluster-specic measures are also presented in Table
4.2. The estimates of both the parametric and non-parametric C-indices ^ C
np
w and ^ C
p
w
suggest that the model has reasonable ability to discriminate between patients who died
in the hospital and those who survived, given that both patients in the pair considered
in the calculation belong to the same hospital. A similar result was observed for Dw.
The non-parametric C-index based on Oirbeek and Lesare's QW approach was 0.773,
which is similar to ^ C
np
w . The `pooled' calibration slope CSw was estimated to be 0.99
(95% CI: 0.92 to 1.07), which indicates that the model has good calibration when
predicting within a cluster. The `pooled estimates' of the Brier scores suggest that the
prediction error of ^ ij(u), ^ ij(0), and ^ ij(pa) were reasonably low. As with the `overall
estimates', the `pooled estimate' of the cluster-specic Brier score based on ^ ij(u) is
slightly smaller than those based on ^ ij(0) and ^ ij(pa).
The `pooled cluster-specic' approach based on the random eects summary statis-
tic method provided the method-of-moments estimates of the between-cluster variances
of the cluster-specic measures, 2, as 0.003, 0.036, 0.001, 0.001 for C
np
w , Dw, CSw, and
BSw, respectively. To examine whether the method-of-moments provided comparable
results with other available methods, 2 was also estimated using the method of max-
imum likelihood (ML) and restricted maximum likelihood (REML). Both approaches
showed results similar to that obtained from the method-of-moments. Furthermore, the
random eects summary statistic method is usually preferred to a xed eect method
as it may be considered to encompass the xed eects method when 2 zero.
The cluster (hospitals)-specic estimates (with their 95% CIs) of the validation
measures are plotted in Figure 4.3. Each of the four plots shows the rank order of
the hospitals based on the hospital-specic estimates of the validation measures. The
horizontal solid line based on the `pooled estimate' represents the average performance
of the model within a hospital. The plots show the results of 25 hospitals, because
the model could not be applied to 5 of the hospitals as they did not contribute to
834.4 Application to clustered binary data
Figure 4.3: Cluster (hospital)-specic estimates against their rank order: the C-index
(non-parametric), D statistic, calibration slope, and Brier score. Each horizontal solid line
indicates the `pooled estimate' of the respective measures.
the validation data due to lack of events. This type of plot may be used to make a
comparison between hospitals and to identify hospitals where model performance is
good or poor, relative to the averaged performance. This type of comparison may also
shed some light on monitoring hospital performances. One could also compare the
observed and predicted deaths to evaluate hospital performance [130].
It can be seen in Figure 4.3 that the predictive ability of the model for some of
the hospitals were signicantly worse (better) than the pooled averaged as the points
estimates of the validation measures, except the calibration slope, for these hospitals
were smaller (greater) than the `pooled estimate' and the 95% CIs did not include the
average value. The point estimates of the calibration slope for some of the hospitals
somewhat dierent from 1 and 95% CI did not include this value, which indicates
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poor calibration of the model for these hospitals. The heterogeneity in the model
performance between hospitals may be caused by the unobserved patient or hospital
level characteristics. This may also suggest a mis-specication of the model for these
hospitals. Therefore, it would be important to investigate the factors which explain
this heterogeneity.
One issue that may be raised before making a comparison between hospitals based
on the hospital-specic estimates of the validation measures is to examine whether
these estimates are associated with the hospital sizes or hospital-specic prevalence
(mortality rate). It appears in Figure 4.3 that the estimates of the validation measures
for some of the hospitals with narrow CIs, which indicate some of the larger hospitals or
hospitals with higher prevalence, are still below the averaged line (horizontal solid line).
Furthermore, a scatter plot between the hospital-specic estimates of the validation
measures and the prevalence did not suggest an association between these two (results
not shown).
In summary, this illustration has showed that the `overall' and `pooled' estimates of
the validation measures have meaningful interpretations when assessing the predictive
ability of a model for clustered binary outcomes. In the next section, performance of
these validation measures for clustered data are evaluated using simulation studies.
4.5 Simulation study
In this section, the properties of both the point estimates and condence intervals of
the validation measures such as bias, root Mean Squared Error (rMSE), and coverage
were investigated by simulation studies. Both development and validation data were
simulated from a true model. Prognostic models were developed using the simulated de-
velopment data and then evaluated using the corresponding simulated validation data.
The properties of the validation measures were investigated in a range of scenarios, cre-
ated by varying the number of clusters and their size and the intra-cluster correlation
coecient (ICC) between subjects within the same cluster in the validation data, to see
how these measures perform across these scenarios. The aim was to identify scenarios
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where the validation measures did not perform adequately, for example, whether the
validation measures were aected by number of clusters, cluster size, and the level of
clustering. The section begins by describing the simulation design and is followed by
describing the strategies for evaluating the measures and the results.
4.5.1 Simulation design
4.5.1.1 True model
Clustered binary data were generated from a true model based on the random-intercept
logistic model with normally distributed random eects and one xed predictor that
has a xed eect. One of the aims was to generate data under dierent values of ICC,
to mimic scenarios with no, moderate, and high levels of clustering. Accordingly the
subject level variability (represented by the xed predictor) was varied and the total
predictive variability that combines the xed and random eects to represent both
the subject and cluster level characteristics has been xed to a specic value over the
dierent ICC scenarios. For a sample of size N with J clusters, the predictor value
xij for the ith subject in the jth cluster (i = 1;:::;nj;j = 1;:::;J) was generated
from N(0;1), and the true random eects uj were from N(0;2
u). Then the outcomes
yij were generated from the Bernuolli distribution with probability calculated from the
true random-intercept logistic model using
(0;1jxij;uj) =
exp[(0;1;xij;uj)]
1 + exp[(0;1;xij;uj)]
: (4.33)
where (0;1;xij;uj) = 0 +1xij +uj is the true prognostic index with intercept 0
and slope 1. As X  N(0;1), 1X  N(0;2
1), and therefore (0;1;xij;uj) follows
N(0;2
1 +2
u), assuming one subject per cluster. Note that 2
1 +2
u represent the total
predictive variability in the log-odds of having the event, which can be decomposed into
subject level variability (2
1) and cluster level variability (2
u). Then the intra-cluster
correlation (ICC) between subjects within a cluster can be specied as 2
u=(2
1 + 2
u),
where relatively high values of 2
u indicate high ICC.
To simulate data under dierent ICC scenarios, the values of 2
u were varied keeping
864.5 Simulation study
the total predictive variability xed to 1:42, and 1 was determined from 2
1+2
u = 1:42.
The choice of the value of the total predictive ability is arbitrary, but the aim was to
assess the performance of the validation measures for a model with reasonably strong
predictive ability. In addition, 0 was set to a xed value of -1.8 to generate data with
a prevalence of approximately 20% for each of the ICC scenarios.
4.5.1.2 Simulation scenarios
A total of four ICC values such as 0%, 5%, 10%, and 20% were considered, to mimic
scenario with low, medium, and high level of clustering. Under each ICC value, develop-
ment datasets each with 100 clusters of size 100 were generated. For each development
set, validation datasets from several scenarios were generated, to represent scenarios
with small number of large clusters and large number of small clusters. The validation
scenarios considered were (i) 10 clusters of sizes 10 and 300, and (ii) 100 clusters of
sizes 10, 30, and 100. For each of the four ICC values, there are one development and
ve validation scenarios, and in total four development and twenty validation scenar-
ios. For each of the development and validation scenarios, 500 datasets were generated.
This specication (500 replications) was determined following Burton et al. [78] and
provided very low Monte Carlo standard error for the validation measures for clustered
binary outcome. The level of clustering in the development and validation data were
kept equal, generating both data from the same ICC value. This would represent a
scenario where subjects in development and validation data are sampled from the same
population of clusters, where the level of clustering in both datasets are equal.
4.5.2 Strategies for evaluating the measures
4.5.2.1 Model tting and calculation of the measures
A random-intercept logistic model with normally distributed random eects was t-
ted to each of the development datasets. Maximum likelihood estimation based on
adaptive Gaussian quadrature [97, 99] was employed to obtain the estimates of the
model parameters, (^ 0; ^ 1; ^ 2
u). The gllamm package in Stata version 11 [129] was used
to obtain these estimates. To calculate the validation measures, the estimated event
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probabilities based on ij(u), ij(0), and ij(pa) and the associated predicted prog-
nostic indices ij(u), ij(0), and ij(pa) were obtained in the corresponding simulated
validation datasets by plugging in the estimates of the model parameters from the
development data. The gllapred package was used to obtain these predictions.
To make predictions based on ij(u), the random eects u were estimated from the
validation data. The gllapred package calculates the empirical Bayes estimates of the
random eects in the validation data using equation (4.9), without tting a model, but
using the estimates (^ 0; ^ 1; ^ 2
u) from the development data. This can be considered as
a re-calibration of the model based on the random eects. Finally the point estimates
and condence intervals of the validation measures were calculated using user written
Stata code (Appendix B: Figure B.2).
4.5.2.2 Assessing the properties
The eects of the ICC, the number of clusters and their size on the validation measures
were investigated through simulation by estimating the empirical bias and rMSE of the
point estimates and coverage of the nominal 90% condence intervals. The true values
of the `overall' and `pooled' validation measures were obtained empirically by averaging
the estimates of the measures over 100 very large simulated datasets (N=300,000 with
clusters J=1000). The `overall' validation measures were calculated using the true
values of the regression parameters and the random eects. The rank-based `pooled'
measures (Cw and Dw) and the calibration slope (CSw) were calculated using the true
values of the regression parameters only as the random eects do not contribute to the
calculation of these measures (for more details see Section 4.3.5). However, the true
value of the `pooled' Brier score was calculated using the true value of the regression
parameters and the random eects.
Bias in the estimate of the validation measure was calculated as the mean of the
dierences between the true and estimated values for each validation measure, over 500
simulations. The rMSE was calculated as the square root of the mean of the squared
dierences between the true and estimated values for each validation measure. Coverage
was calculated as the percentage of simulations where the estimated condence interval
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contained the true value of the validation measure. Coverage was calculated for both
analytical and bootstrap based condence intervals for each validation measure. In the
bootstrapping approach, 200 bootstrap samples were used, where the sample drawn
during each replication was a bootstrap sample of subjects within each cluster.
The validation measures have dierent scales and hence their bias and rMSE are
not directly comparable. Therefore, the bias was rescaled to a percentage in a similar
manner to that discussed in Chapter 3. Similarly, the rMSE was rescaled to a percentage
as
rMSE =
v u
u t 1
G
G X
g=1
 
^ mg   m
jm   m0j
 100
!2
;
where ^ mg is the estimate for the gth simulation (g = 1;:::;G), m is the true value and
m0 is the null value.
4.5.3 Results
4.5.3.1 The Overall validation measures
The relative bias in the `overall' estimates of the validation measures were plotted
against dierent ICC values, for all the simulation scenarios. Figure 4.4 shows the
results for the validation measures based on the dierent approaches to prediction.
When there was no clustering in the data (ICC=0%), the validation measures in general
showed approximately unbiased estimates for all simulation scenarios, though the D
statistic and calibration slope showed a small amount of bias when both the number
of clusters and their sizes were small. In the presence of clustering (ICC > 0%), the
validation measures C
np
re(u), Dre(u), CSre(u), and BSre(u) showed approximately unbiased
estimates when the clusters were large. However, they showed bias for the small clusters.
The bias associated with C
np
re(u), Dre(u), and CSre(u) increased with increasing ICC while
for BSre(u), it decreased. The results for the parametric C-index were similar to those
for the non-parametric C-index (not shown). Since both these C-indices had similar
results for all the stimulation scenarios, no results for the parametric C-index will be
shown in the rest of the chapter.
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Figure 4.4: Relative bias (%) in the `overall' estimates of the validation measures for dierent ICC values. The results are from
the dierent simulation scenarios based on the number of clusters and their size (clusterssize). Each column represents plots of
bias for the dierent estimates of a validation measure based on the model prediction ^ ij(u), ^ ij(0), and ^ ij(pa).
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For all simulation scenarios, both C
np
re(0) and C
np
pa showed substantial negative bias
(but of equal amount) in the presence of clustering, and the bias increased with increas-
ing ICC values. Similar results were observed for Dre(0) and Dpa. Furthermore, for all
simulation scenarios, the bias associated with BSre(0) and BSpa were positively corre-
lated with the ICC values. The calibration slopes CSre(0) and CSpa were not aected
by the level of clustering, but were aected by the number and size of the clusters, for
example, 10 clusters of size 10.
Figure 4.5: Agreement between the estimated (^ u) and the true random eects u in the
validation data. The results are from the dierent simulation scenarios under ICC=20%:
number of clusters (a) 10 of size 10, (b) 10 of size 300, (c) 100 of size 10, and (d) 100 of
size 100. Figure 2b shows nine points, because two points amongst the ten correspond to
the same values and hence represents one point.
The reason for bias in the validation measures based on ^ ij(u) when the clusters
are small is possibly due to the poor estimation of the random eects. To investigate
this, the empirical Bayes estimates of the random eects from the validation data were
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Figure 4.6: Relative bias (%) in the `overall' estimates of the validation measures for
ij(u) when they were calculated using the true values of the random eects u, rather than
the estimates. The results are from the dierent simulation scenarios (clusterssize).
plotted against their true values in Figure 4.5. It appears that the random eects were
poorly estimated especially when the cluster sizes were small and the level of clustering
was high. Figure 4.5 shows that there was poor agreement between the estimated and
the true values of the random eects when the clusters were small (Figure 4.5(a) and
(c)), but there was close agreement when the clusters were large (Figure 4.5(b) and (d)).
The empirical Bayes estimates are conditionally biased, that is, conditional expectation
of random eects given the population value of the random eects E(^ ujjuj;xij^ u) 6= 0,
which pull the empirical Bayes towards 0, the mean of the prior distribution [86]. This
is because the prior dominates the likelihood when cluster sizes are small.
When the empirical Bayes estimates of the random eects were replaced by their
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true values in the calculation of the validation measures while still using the estimates
of the xed predictors, the measures showed a reasonably good performance, even for
the small clusters (Figure 4.6). These results are analogous to those derived by Oirbeek
and Lesare [131]. However, Dre(u) and CSre(u) were slightly biased when the number
and size of the clusters were small, even if clustering did not exist. This implies that
these two measures are aected by small sample size. The validation measures based
on ^ ij(0) and ^ ij(pa), excluding the calibration slope (CS), showed bias in the presence
of clustering. This is because all these measures ignore the actual contribution of the
random eects and therefore underestimate the true value.
The relative rMSE of the `overall' estimates of the validation measures are presented
for dierent ICC values, for the various simulation scenarios in Figure 4.7. Figure 4.7
shows the results for all validation measures based on the model's dierent approaches
to prediction. The validation measures in general had high rMSE for small clusters.
The measures based on ^ ij(u) had low rMSE for all ICC values when the clusters were
large. The validation measures based on ^ ij(0) and ^ ij(pa) had low rMSE when there
was no clustering and the clusters were large. However, the rMSE associated with these
measures, except for the calibration slope, increased with increasing ICC values.
Coverage of nominal 90% condence intervals (CIs) for each of the validation mea-
sures based on both analytical and bootstrap standard errors (SEs) are reported in
Table 4.2. The table shows the results for the validation measures based on ^ ij(u).
Coverage for BSre(u) based on analytical CIs is not reported as it is not available.
The estimated coverage for C
np
re(u), Dre(u), and CSre(u), based on both analytical and
bootstrap CIs, were approximately close to the nominal 90% value when the clusters
were large. When the clusters were small, both the analytical and bootstrap CIs had
poor coverage, because the point estimates of the measures were biased. Similar results
were observed for BSre(u) based on bootstrap based CIs. In general, coverage for all
the simulation scenarios decreased slightly with increasing ICC as their SE decreased.
All the validation measures based on ^ ij(0) and ^ ij(pa) had good coverage when the
clusters were large and there was no clustering, but they had poor coverage when the
level of clustering was high as their point estimates were biased (results not shown).
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Figure 4.7: Relative rMSE (%) of the `overall' estimates of the validation measures for dierent ICC values. The results are from
the dierent simulations scenarios (clusterssize). Each column represents plots of rMSE for dierent estimates of a validation
measure based on ^ ij(u), ^ ij(0), and ^ ij(pa).
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Table 4.2: Coverage (%) of nominal 90% condence intervals (CIs) of the `overall' val-
idation measures. The condence interval are based on both analytical and bootstrap
standard errors. Maximum Monte Carlo Standard Error=2.25%.
Coverage (analytical CIs)
C
np
re(u) Dre(u)
Cluster Size ICC 0% 5% 10% 20% 0% 5% 10% 20%
10 10 91 87 78 77 92 84 81 79
300 90 88 87 85 90 86 83 81
10 89 79 65 58 88 83 72 57
100 30 87 78 68 60 90 72 63 54
100 90 86 85 84 89 83 80 78
CSre(u) BSre(u)
10 10 93 75 86 81 - - - -
300 89 87 88 86 - - - -
10 88 69 49 35 - - - -
100 30 88 56 45 30 - - - -
100 87 83 84 82 - - - -
Coverage (normal-based bootstrap CIs)
C
np
re(u) Dre(u)
10 10 84 85 84 82 93 95 95 87
300 90 89 88 87 90 88 87 86
10 85 84 83 75 86 82 78 70
100 30 86 82 74 66 85 80 73 64
100 89 85 86 84 91 85 84 80
CSre(u) BSre(u)
10 10 93 95 94 97 94 91 88 87
300 88 87 87 86 89 90 88 87
10 88 87 84 82 88 87 84 82
100 30 86 78 72 76 87 87 85 83
100 89 88 88 84 88 89 86 85
The above simulation study was performed using data with equal cluster sizes.
However, most real datasets have clusters of unequal sizes. Therefore, further simula-
tion studies were performed to investigate the performance of the validation measures
in this scenario. Two validation scenarios were considered with 30 clusters of either
median size 50 (IQR: 29 to 90) or 145 (IQR: 54 to 365). The same ICC values were con-
sidered as before. The relative biases of the `overall' validation measures are presented
in Figure 4.8. In general, these results are similar to those obtained for the simulations
based on equal cluster sizes. The results for rMSE and coverage were also similar to
those obtained before (not shown).
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Figure 4.8: Relative bias (%) in the `overall' estimates of the validation measures for dierent ICC values. The results are from
the dierent simulation scenarios based on unequal cluster sizes: 30 clusters with median sizes 50 or 145. Each column represents
plots of bias for the dierent estimates of a validation measure based on the model prediction ^ ij(u), ^ ij(0), and ^ ij(pa).
9
64.5 Simulation study
4.5.3.2 The Pooled cluster-specic validation measures
The bias in the `pooled' estimates of the cluster-specic validation measures were plot-
ted for dierent values of the ICC, for various simulation scenarios in Figure 4.9. The
rank-based measures (Cw, Dw) and the calibration slope (CSw) were unbiased when
clusters were large, but they showed large bias for small clusters. The Brier score
BSw;re(u) based on ij(u) includes the random eects and was therefore aected by
the ICC when the clusters were small, as the random eects were poorly estimated for
these clusters. However, BSw;re(u) was unbiased when the clusters were large. Both
BSw;re(0) and BSw;pa based on ij(0) and ij(pa) respectively also showed bias in the
presence of clustering, even when the clusters were large (results not shown).
Figure 4.9: Relative bias (%) in the `pooled' estimate of the validation measures for dif-
ferent ICC values. The results are from the dierent simulations scenarios (clusterssize).
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Figure 4.10: Relative bias (%) in the `pooled' estimates of the C-index and D statistic
when calculating bias against the `overall' true values. The results are from the dierent
simulations scenarios (clusterssize).
The extent of bias in the `pooled' estimates of the validation measures was also
compared with the `overall' true values, since these values are able to capture the
variability between the clusters (cluster characteristics) in addition to the subject-level
variability (subject characteristics). Only results for the C-index (Cw) and D statistic
(Dw) are presented in Figure 4.10. The measures were approximately unbiased when
the clusters were large and there was no clustering. However, the bias increased with
increasing ICC values, even with the large clusters.
The possible reason for bias in the `pooled' estimates of the cluster specic measures
when the clusters are small is as follows. The prevalence of the outcome was set at 20%
for the simulations. However, the number of events varied between the clusters for high
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values of the ICC. The minimum number of events required per cluster to calculate the
non-parametric C-index and the Brier score is one and is two for the parametric C-
index, D statistic, and calibration slope. When calculating a validation measure based
on small clusters, if the number of events for a cluster was too low, the cluster was
ignored. Thus the calculation of the `pooled estimate' was often based on a reduced
number of clusters, resulting in bias. In Table 4.3, the number of dropped clusters is
reported. This shows that approximately 12-20% of small clusters were dropped as they
did not have at least one event to calculate C
np
w and BSw;re(u), whereas 50-55% clusters
were dropped for the calculation of Dw and CSw. Consequently, for the simulation
scenarios with small clusters, the bias in Dw and CSw was larger than that for C
np
w and
BSw;re(u). However, when the clusters were large, hardly any clusters were dropped,
resulting in unbiased pooled estimates.
Table 4.3: Distribution of the number of clusters dropped when calculating validation
measures within a cluster. The results are presented by the number of events required to
calculate a measure. Each gure is the average over 500 simulations.
Number of events required
One event Two events
Clusters Size ICC 0% 5% 10% 20% 0% 5% 10% 20%
10 10 1.2 1.5 1.6 1.8 4.9 4.9 5.1 5.2
300 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.01
10 12.2 14.5 17.4 20.2 49.3 50.2 51.6 53.5
100 30 0.1 0.4 0.9 1.3 1.9 3.6 6.3 10.1
100 0.0 0.0 0.01 0.11 0.0 0.01 0.08 0.34
The estimated rMSE for the `pooled estimate' of the cluster-specic measures are
presented for dierent ICC values in Figure 4.11. All the `pooled' cluster-specic mea-
sures had very low rMSE when clusters were large, but had high rMSE for small clusters.
The coverage of nominal 90% CIs for the `pooled estimate' of the cluster-specic mea-
sures based on analytical SEs are reported in Table 4.4. For all simulation scenarios
with dierent ICC values, the measures had good coverage when the clusters were
large. However, the coverage was poor when the clusters were small, because the point
estimates of the measures were biased.
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Figure 4.11: Relative rMSE (%) of the `pooled' estimates of the validation mea-
sures for dierent ICC values. The results are from the dierent simulations scenarios
(clusterssize).
The relative biases in the `pooled' estimates of the cluster-specic measures obtained
from the simulations based on unequal cluster sizes are presented in Figure 4.12. These
results are similar to those observed in the simulations that used equal cluster sizes.
The results for rMSE and coverage were also similar to those obtained before (not
shown).
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Table 4.4: Coverage (%) of nominal 90% condence intervals (CIs) for the `pooled' esti-
mates of the cluster-specic measures. The CIs are based on analytical standard errors of
the measure. Maximum Monte Carlo Standard Error = 2.37%.
Coverage (analytical CIs)
C
np
w Dw
Clusters Size ICC 0% 5% 10% 20% 0% 5% 10% 20%
10 10 92 89 88 88 89 86 88 91
300 90 91 90 89 90 91 90 91
10 55 56 58 57 97 91 95 96
100 30 89 90 90 91 55 56 55 59
100 89 90 89 89 84 85 87 88
CSw BSw;re(u)
10 10 90 97 92 91 82 75 71 67
300 87 89 89 88 90 89 88 89
10 97 92 97 87 80 75 70 63
100 30 62 68 67 70 86 85 83 84
100 86 84 85 84 87 88 84 86
Figure 4.12: Relative bias (%) in the `pooled' estimate of the validation measures for
dierent ICC values. The results are from the simulations based on unequal cluster sizes.
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4.6 Conclusion
This chapter has described an adaptation of the C-index, D statistic, calibration slope,
and Brier score for use with models for clustered binary outcomes. Two approaches
are proposed: an `overall' and a `pooled cluster-specic' measures. Each approach
produces three dierent values depending on the model predictions ^ ij(u), ^ ij(0), and
^ ij(pa). The decision regarding which predictions to use should depend on the research
objective.
The new validation measures were illustrated using a dataset of patients who un-
derwent heart valve surgery. The results showed that both the `overall' and `pooled
cluster-specic' validation measures have a meaningful interpretation in a clustered
data setting. The properties of the measures were evaluated by a simulation study in
a range of clustered data scenarios. The simulation results showed that the `overall'
validation measures based on ^ ij(u) showed reasonable performance when there was
clustering in the data and the clusters were reasonably large, possibly due to the fact
that the random eects were better estimated in larger clusters. The empirical Bayes
estimates of the random eects are poorly estimated when the clusters are small, in
other words, do not have sucient number of events [86]. This is because the prior
dominates the likelihood, which pulls the empirical Bayes towards 0, the mean of the
prior distribution. When the empirical Bayes estimates were replaced by the true val-
ues of the random eects while still using the xed predictor eects, the measures
showed good performance even for the small clusters. The `overall' measures based
on ^ ij(0) and ^ ij(pa) performed poorly when there was a moderate level of clustering
in the data, because they ignore the eect of clustering. The `pooled cluster-specic'
measures showed bias when the cluster sizes were small. This is because this approach
ignores information from some of these clusters due to lack of events to calculate the
measures.
In general, both the `overall' and `pooled cluster-specic' measures are recommended
to use to assess the predictive ability of the cluster-data model. However, one needs
to check whether the clusters are suciently large (for example, greater than 30) and
each of these contains at least two events before using the `pooled' measures.
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Similar to the measures for independent survival outcomes, the validation measures
for binary outcome dier in their exibility regarding their assumptions and the form
of the prognostic model. Both the parametric C-index and D statistic assume that
the prognostic index derived from the model is distributed as normal. In contrast,
the non-parametric C-index only requires that the prognostic model is able to rank the
patients. The calibration slope assumes that the model is correctly specied. The Brier
score only requires that a risk algorithm can be calculated for all patients. One needs
to be aware of these before choosing the measures. In practice, the non-parametric
C-index, calibration slope, and Brier score are recommended since they are free from
a distributional assumption of the prognostic index. The parametric C-index and D
statistic can be used only if the prognostic index is normally distributed.
In practice, when validating the model using subjects from the same cluster as
that of the development data, predictions using the estimate of the random eects,
^ ij(u), and the validation measures based on this approach are recommended. This is
because the random eects for the clusters are known and validation measures based
on this approach showed reasonable performance in the simulation study. It would not
be straightforward to use this approach for validating model using subjects from new
clusters, since the random eects of the new cluster are unknown. In this situation,
rstly, one may inspect the characteristics of the new clusters to see whether these are
similar to those of the development data. Then it may be reasonable to assume that
the clusters in the development and validation data come from the same population of
clusters and thus the level of clustering in both datasets are approximately equal. In
this case, one could assess the equality in the level of clustering between development
and validation data by using the condence intervals for the variance parameters of
the random eects estimated from both datasets or using F-test, provided that the
number of cluster is reasonably large and the random eects are normally distributed.
If equality holds then one could make predictions based on ^ ij(u) and use the validation
measures based on this approach. In this case, the random eects can be estimated
from the validation data using the estimates of the variance parameter of the random
eects from the development data. Then one could consider this as a form of model re-
calibration. However, equality in the level of clustering between two datasets is unlikely
in practice.
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If the type of between cluster heterogeneity is dierent between the validation and
development datasets, marginal predictions ^ ij(pa) or conditional predictions that set
the random eects at their mean value of zero, ^ ij(0), could be used if ICC is less than
0.05.
In summary, it is important to investigate the validation data before choosing the
validation measures. In particular, one needs to check whether the validation data
involve the same (or dierent) clusters as the development data, the level of clustering,
cluster size, prevalence, and the distribution of prognostic index.
Using a similar approach to that discussed in this chapter, the next chapter dis-
cusses possible extensions of some of the validation measures for independent survival
outcomes discussed in Chapter 3 for use with models for clustered survival outcomes.
104Chapter 5
Measures for clustered survival
outcomes
5.1 Introduction
The last chapter has investigated the use of validation measures for clustered binary
outcomes. This chapter focuses on validation measures for clustered survival outcomes.
Although a number validation measures for standard survival models have been devel-
oped (see, Chapter 3), very limited work has been done validation measures for models
with clustered survival outcomes. This chapter discusses possible extensions of some
of the standard validation measures for use with risk models that can handle clustered
survival outcomes.
Frailty models are extensions of standard survival models with a frailty term or
random eect included in the models [132{134]. These models are often used to anal-
yse clustered survival data and have a cluster-specic or conditional interpretation,
given the frailty. A possible alternative to the frailty models are the standard survival
models with an adjustment, for the clustering of the data, for standard errors of the
regression parameters [135{137]. These models have a population-averaged or marginal
interpretation and are referred to as `marginal models'. Generally, preference for using
one of these two classes of models depends on the research question. However, frailty
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model may be considered to be a more general type of model for analysing clustered
survival data, because marginal interpretation of the predictors, can be derived from
the frailty model by integrating out the frailty term [134]. This research discusses the
use of frailty models in risk predictions for clustered survival data.
Some of the more commonly used validation measures for standard survival models
have been considered in Chapter 3. For example, the calibration slope [44] is used
to assess the calibration of a standard survival model. Similarly, Harrell's C-index
[40], G onen and Heller's K() [48], and Royston and Sauerbrei's D [49] have been
developed to assess discrimination, and Graf et al'e IBS and its R2 extension assess
both calibration and discrimination. In this chapter, these measures are extended for
use with frailty models.
This chapter is organised as follows. Section 5.2 discusses the extensions of the val-
idation measures mentioned above for use with clustered survival data. In Section 5.3,
an application of the methods is illustrated using child mortality data from Bangladesh.
Section 5.4 discusses simulation studies to evaluate the performance of the measures,
and Section 5.5 ends this chapter with a discussion and conclusion.
5.2 Extension of the validation measures for use with clus-
tered survival data
This section begins with a description of basic notation based on the Proportional
Hazards (PH) frailty model and is followed by the detailed calculation of the validation
measures for use with the PH frailty models.
5.2.1 The Proportional Hazards frailty model
Let us suppose that we have data (tij;ij;xij) (i = 1;:::;nj;j = 1;:::;J) on N subjects
from J dierent clusters of size nj and
PJ
j=1 nj = N, where for the ith subject belonging
to the jth cluster, tij is the observed time, ij is 1 if the event of interest is experienced
at tij or 0 otherwise (right censoring), and xij is the ith row vector of the p-predictors.
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To take account of the clustering eect, the standard proportional hazards (PH) model
is extended to the PH frailty model by introducing a frailty term !j for the jth cluster.
These frailties !js represent the eect of unobserved cluster-level predictors and vary
across clusters. Since all subjects in the same cluster share the same frailty, this model
is also called a shared frailty model. The hazard function of the PH shared frailty
model takes the following form:
h(tjxij;!j) = !jh0(t)exp(Txij)
= h0(t)exp(Txij + ln!j)
= h0(t)exp(Txij + $j) (5.1)
where $j(= ln!j) is the log frailty, and Txij + $j is known as the prognostic index.
The frailties are independent and identically distributed random variables that have
a probability distribution f(!j), called the frailty distribution. Popular frailty distri-
butions are the Gamma distribution and the inverse Gaussian distribution, which are
all well-known members of the power variance family [138]. In this Chapter, the one
parameter Gamma distribution [139] is considered as the frailty distribution because
of its computational convenience. The frailties !js follow a Gamma distribution with
mean 1 and variance , which is estimated from the data. The variance parameter 
is interpreted as a measure of heterogeneity in the risk of failures across clusters. If
 = 0, then values of ! are all identical to 1, which implies that there is no eect of
clustering and the survival times are independent within as well as between clusters.
When  is large, values of ! are more dispersed, indicating greater heterogeneity in the
cluster specic baseline hazards !jh0(t). The variance parameter  can also be used to
estimate the intra-cluster correlation coecient Kendall's , which is equal to =(2+).
Various estimation methods have been proposed for estimating the model param-
eters, the xed predictor eects T, the variance parameter of the frailty, , and the
cumulative baseline hazard function H0(t) =
R t
0 h0(u)du. These include the expectation
maximisation (EM) algorithm [134, 140, 141], and the penalised likelihood approach
[133, 134]. For a semiparametric shared gamma frailty model, both approaches have
been shown to provide similar results [134].
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5.2.2 Predictions from the frailty model
The predictive form of the PH frailty model can be written in terms of the survival
function as
S(tjxij;!j) = [S0(t)]exp(Txij+$j): (5.2)
To make predictions, one uses the estimates of T and S0(t) and the estimate of the
log frailty $j. One approach to obtain the estimate of $j is empirical Bayes estima-
tion [133, 142]. Briey, the empirical Bayes estimates are the means of the posterior
distribution of the frailty distribution, given the estimated model parameters and the
data.
Similar to the random-intercept logistic model discussed in Chapter 4, the frailty
model can be used to predict the survival probability using three dierent approaches
depending on how the frailties are used in the predictions. These are conditional
predictions obtained by either plugging in the estimated log-frailties ^ $j or specifying
the frailty at their mean value 1 (or the log-frailty at 0), and marginal predictions
obtained by integrating out the frailty term from the conditional frailty model. The
resulting marginal survival function takes the following form for marginal predictions:
S(tjxij) =
Z
S(tjxij;!)f(!j)d!:
For convenience, these three approaches to prediction are denoted by S(tj!), S(tj1),
and S(t), respectively. This chapter only discusses the extension of the validation
measures for use with S(tj!). However, the validation measures for S(tj1) and S(t) can
be derived in an analogous way to those derived for S(tj!).
5.2.3 Approaches for the calculation of the validation measures
As in Chapter 4, an `overall' and a `pooled cluster-specic' measures are considered to
calculate validation measures for clustered survival data. Briey, the `overall' measure
can be estimated by comparing the subjects within as well as between clusters, and the
resulting estimate assesses the overall predictive ability of the model. For the `pooled
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cluster-specic' measure, one calculates the validation measure for each cluster, and
these estimates are pooled across clusters using the random eects summary statistic
methods described in Chapter 4. The `pooled cluster-specic' measure does not com-
pare subjects across clusters and thus assess the predictive ability of the predictors
whose values vary within a cluster. The detailed calculations of validation measures
for each these approaches are considered in the following sections of this chapter.
5.2.4 Estimation: Overall measures
5.2.4.1 Harrell's C-index
Harrell's C-index is an estimator of concordance probability and is based on the idea
that, for a randomly selected pair of subjects, a survival model should predict a lower
survival probability for the subject who fails earlier than that for the subject who fails
later. The overall C-index is the proportion of all usable pairs in which predictions and
outcomes are concordant (see Section 3.3.3.1, Chapter 3). This denition is adapted
here for use with clustered data in the following way. A randomly selected pair of
subjects i and k from clusters j and l respectively, with survival times tij and tkl is
said to be a usable pair if tij 6= tkl. For censored data, a pair is usable if the shorter
time corresponds to an event. With corresponding predicted survival probabilities
S(tjxij;!j) and S(tjxkl;!l), a usable pair is said to be concordant if either S(tjxij;!j) <
S(tjxkl;!l) and tij < tkl or S(tjxij;!i) > S(tjxkl;!l) and tij > tkl. Otherwise, the pair
is said to be discordant. The concordance probability for clustered survival data can
be dened as
Cre = Pr
h
S(tjxij;!i) < S(tjxkl;!l)jtij < tkl
i
;
or equivalently
Cre = Pr
h
(Txij + $j) > (Txkl + $l)jtij < tkl
i
:
This applies to all possible pairs (i;k) in the data, where the pairs can be formed
by taking subjects from the same cluster or from dierent clusters. If subjects are
from dierent clusters, their frailty values contribute in determining whether the pair
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is concordant, even if both subjects have the same predictor values. However, the
frailties do not contribute in determining a concordant pair if both subjects in the pair
are from the same cluster, as they share the same frailty value.
Comparing all possible pairs (i;k), in which at least one subject of a pair had
an event, with observed data f(tij;ij;xij);(tkl;kl;xkl)g, the C-index then can be
calculated for the frailty model as
^ Cre =
J X
j=1
J X
l=1
nj X
i=1
nl X
k=1
h
I

(^ Txij + ^ $j) > (^ Txkl + ^ $l) & tij < tkl & ij = 1
i
J X
j=1
J X
l=1
nj X
i=1
nl X
k=1
h
I(tij < tkl & ij = 1)
i
; (5.3)
where I() is the indicator function, ^ T is the estimate of T, and ^ $j is the empirical
Bayes estimate of the log frailty $j.
Condence interval for Cre
The method discussed by Pencina and D'Agostino [75] for the C-index for indepen-
dent survival data is adapted to derive a condence interval for Cre for clustered data.
Let us dene
cijkl = 1 if the pair (i;k) from clusters (j;l) is concordant
= 0 if discordant: (5.4)
Further let cij be the number of subjects in the dataset that are concordant with the
ith subject from the jth cluster, then applying the above denition
cij =
J X
l=1
nl X
k=1
cijlk: (5.5)
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Considering the entire sample, the unconditional probability of concordance
c = Pr
h
(Txij + $j) > (Txkl + $l) & tij < tkl
i
can be estimated as
^ c =
1
N(N   1)
J X
j=1
nj X
i=1
cij: (5.6)
Similarly, if we let dij be the corresponding number of subjects that are discordant
with the ith subject from the jth cluster, then the estimated unconditional probability
of discordant is
^ d =
1
N(N   1)
J X
j=1
nj X
i=1
dij: (5.7)
As discussed by Pencina and D'Agostino [75], ^ c and ^ d are unbiased estimates of c
and d, respectively. Note that c + d = 1 if there are no ties. Using the relationship
between Harrell's C-index and the modied Kendall's m [143] developed by Pencina
and D'Agostino [75], ^ Cre dened in equation (5.3) can be written as
^ Cre =
^ c
^ c + ^ d
=
1
2
(^ m + 1); (5.8)
where ^ m =
^ c   ^ d
^ c + ^ d
is an estimate of m.
Using these estimates, the following expression can be written:
p
N( ^ Cre   Cre) =
p
N
 
^ c
^ c + ^ d
 
c
c + d
!
=
p
N(d ^ c   c^ d)
(^ c + ^ d)(c + d)
;
which is asymptotically equivalent to
 =
p
N(d ^ c   c^ d)
(c + d)2 :
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By virtue of the central limit theorem, the above statistic is approximately normally
distributed for large N [75, 143]. Since ^ c and ^ d are unbiased estimates of c and
d, respectively, it can be shown that E[] = 0. Therefore, ^ Cre is an asymptotically
unbiased and normal estimator of Cre [75]. Using the result of Pencina and D'Agostino
[75], the variance expression for  can be written as
var() =
4
(c + d)4(2
dcc   2cdcd + 2
cdd);
where, for three subjects (i;k;r) from clusters (j;l;s) respectively,
cc = Pr[i is concordant with both k and r];
dd = Pr[i is discordant with both k and r];
cd = Pr[i is concordant with k but discordant with r];
dc = Pr[i is discordant with k but concordant with r]:
The last two probabilities are equal, since k and r can be interchanged.
These probabilities can be estimated from data in the following way. The term cc
is interpreted as the probability that a given subject from a given cluster is concordant
with two other randomly selected subjects from any clusters. For subject i from cluster
j, the possible number of pairs of subjects that are concordant with i can be calculated
as
cij!
(cij   2)!
= cij(cij   1), where cij can be calculated using equation (5.5). Summing
over all subjects and clusters and dividing by all possible number of ordered triples,
N!
(N   3)!
= N(N   1)(N   2), the following estimate for cc can be obtained:
^ cc =
1
N(N   1)(N   2)
J X
j=1
nj X
i=1
cij(cij   1):
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Similarly, dd and cd can be estimated as
^ dd =
1
N(N   1)(N   2)
J X
j=1
nj X
i=1
dij(dij   1) and
^ cd =
1
N(N   1)(N   2)
J X
j=1
nj X
i=1
cijdij;
respectively. Therefore, the estimate of var() can be written as
c var() =
4
(^ c + ^ d)4(^ 2
d^ cc   2^ c^ d^ cd + ^ 2
c^ dd):
Finally, the condence interval for Cre can be constructed as:
^ Cre  z=2
r
c var()
N
;
where z=2 denotes the =2 percentile of the standard normal distribution.
5.2.4.2 Gonen and Heller's K()
Gonen and Heller's K() [48] is also an estimator of concordance probability under the
Cox PH model (see, Chapter 3). In this chapter, the method of Gonen and Heller [48]
is adapted to derive a concordance probability estimator Kre(j!) for the PH frailty
model. Kre(j!) is a function of the regression parameters, the predictor distribution,
and the frailty parameter.
For a pair of subjects (i;k) from clusters (j;l) respectively with corresponding prog-
nostic indices (log hazards) fTxij + $j;Txkl + $lg, the concordance probability
Kre(j!) = Pr
h
tkl>tijj(Txij + $j) > (Txkl + $l)
i
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can be calculated for the PH frailty model as
Kre(j!) = Pr
h
T(Txkl + $l) > T(Txij + $j)
i
=
Z 1
0
S(tjxkl;!l)dS(tjxij;!j)
=
1
1 + exp[T(xkl   xij) + ($l   $j)]
;
where T(Txij + $j) represents the survival time that corresponds to Txij + $j. If
one considers all possible pairs (i;k), Kre(j!) can be estimated as
Kre(^ j^ !) =
1
N(N   1)
J X
j=1
J X
l=1
nj X
i=1
nl X
k=1
"
I

(^ Txij + ^ $j) > (^ Txkl + ^ $l)

1 + exp[^ T(xkl   xij) + (^ $l   ^ $j)]
#
=
1
N(N   1)
J X
j=1
J X
l=1
nj X
i=1
nl X
k=1
"
I

[^ T(xkl   xij) + (^ $l   ^ $j)] < 0

1 + exp[^ T(xkl   xij) + (^ $l   ^ $j)]
#
=
1
N(N   1)
J X
j=1
J X
l=1
nj X
i=1
nl X
k=1
"
I

(^ Txklij + ^ $lj) < 0

1 + exp[^ Txklij + ^ $lj]
#
(5.9)
where xklij and ^ $lj represent the dierences xkl   xij and ^ $l   ^ $j, respectively.
Kre(^ j^ !) is a conditional concordance probability estimator of the PH frailty model as
^  is conditional on the frailty !.
Asymptotic variance of Kre(j!)
The method of Gonen and Heller [48] for the standard K(^ ) is adapted here to
derive an asymptotic variance expression for Kre(^ j^ !). The estimator Kre(^ j^ !) is a
non-smooth function of ^  and ^ $. As a result, Kre(^ j^ !) is a nondierentiable statistic
for which it is dicult to obtain a local linear approximation to Kre(^ j^ !), from which
the asymptotic distribution of Kre(^ j^ !) and the corresponding asymptotic variance can
be derived. To address this problem, a smooth approximation to the above estimator
can be obtained following Gonen and Heller [48] who used kernel smoothing technique
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[144] as
~ Kre(^ j^ !) =
1
N(N   1)
J X
j=1
J X
l=1
nj X
i=1
nl X
k=1
"


  (^ Txijkl + ^ $jl)=h

1 + exp[^ Txklij + ^ $lj]
#
; (5.10)
where h is the bandwidth which controls the amount of smoothing, and  is the stan-
dard normal cumulative distribution. Note that for N ! 1, h ! 0 and therefore
(u=h) ! I(u > 0). As suggested by Gonen and Heller [48], we choose h so that
Nh4 ! 0 as N gets large. Based on this condition, it can be shown that the asymp-
totic distributions of the non-smoothed estimator Kre(^ j^ !) and the smoothed estimator
~ Kre(^ j^ !) are equal, and the variance of Kre(^ j^ !) can be calculated using a linearisa-
tion argument based on the Taylor series expansion for smoothed ~ Kre(^ j^ !). Following
Gonen and Heller [48] the bandwidth used in the above approximation is chosen as
h = 0:5^ N 1=3, where ^  is the estimated standard deviation of the predicted prognos-
tic index ^ Txij + ^ $j. The term N 1=3 conrms the asymptotic condition Nh4 ! 0
required for the asymptotic equivalence of the smooth and non-smooth concordance
probability estimator.
The asymptotic variance of ~ Kre(^ j^ !) can be obtained by calculating its rst-order
Taylor series expansion. Using the results of Gonen and Heller [48] the variance ex-
pression can be written as:
var[ ~ Kre(^ j^ !)]  var[ ~ Kre(0j!)] +
"
@ ~ Kre(j!)
@
#T 
 

=0
var(^ j^ !)
"
@ ~ Kre(j!)
@
# 
 

=0
; (5.11)
which can be estimated by plugging in the estimates of the various components of
this expansion. The variance of ^ j^ ! can be computed from the inverse of the Fisher
information matrix. The asymptotic variance of ~ Kre(^ 0j^ !) can be estimated from data
based on the U-statistic formulation. The U-statistic is a class of statistics in statistical
estimation theory that produces minimum variance unbiased estimator, for more details
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see Hoeding [145] and Lee [146]. The resulting estimate is:
c var[ ~ Kre(0j!)] =
1
fN(N   1)g2
J X
j=1
J X
l=1
nj X
i=1
nl X
k=1
nl X
r6=k
[ijkl   ~ K(^ j^ !)][ijrl   ~ K(^ j^ !)];
where ijkl = 

 (^ Txijkl+ ^ $jl)=h
h
1+exp[^ Txklij+ ^ $lj]
i 1
. The partial derivative
vector
@ ~ Kre(j!)
@
can be estimated at  = ^  and is given by
@ ~ Kre(j!)
@
 
 

= ^ 
=
J X
j=1
J X
l=1
nj X
i=1
nl X
k=1
nl X
r6=k
"


  (^ Txklij + ^ $lj)=h

1 + exp[^ Txklij + ^ $lj]
[ xklij=h]
+


  (^ Txklij + ^ $lj)=h


1 + exp[^ Txklij + ^ $lj]
2 exp[^ Txklij + ^ $lj][ xklij]
#
;
where  is the normal density. For notational convenience, Kre instead of ~ Kre(^ j^ !) is
used in the rest of the chapter.
5.2.4.3 Royston and Sauerbrei's D
The D statistic quanties the separation between subjects with low and high predicted
risks, as predicted by the model. The D statistic for the frailty model, Dre, can be
obtained by transforming the prognostic index ^ re = ^ Txij + ^ $j to a normal order
statistic z in a similar way to that described for the standard Cox model and then
tting a PH frailty model with z as the only predictor. The resulting model takes the
following form:
h(tjz;!j) = !jh0(t)exp(zz);
where Dre = ^ z and has the same interpretation to the standard D statistic. One can
also obtain Dre by tting a standard Cox model with z, since the frailties are already
included in z.
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5.2.4.4 Calibration slope
The calibration slope for the PH frailty model, denoted by CSre, can be obtained by
tting a PH frailty model (or a standard Cox model) with the estimated prognostic
index ^ re obtained for validation sample as the only predictor:
h(tj^ re;!j) = !jh0(t)exp(re^ re);
where CSre(= ^ re) is the coecient of ^ re in the above frailty model, and has the
same interpretation to the standard calibration slope.
5.2.4.5 Brier score
The Brier score for the frailty risk model can be calculated by comparing the predicted
survival probabilities ^ S(tjxij; ^ !) with the observed outcomes at time t over the study
period and averaging over the N subjects. Let Yij(t) be the observed outcome that
takes value 1 if the ith subject from the jth cluster is alive at t, and 0 if not. If a
subject is alive at time t, the predicted survival probability should ideally be close to
1, otherwise it should be close to 0. The Brier score can be estimated as
BSre(t) =
1
N
J X
j=1
nj X
i=1

Yij(t)   ^ S(tijjxij; ^ !j)
2
W(t; ^ G): (5.12)
The weights W(t; ^ G) are to compensate for earlier censoring and are given by
W(t; ^ G) =
1ftij  tgij
^ G(tij)
+
1ftij > tg
^ G(t)
;
where ^ G(t) is the Kaplan-Meier estimate of the probability of being uncensored at time
t. The corresponding integrated Brier score (IBS) is the cumulative Brier score over
the interval [0;] and can be calculated for the PH frailty model as
IBSre() =
Z 
0
BSre(t)dW(t); (5.13)
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where W(t) is a function to weight the contribution of the Brier score at individual
time point, and  is chosen as a time before the last event time.
5.2.5 Estimation: Pooled cluster-specic measures
The estimation of the pooled cluster-specic measure for the frailty model is similar
to that discussed for the random-intercept logistic model. For example, the pooled
cluster-specic Harrell's C-index is calculated as follows.
Let ^ cj be the estimate of the C-index for the jth cluster with its estimated variance
s2
j (j = 1;:::;J), and 2 be the between cluster variance. Then the pooled C-index
can be obtained as
^ Cw =  w 1
J X
j=1
^ cj ^ wj
where ^ wj = 1=(s2
j + ^ 2),  w =
PJ
j=1 ^ wj, and 2 can be estimated using the method of
DerSimonian and Laird [113], which was described in Section 4.3.5, Chapter 4.
Similarly, pooled estimates for K(), D-statistic, calibration slope, and integrated
Brier score (IBS) can be obtained in a similar manner and the resulting measures are
denoted by Kw, Dw, CSw, and IBSw, respectively. Since analytical standard errors are
not available for IBS, bootstrap based standard errors obtained (from 200 bootstrap
samples) for each of the clusters are used to calculate the pooled estimate of IBSw.
All these `pooled' validation measures have the same interpretation to the analogous
versions of the `pooled' validation measures for clustered binary data.
5.3 Application to child mortality data
In this section, the validation measures described above are illustrated using data on
mortality of children under the age of ve in Bangladesh. The following sections de-
scribe the data and present the analysis and results.
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5.3.1 Child mortality data
Data on the mortality of children under ve in Bangladesh were obtained from the
database of the Bangladesh Demographic and Health Survey (BDHS) [147, 148]. The
BDHS is a nationally representative survey that has been carried out once every two
years since 1993 as part of the world-wide Demographic and Health Survey (DHS)
programme, which has been carried out mostly in developing countries. This survey
collects information on the reproductive history of women and their socio-demographic
and health status, immunisation, and child mortality. Although the women were inter-
viewed at one time point, they were asked to give information on predictors at the time
of the event or before the event occurred as approximately. Therefore, although this
is a survey design, it can be considered as a retrospective cohort study. The strategic
objective of this survey is to improve the collection and use of data by host countries for
programme monitoring and evaluation and for policy development decisions. Here the
aim is to develop a risk model using data on mortality of children under ve. The model
may be useful to the country's health care providers to oer advice to women who are
planning pregnancy and to identify high risk groups. Data used for this analysis were
extracted from the 2004 and 2007 BDHS databases. Data collected in 2004 were used
to develop the risk model and a `temporal validation' of the model was conducted using
data collected in 2007.
In each of the both 2004 and 2007 surveys, a total of 361 clusters were selected
according to the country's geographical locations. For more details, see BDHS reports
[147, 148]. Figure 5.1 shows the geographical location of urban and rural clusters across
the country. From each cluster, 30 households, on average, were selected using an equal
probability systematic sampling scheme. All married women age 10-49 in the selected
households were interviewed to collect information on the survival history for each birth
along with relevant background information. For this analysis, only singleton births
that occurred in the 5 years preceding the interview were selected. Clustering was
considered at only the cluster/geographical-location level, and one birth per household
was randomly selected to avoid clustering of children at the household level. The risk
model was developed using the data on 6,776 singleton births (with 440 events/deaths)
collected in 2004, and the model was validated using data on 6,052 singleton births
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(with 325 events/deaths) collected in 2007. In both datasets, survival times of more
than 90% of the children were reported to be censored.
 
Figure 5.1: Map of Bangladesh indicating the distribution of the urban and rural sampling
points (a total of 361 clusters), visited in the 2007 BDHS survey. Source: 2007 BDHS
report.
The distribution of the clusters by the number of births per cluster (cluster size)
and by the number of deaths per cluster is presented in Figure 5.2. For both the
development and validation data, the distributions of the clusters by the number of
births per cluster were approximately the same, with the median number of births per
cluster reported as 20 (IQR: 16 to 25) and 18 (IQR: 14 to 23) during the period of
1999-2004 and 2002-2007, respectively. Similarly, the distribution of the clusters by
the number of deaths per cluster for both datasets were similar, with both average
deaths per cluster reported as 1.2 during the period of 1999-2007. From the total of
361 clusters, 132 clusters in the development data and 179 clusters in the validation
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data had no deaths. The reason for similarities between these two datasets may be due
to the fact that both were sampled from the same population of clusters, where clusters
represent the geographical location.
Figure 5.2: Distribution of clusters in both the development and validation data by the
number of births per cluster (a,c) and by the number of deaths per cluster (b,d).
The outcome time-to-event (death/survived) was measured in days and was cal-
culated for the births in the 5 years preceding the interview by subtracting the date
of birth from the date of death or from the date of interview. The median follow-up
times for the children in the development and validation datasets were 870 days and
900 days, respectively. The predictors included in the risk model were maternal age,
mother's education, household's socio-economic status, child's birth order, and birth
spacing which included both preceding and subsequent birth intervals. These predic-
tors were found to be signicantly associated with child mortality in previous studies
in this area [149{155].
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Maternal age was measured as the age (in years) of the mother at the birth of the
child and had a non-linear relationship with outcome. A log transformation was unable
to make the relationship linear and therefore maternal age was categorised, as in the
BDHS report, as 14-19, 20-29, and 30+ years. Mother's education was categorized
based on the number years of schooling the mother had attained: no-education (0 year
of schooling), primary (5 years), secondary (10 years), and higher (11+ years). House-
hold socio-economic status (poorest/poorer/middle/richer/ richest) was determined by
calculating a wealth index for each household using a principal component analysis of
the assets owned (yes/no) by the household. The 1st quintile of the index was referred
to as the `poorest' and the 5th quintile as the `richest'.
The predictors based on child's birth order and birth spacing were categorized in
a similar way to that described in previous studies [149, 154, 155]. Child's birth order
was categorised as rst birth, order 2-4, and order 5+. The preceding birth interval
was categorised as short (20 months), medium (21-36 months), long (37+ months),
following the rst birth. Similarly, the subsequent birth interval was categorised as
short, medium, long, following the last birth. Since the information on the rst birth is
similar in both `child's birth order' and `preceding birth interval', these two predictors
were combined together to create a single predictor dened as `birth-order/preceding-
birth-interval'. The categories of this combined predictor was dened as rst birth,
order 2-4/short, order 2-4/medium, order 2-4/long, order 5+/short, order 5+/medium,
order 5+/long.
5.3.2 Analysis and results
5.3.2.1 Model development
Using the Cox PH model with shared gamma frailty parameters, a prognostic model
of child mortality was developed using the development data. The model parameters
(, ) were estimated using penalised likelihood estimation [133]. The Stata package
stcox using the shared option was used to t the model. The results are presented
in Table 5.1. All the predictors in the model were found to be statistically signicant
at the 5% level of signicance. The predictor subsequent-birth-interval showed the
strongest association with the outcome. The frailty parameter  is estimated as 0.11,
1225.3 Application to child mortality data
which corresponds to the intra-cluster correlation calculated as =(2 + ) = 0:05. This
suggests that the eect of clustering is weak; there is a low variation between the
clusters in the risk of failures.
Table 5.1: Estimates of the PH frailty model in the development data
Variables HR 95% CI P-value
Maternal Age <0.01
14-19 yrs 1.00 -
20-29 yrs 1.01 [0.77, 1.32]
30+ yrs 1.72 [1.15, 2.56]
Mother's education <0.05
no education 1.00 -
primary 0.70 [0.55, 0.89]
secondary 0.75 [0.56, 1.01]
higher 0.57 [0.31, 1.04]
Birth order/preceding birth interval <0.01
rst birth 1.91 [1.39, 2.62]
2-4/short 1.77 [1.15, 2.72]
2-4/medium 1.41 [1.04, 1.93]
2-4/long 1.00 -
5+/short 1.74 [1.03, 2.92]
5+/medium 1.28 [0.85, 1.94]
5+/long 1.06 [0.68, 1.64]
Subsequent birth interval <0.001
short 1.00 -
medium 0.29 [0.22, 0.39]
long 0.21 [0.13, 0.33]
last birth 0.12 [0.09, 0.16]
Socio-economic status <0.05
poorest 1.00 -
poorer 0.74 [0.55, 0.99]
middle 1.02 [0.77, 1.34]
richer 0.68 [0.48, 0.94]
richest 0.74 [0.53, 1.04]
Variance parameter  (SE) 0.11 (0.07) - -
5.3.2.2 Model Validation
The model was then used to predict the survival probability in the validation data,
and the predictive performance of the model was assessed using the validation mea-
sures described in Section 5.2. To calculate the validation measures, the frailties, the
survival probabilities S(tj!), and the associated prognostic indices were estimated in
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the validation data, using the estimated model parameters from the development data.
User written Stata code was used to calculate the validation measures (Appendix B:
Figure B.3).
Figure 5.3: (a) Distribution of the predicted prognostic index ^ re = ^ Txij + ^ $j (b)
Kaplan-Meier survival function at the tertiles of the predicted prognostic index.
Some of the validation measures are based on a normality assumption of the pre-
dicted prognostic index. Therefore, the distribution of the predicted prognostic index
is presented in Figure 5.3(a); there appears to be some skewness towards the right,
however it is perhaps not unreasonable to consider the distribution of the predicted
prognostic index as normal. Furthermore, to examine the spread in survival predic-
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tions as predicted by the model in the validation data, Kaplan-Meier survival function
at the tertiles of the predicted prognostic index is presented in Figure 5.3(b). This plot
suggests that the model had good ability to separate (discriminate) children with low
risk of mortality from those with high risk.
The estimates of the validation measures are presented in Table 5.2. The concor-
dance statistic Cre was estimated as 0.750 (95% CI:0.723 to 0.785), which suggests
that the model has reasonably good ability to discriminate between low and high risk
children. However, Kre suggests relatively a lower ability for discrimination, with an
estimate of 0.686 (95% CI: 0.669 to 0.701). The possible reason for this dierence is
similar to that for the standard C-index that Cre may be aected by the high degree
of censoring in the child mortality data. The estimate of the D statistic (Dre) also
suggests moderate discrimination between low and high risk children. Similar to the
standard D and K statistics, both Dre and Kre may not be aected by the censoring
in this dataset. The calibration slope (CSre) suggests that the model has good overall
calibration. The extent of inaccuracy in the individual survival prediction (IBSre) was
estimated to be 0.07, suggesting reasonably lower inaccuracy in survival predictions.
Additionally, the Brier score calculated at each time point was plotted against the ob-
served time points in Figure 5.4, to see the model's predictive accuracy over the entire
follow-up period. Two additional plots of the Brier score for the null model and the
model with all xed predictors only (frailties set to one) were obtained, to examine the
dierence in predictive accuracy between these three models. The survival prediction
error (the Brier score) was lower when the predictions were made by the model with
all the xed predictors along with the frailties compared to those obtained from the
model with only xed predictors and the null model.
The `pooled' estimate of the cluster-specic C-indices, Cw, indicates a good discrim-
ination between low and high risk children belonging to the same cluster, whereas Kw
indicates relatively less discrimination, and Dw suggested poor discrimination between
these two groups (Table 5.2). However, these `pooled' estimates are smaller than their
corresponding `overall' estimates, although the frailty eects in these data were not that
strong. Similarly the `pooled' estimate of the cluster-specic calibration slopes (CSw)
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Table 5.2: Estimates of the validation measures based on the validation data
Overall measures
Measures' name Notations Estimate 95% CI
Harrell's C-index Cre 0.750 [0.723, 0.785]
Gonen and Heller's K() Kre 0.686 [0.669, 0.701]
D-statistics Dre 1.52 [1.29, 1.74]
Calibration slope CSre 1.01 [0.91, 1.09]
Integrated Brier score IBSre 0.07 [-]
Pooled cluster-specic measures
Harrell's C-index Cw 0.701 [0.671,0.742]
Gonen and Heller's K() Kw 0.649 [0.626, 0.679]
D-statistics Dw 0.89 [0.65, 1.13]
Calibration slope CSw 0.64 [0.48, 0.81]
Integrated Brier score IBSw 0.06 [0.05, 0.07]
Figure 5.4: Brier scores over the entire follow-up period. The results are obtained for
the predictions from the model with all xed predictors and the frailties, the model with
all xed predictors only, and the null model.
suggests worse calibration than the `overall' calibration. This dierence may be caused
by the cluster size of the child mortality data, where clusters are reasonably small and
several of the clusters have no events. These clusters were dropped due to the lack
of events to calculate the measure and the pooled estimate was based on the reduced
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number of clusters. The reason is similar to those described for `pooled cluster-specic'
measures for clustered binary data in pages 98-99, Section 4.5.3.2, Chapter 4. However,
the estimate of the `pooled' Brier score (IBSw = 0:06) was close to that of the `overall'
Brier score.
Since the cluster-specic estimates are useful in detecting outlying clusters (regions),
these estimates with their level of uncertainty are plotted against the rank order of the
clusters in Figure 5.5. Each horizontal solid line indicates the `pooled estimate' of the
respective measure. Figure 5.5 shows the estimates for 76 clusters only. It was not
possible to estimate the validation measures for the rest of the clusters as the required
number of events to enable the calculation of the measures were not observed in these
clusters. Note that to enable the calculation, some of the measures, for example, Cw
requires at least one event, and the other measures, for example, Dw requires two events
(see, Section 5.2). This plot made a comparison between clusters (regions) in terms
of the model performance. The results shows that the predictive ability of the model
for some of the clusters were signicantly worse (better) than the average performance.
This heterogeneity in the model predictive performance between the clusters (regions)
may be caused by unobserved cluster (region) level characteristics. Therefore, it may
be important to identify the factor which explains this heterogeneity.
In summary, this illustration of the validation measures using the child mortal-
ity data showed that both the `overall' and `pooled cluster-specic' measures have a
meaningful interpretation in a clustered survival data setting. However, the valida-
tion measures appeared to provide dierent conclusions regarding the model's predic-
tive performance. For example, the C-index suggested strong discrimination, whereas
K() suggested moderate discrimination. Furthermore, while the `overall' estimates
of both the D-statistic and calibration slope indicated a reasonably good predictive
performance of the model, their `pooled' estimate indicated very poor performance.
These dissimilarities may be caused by high degree of censoring in the child mortality
data and/or by the small clusters. Therefore, in the next section, a simulation study is
conducted to evaluate the performance of the measures in a range of conditions based
on a clustered survival data setting.
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Figure 5.5: Cluster-specic estimates of the validation measures with their level of uncertainty against the rank order of the
clusters. The horizontal solid line indicates the pooled estimate of the measure.
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5.4 Simulation study
A simulation study was conducted to evaluate the bias, rMSE, and coverage of the esti-
mate of the validation measures. Both development and validation data were simulated.
Models were developed using the simulated development data and then evaluated using
the corresponding simulated validation data. The properties of the measures were as-
sessed in various clustered survival data scenarios, constructed by varying the number
of clusters and their size, the intra-cluster correlation between patients within a cluster,
and the degree of censoring in the validation data. In practice, censoring is common in
survival data, and some of the validation measures for standard survival models were
found to be considerably aected by censoring (see, Chapter 3). In addition, number
of clusters and their sizes and the intra-cluster correlation may inuence their perfor-
mance. The validation measures for clustered binary data were found to be aected by
small clusters and the level of ICC. The simulation studies would help in identifying
which factors aected the performance of the validation measures.
5.4.1 Simulation design
5.4.1.1 True model
To simulate clustered survival data, a PH frailty model with Weibull baseline hazard
with shape parameter  = 1:1 and scale parameter  = 1 was chosen as a true model.
The frailty distribution was chosen as Gamma with mean 1 and variance . For a sample
of N subjects with J clusters, the predictor value xij for the ith subject in the jth cluster
was generated from the standard normal distribution (i = 1;:::;nj;j = 1;:::;J). The
clustered survival data were then generated as follows:
(i) the frailty value !j for the jth cluster was generated from a Gamma distribution
with mean 1 and variance .
(ii) the survival times t
ij were generated as
t
ij =
 
 log(vij)
exp(xij)!j
!1=
where vij  U(0;1).
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(iii) to generate random right-censored data, a pseudo-random Weibull distributed
censoring times cij were also generated in a similar manner to that used to gen-
erate the survival times, but the term exp(xij) was replaced by a scalar .
Dierent choices of  were used to produce dierent degrees of censoring.
(iv) the observed survival times were calculated as tij = min(t
ij;cij), and the censoring
indicator as ij = 1 if t
ij  cij.
The value of the frailty parameter  was varied to generate data with dierent levels
of clustering, and the regression coecient  was set to 1.35 for all simulation settings,
indicating strong predictor. The value of  was chosen arbitrarily, but the aim was to
deal with a model with strong prognostic ability.
5.4.1.2 Simulation scenarios
To create scenarios with no, moderate, and high levels of clustering, the values of the
frailty parameter  were set to 0, 0.58, and 0.98, respectively. For each value of , devel-
opment datasets each with 50 clusters of size 30 were generated without considering any
censoring. For each development dataset, validation data from various scenarios were
generated, to mimic scenarios with large number of small clusters and small number of
large clusters. The validation data were also simulated to have low, moderate, and high
degrees of censoring. The validation scenarios considered were: (a) 10 clusters of sizes
10, 30, and 50, and (b) 50 clusters of sizes 10 and 30. For each of these scenarios, four
dierent degrees of censoring: 0%, 20%, 50%, and 80% were considered. This resulted
in 20 validation scenarios for each of the three values of the frailty parameter , thus
60 altogether. For each of the development and validation scenarios, 500 datasets were
generated. Similar to the simulation design discussed in Chapters 3 and 4, this speci-
cation (500 simulations) was also determined following Burton et al. [78] and provided
very low Monte Carlo error for the validation measures for clustered survival data.
The levels of clustering in the development and the corresponding validation datasets
were set to equal, by generating both datasets from the same value of . This would
represent a scenario where clusters in both the development and validation datasets
are from the same population of clusters.
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5.4.2 Strategies for evaluating the measures
5.4.2.1 Model tting and calculation of the validation measures
A Cox PH hazard model with shared gamma frailty was tted to each of the devel-
opment datasets. The model parameters were estimated using penalised likelihood
estimation [133]. These estimates were used to obtain the empirical Bayes estimates
of the frailties and the predicted survival probability ^ S(tj^ !) in the corresponding sim-
ulated validation datasets. Then the point estimates and condence intervals for the
validation measures were calculated for each of the validation datasets.
5.4.2.2 Assessing the properties of the measures
The eects of censoring, number of clusters and their size, and intra-cluster correlation
were investigated by assessing the empirical bias, empirical rMSE, and coverage of
nominal 90% condence intervals for the validation measures. The true values of the
validation measures were obtained empirically by averaging over 100 simulations of very
large uncensored datasets (N=100,000 with J=500 clusters). In each simulated dataset,
the `overall' validation measures were calculated using the true regression parameter
() and the frailty values. Since the true value of the frailty parameter  was varied
to create the scenarios with dierent levels of clustering, true values of the `overall'
measures were calculated as above for each value of . However, similar to the measures
for clustered binary data, the true value of the rank-based `pooled' measures (Cw, Kw,
and Dw) and the calibration slope CSw were calculated using the true value of the
regression parameter () only, because the frailties do not contribute to the calculation
of these measures (see Section 5.2.5). The IBS for each cluster however includes the
frailties. Thus the true value of the `pooled' IBS (IBSw) was calculated using both the
true value of the regression parameter () and the frailties.
The bias in the estimate of the validation measure was calculated as the mean of
the dierence between the estimate and the true value, over 500 simulations. Similarly,
rMSE was calculated as the square root of the mean of the squared dierence between
the estimate and the true value. Coverage was calculated as the proportion of simula-
tions where the estimated condence interval contained the true value. Analytical as
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well as bootstrap CIs (with 200 bootstrap samples) were used to calculate coverage.
The bias and rMSE were rescaled to a percentage in a similar way to that discussed in
Chapter 3 and Chapter 4.
5.4.3 Results
5.4.3.1 The Overall validation measures
The empirical (sampling) distribution of the `overall' estimates of the validation mea-
sures, by dierent degrees of censoring, is summarised using box plots. Figure 5.6 shows
the results for the simulation scenario with 10 clusters of size 100 where clustering was
high ( = 0:98). The horizontal dashed lines show the true values of the measures. The
inter-quartile range for each of the validation measures increases with the degree of cen-
soring. The medians for CSre, Kre, and Dre are approximately close to the true value,
suggesting correct inference regarding the model's predictive performance. However,
the medians for Cre and IBSre increased with increasing degree of censoring, which
indicates that misleading conclusions could be drawn regarding the model's predictive
performance in the presence of censoring. Cre performed adequately for up to 20%
censoring, however IBSre was aected even with 20% censoring. Similar results were
observed for the other simulation scenarios (not shown). These results are analogous
to those for the standard validation measures for independent survival outcomes.
The relative percentage of bias induced by censoring was plotted against the degree
of censoring in Figure 5.7. For the uncensored survival simulations, all the validation
measures under investigation were approximately unbiased, particularly when cluster
sizes were large and there was no clustering. For the censored survival simulations,
Cre and IBSre showed bias, which increased with increasing degree of censoring. This
was the case for all simulation scenarios. The eect of censoring was also observed
for Dre and CSre particularly when the cluster sizes were small and there was some
degree of clustering. Bias in all these cases suggest the possibility of reaching misleading
conclusions regarding the model's predictive performance. However, Kre was unbiased
in the presence of censoring, which was the case for all simulation scenarios. In addition,
the validation measures, in general, were aected by non-zero intra-cluster correlation
( > 0) when clusters were small.
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Figure 5.6: Empirical (sampling) distribution of the validation measures by degree of censoring, summarised using box plots. The
results are from the simulations with 10 clusters of size 100 under  = 0:98. The horizontal (dashed) lines indicate the true values
of the measures.
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The reasons for bias in Cre and IBSre induced by censoring are similar to those
discussed for the standard C-index and IBS for independent survival data (see Section
3.5.2, Chapter 3). Briey, these measures are calculated by comparing the predicted
survival probability with the observed survival status of the two categories of subjects:
those who developed the event and those who did not. For the dataset with large
amount of censoring, there are far fewer comparisons than the value what we would
obtain if the actual survival times were available, which may result in bias. The possible
reason for bias caused by the non-zero intra-cluster correlation when the clusters are
small is that the empirical Bayes estimates for the frailties were poorly estimated for
small clusters. This reason is analogous to that discussed for validation measures for
clustered binary outcomes.
In general, the relative rMSE (%) of the validation measures increased with in-
creasing degree of censoring (Figure 5.8). The increase was sharp for Cre and IBSre
as their point estimates were biased. However, for the measures whose point estimates
were unbiased in the presence of censoring, for example, Kre, there was also a steady
increase, because of increasing empirical standard error. For all validation measures,
the rMSE was low for the scenario with large number of large clusters while it was high
for the scenario with small number of small clusters. The rMSE of the measures was
also aected by the non-zero intra cluster correlation as their bias aected. Amongst
the validation measures, rMSE was lowest for Kre, followed by Dre and CSre, and it
was the highest for Cre and IBSre.
Coverage of nominal 90% condence intervals for the `overall' validation measures
were calculated based on bootstrap standard errors. Table 5.3 presents the results for all
simulation scenarios with high clustering. For the uncensored survival simulations with
large clusters, coverage for all the validation measures was close to the nominal 90%
value. When the clusters were small, the measures showed somewhat poor coverage as
the point estimates were biased. For the censored survival simulations, the validation
measures which were unbiased had good coverage. Similar results were observed for
the other simulation scenarios (not shown). The results regarding coverage for the
validation measures were similar to that discussed above when analytical standard
errors were used (not shown).
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Table 5.3: Estimated coverage of nominal 90% condence intervals for the `overall' mea-
sures. The condence intervals were calculated based on bootstrap standard errors. The
results are from all simulation scenarios where the level of clustering was high ( = 0:98).
Maximum Monte Carlo Standard Error=2.4%.
Overall measures
Cluster  size Censoring Cre Kre Dre CSre IBSre
0 88 87 80 79 81
1010 20 80 86 78 75 77
50 63 86 72 68 65
80 30 84 65 56 32
0 85 88 83 88 85
1030 20 80 88 84 87 82
50 50 87 84 80 53
80 25 88 86 75 31
0 91 90 89 91 88
10100 20 77 91 89 89 82
50 51 89 88 87 55
80 28 88 89 84 25
0 87 86 84 82 85
5010 20 83 86 80 75 79
50 50 84 68 55 54
80 25 86 54 41 29
0 91 90 87 89 89
5030 20 70 91 88 89 80
50 51 90 88 85 43
80 30 89 87 80 23
The agreement between the validation measures was also investigated by using
scatter plot matrix and the Pearson correlation coecient, r. Figure 5.9 shows the
results for the survival simulations with 50 clusters of size 30 where the level of clustering
was high. The measures closely agree with each other for the uncensored survival
simulations, but the agreement becomes weaker, particularly between Cre and IBSre,
with higher degrees of censoring. For example, the correlation between Cre and IBSre
was -0.99 for 0% censoring and reduced to -0.52 for 80% censoring. Similar results
were observed for all other simulation scenarios (not shown). This nding is analogous
to those for the standard validation measures for independent survival data (Section
4.5.1.3, Chapter 3).
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Figure 5.9: Agreement between the validation measures for dierent degrees of censoring. The results are from the simulations
with 50 clusters of size 30 under  = 0:98. The r values indicate the estimated Pearson correlation coecients between the measures.
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85.4 Simulation study
5.4.3.2 Pooled cluster-specic validation measures
The relative bias and rMSE for the `pooled' estimates of the cluster-specic validation
measures were plotted against the degree of censoring in Figures 5.10 and 5.11, respec-
tively. In general, the pooled estimates of the cluster-specic validation measures were
aected by the cluster size, with small sizes producing greater bias and higher rMSE.
Similar to the `overall' estimates, Kw, Dw, and CSw were not aected by censoring
when the clusters were large. However, Cw and IBSw were aected by censoring, even
for large clusters. The bias in IBSw increased with censoring up to 50 percent and then
decreased. The probable reason for the decrease is that a very small number of events
was observed for each cluster for the simulations with 80 percent censoring, resulting
in low values of the Brier score and hence in IBSw. For example, for the clusters of
size 10, the simulations with 80 percent censoring provide just two events on average,
and therefore the IBSw underestimated the true value. Amongst the `pooled' cluster-
specic validation measures, only IBSw includes frailties and appeared to be aected
by the level of clustering when the clusters were small. This is because the frailties
were not well estimated for these clusters.
The reason for bias in the `pooled cluster-specic' validation measures when the
cluster sizes are small is similar to those discussed for the measures for clustered binary
data (Section 4.5.3.2, Chapter 4). With the simulations with 80 percent censoring,
approximately 20% small clusters did not have the required number of events to calcu-
late the measures and were ignored. The pooled estimate was based on the available
clusters, which resulted in bias.
Coverage of nominal 90 percent condence intervals for the `pooled' cluster specic
validation measures were calculated based on analytical standard errors. Table 5.4
presents the results for all simulation scenarios under a high level of clustering ( =
0:98). For the uncensored survival simulations with large clusters, coverage for all the
validation measures was close to the nominal 90% value. For the censored survival
simulations, the unbiased validation measures had good coverage. Of these, Kw had
best coverage performance.
1395
.
4
S
i
m
u
l
a
t
i
o
n
s
t
u
d
y
Figure 5.10: Relative bias (%) in the `pooled estimates' of cluster-specic validation measures for dierent degrees of censoring.
The results are from the dierent simulation scenarios.
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y Figure 5.11: Relative rMSE (%) of the `pooled estimates' of the cluster-specic validation measures for dierent degrees of
censoring. The results are from the dierent simulation scenarios.
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15.5 Conclusion
In general, the pooled cluster-specic validation measures had poor coverage for
the censored survival simulations with small clusters, as their point estimates were
biased. Similar results were observed for the other simulations scenarios (not shown).
In addition, the validation measures had similar coverage performance to that discussed
above when bootstrap standard errors were used (not shown).
Table 5.4: Coverage of 90% nominal condence intervals for the `pooled cluster-specic'
measures. The condence intervals were calculated based on analytical standard errors.
The results are from the dierent simulation scenarios under  = 0:98. Maximum Monte
Carlo Standard Error=2.5%.
Pooled cluster-specic measures
Cluster  size Censoring Cw Kw Dw CSw IBSw
0 90 87 87 78 88
1010 20 86 87 75 86 71
50 71 83 70 75 72
80 74 77 65 70 20
0 88 90 88 91 86
1030 20 84 90 89 91 84
50 75 90 89 91 81
80 63 84 89 88 35
0 91 90 89 90 89
10100 20 82 90 90 91 83
50 55 89 90 90 84
80 30 89 91 91 41
0 61 84 42 55 73
5010 20 54 86 32 49 74
50 35 88 25 31 73
80 72 78 10 14 19
0 91 89 87 89 88
5030 20 88 90 87 88 81
50 69 89 84 86 84
80 32 88 76 75 38
5.5 Conclusion
This chapter has discussed extensions of some of the standard validation measures for
use with models for clustered survival data, using the same approach discussed for clus-
tered binary data. This has lead to an `overall measure' and a `pooled cluster-specic
measure', for each of the standard measures. Each of these approaches have three
dierent denitions based on the model's conditional predictions using the frailties,
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S(tj!), or setting the frailties at their mean, S(tj1), and the marginal predictions S(t).
This chapter has discussed the validation measures for use with S(tj!). The validation
measures for S(tj1) and S(t) can be derived in a similar manner to that discussed for
S(tj!).
The illustration of the validation measures using child mortality data from Bangladesh
showed that the measures have meaningful interpretations in clustered survival settings.
The statistical properties of the measures are also evaluated using simulation studies.
The validation measures, in general, behaved similarly as their corresponding standard
measures for independent survival data, particularly in the presence of censoring. The
`overall' K statistic (Kre) was not aected by censoring. The eect of censoring on the
D statistic (Dre) was negligible except for the small clusters, which is to be expected
since the distribution of the prognostic index was specied as normal. Based on central
limit theorem, the prognostic index, in practice, is likely to be normally distributed
as the number of predictors in the model increases. The eect of censoring on the
calibration slope (CSre) was also negligible in all simulation scenarios, except when the
clusters were small and the intra-cluster correlation exists. The C-index (Cre) showed
bias in the presence of censoring; the bias was acceptable for censoring up to 30%.
The IBS (IBSre ) performed poorly even when there is small amount of censoring in
the data. The `overall' validation measures, in general, were aected by the non-zero
intra-cluster correlation particularly when the clusters were small, possibly due to the
fact that the frailties are poorly estimated for these clusters. The pattern of the eect
of censoring on the `pooled cluster-specic' measures were similar to the correspond-
ing `overall' measures. The `pooled' measures, in general, were aected by the small
clusters when the level of censoring was high. This is because this approach ignores
some of the clusters due to lack of events to calculate the measures. These ndings are
similar to those with the validation measures for clustered binary outcome (Chapter
4).
Similar to the standard validation measures for independent survival outcome, these
validation measures also dier in their exibility regarding their assumptions and the
form of the prognostic model. The C-indices (Cre and Cw) only require that the
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prognostic model is able to rank the patients. However, the K statistics (Kre and
Kw) require that the prognostic model was tted using the proportional hazards (PH)
frailty model, that is, the proportional hazards assumption given the frailty holds.
The D statistics (Dre and Dw) assume that proportional hazards holds and that the
prognostic index is normally distributed. Similarly, the calibration slopes (CSre and
CSw) also assumes proportional hazards given the frailty. The predictive accuracy
measure IBS (IBSre and IBSw) only requires that a survival function given the frailty
can be calculated for all patients. In addition, all these measures have the same clinical
interpretation as their corresponding standard measures.
A similar pattern of recommendations regarding the practical use of these measures
for censored data can be made to those with the standard measures. The K statistic
(Kre and Kw) and calibration slope (CSre and CSw) can be recommended for validating
prognostic models developed with PH frailty model. The D statistic (Dre and Dw) can
be recommended provided that the distribution of prognostic index is normal. The C-
index (CSre and CSw) can be used when there is a relatively low amount of censoring,
for example, not more than 30%. The IBS (IBSre and IBSw) cannot be recommended
as they are aected by censoring. Generally, both the `overall' and `pooled cluster-
specic' measures are recommended to use in practice. However, one needs to check
whether the cluster sizes are suciently large (for example, greater than 30) before
using the `pooled' measures.
Similar to the analogous measures for clustered binary data, the validation measures
based on the model's conditional predictions using frailty, S(tj!), can be recommended
for validating models using subjects from the same clusters as that of the development
data. It would not be straightforward to use these methods when validation data in-
volve subjects from new clusters. In this case, validation measures based on marginal
predictions S(t) or conditional predictions setting the frailties at their mean, S(tj1),
could be used. If validation data involve several clusters with moderate to high vari-
ability between the clusters, these methods may not produce optimal results. One
alternative possibility is to investigate the characteristics of the new clusters to see
whether they are similar to that of the existing clusters of the development data. Then
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it may be reasonable to assume that clusters in both datasets were sampled from the
same population of clusters. In this case, one could estimate frailties from validation
data using the estimate of the frailty parameters from the development data and use
them to make predictions. If this happens, one may consider this as a form of model
re-calibration.
In summary, before choosing the validation measures, it is very important to check
the characteristics of the validation data. For example, one needs to check whether the
validation data involve the same or dierent clusters to those with the development
data, the level clustering, cluster size, the level of censoring, and the distribution of the
prognostic index.
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Summary and Conclusions
6.1 Summary of the research
Prognostic models play a vital role in the clinical management of patients by providing
useful information regarding a patient's future health status. These models also have
an important application in monitoring the performances of health institutions after
adjusting for the case mix of patients. Therefore, it is essential for prognostic models
to have the ability to make accurate predictions. One of the key requirements in
the prognostic modelling process is the availability of useful and reliable validation
measures to assess the predictive ability of these models. This research focuses on
validation measures for prognostic models for binary and survival outcomes. The thesis
starts with a motivation for this research in Chapter 1, followed by a description of the
general procedure for validating a prognostic model and a literature review of some
commonly used or proposed validation measures for binary and survival outcomes in
Chapter 2.
The literature review on the validation measures for binary and survival outcomes
suggests that validation measures for models for independent binary outcomes are well
developed. Although a number of measures have been proposed in the last two decades,
there is only limited guidance regarding their use in practice. A common feature of
survival data is censoring and ideally the validation measures should not be aected
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by censoring, however for some measures this may not be the case [52, 53]. This thesis
reviews, in Chapter 3, a wide range of validation measures proposed for independent
survival outcomes and evaluates their performances using an extensive simulation study
in order to make practical recommendations for their use.
In risk prediction research, patients' health outcomes are often clustered within a
larger unit, for example, outcomes measure on patients in a hospital, and are likely to
be correlated. Ignoring this clustering may lead to incorrect predictions. Therefore, one
needs to consider this clustering both in the process of model development and valida-
tion of its predictive ability. Random eects logistic and frailty models are often used
to develop models for clustered binary and survival outcomes, respectively. However,
only limited work has been done to develop validation measures to assess the predic-
tive ability of these models. The rest of this thesis focuses on validation measures that
could be used with random eects logistic and frailty models to make risk predictions
for clustered binary (Chapter 4) and survival outcomes (Chapter 5), respectively.
6.2 Summary of the methods and results
6.2.1 Validation measures for independent survival outcomes
The investigation, in Chapter 3, focuses on validation measures for independent survival
outcomes that have the potential of being routinely used in practice. The measures are
selected on the basis of their ease of interpretation and communication, and their avail-
ability or ease of implementation in commonly used statistical software. The validation
measures selected include the calibration slope [44] from the category of calibration
measures; Graf et al's integrated Brier score (IBS) [55] from the category of predictive
accuracy measures; Harrell's C-index [8], G onen and Heller's K statistic [48] and Roys-
ton and Sauerbrei's D [49] from the discrimination measures; and Graf et al's R2
IBS [55]
and Schemper and Henderson's V [23] from the explained variation category. Using
a simulation study based on two clinical datasets with contrasting characteristics, the
performance of the validation measures are compared with respect to their robustness
to the degree of censoring and sensitivity to the exclusion of important predictors from
the model.
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The results from simulation study suggest that the calibration slope (CS) and K
statistic showed negligible bias induced by censoring, which is to be expected since
both are derived from the Cox model. The performance of D statistic depended on
the distribution of the prognostic index derived from the model. Provided that the
prognostic index is normally distributed, the bias in D was negligible. By central
limit theorem, the prognostic index, in practice, is likely to be normally distributed as
the number of predictors in the model increases. The C-index, the most widely used
measure, showed increasing bias with the increasing level of censoring, which may be
expected as it depends on the censoring mechanism. The bias may be acceptable for
censoring up to 30%. The measures of predictive accuracy and explained variation
(IBS, R2
IBS, and V ) performed poorly in the presence of censoring, despite their use
of weighting to alleviate the eect of censoring. The bias in all cases suggests that it
is possible to reach misleading conclusions regarding a prognostic model's predictive
performance using these measures in the presence of censoring. Censoring is a common
feature in survival data and typically the degree of censoring will exceed 20% in most
real clinical datasets. Thus validations measures for censored survival data need to be
selected after careful consideration.
All the validation measures investigated, except the calibration slope, showed sen-
sitivity to the omission of important predictors from a model. However, the ranked-
based measure, the C-index, was less sensitive than the other measures, which may be
expected as it does not incorporate the actual dierence between predictions. The cal-
ibration slope showed only limited sensitivity to omission of important predictor since
the developed risk model eectively re-calibrates itself to compensate for the omitted
predictors.
The validation measures dier in their exibility regarding their assumptions and
the form of the prognostic model. Of the discrimination measures, the C-index only
require that the prognostic model is able to rank the patients. In contrast, K() re-
quires that the prognostic model was tted using the Cox proportional hazards model.
The D statistic assumes that proportional hazards holds and that the prognostic index
is normally distributed. The calibration slope also assumes proportional hazards, al-
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though more general approaches are described by van Houwelingen [44]. The measures
based on predictive accuracy, IBS, R2
IBS, and V , only require that a survival function
can be calculated for all patients.
Based on the ndings of this simulation study, of the discrimination measures, K()
can be recommended for validating a prognostic model developed using the Cox pro-
portional hazards model, since it is both robust to censoring and reasonably sensitive
to the omission of important predictors. The D statistic can also be recommended
provided that the distribution of the prognostic index derived from the model is ap-
proximately normal. It is more sensitive to predictor omission than K() and can be
calculated for models other than those tted using the Cox model. The C-index was
aected when data have high level of censoring and cannot be recommended for use
with data with more than 30% censoring. The calibration slope can be recommended
as a measure of calibration since it is not aected by censoring although it is less sen-
sitive than the other measures to the omission of important predictors. In practice,
one might additionally investigate calibration graphically by comparing observed and
predicted survival curves for groups of patients. This approach also has the benet of
being easy to communicate. The measures of predictive accuracy (IBS) and explained
variation (V and R2
IBS) cannot be recommended for use with survival risk models due
to their poor performance in the presence of censored data. However, these measures
were all conservative with censored data so that high (or low for IBS) values would
still be indicative of a good prognostic model.
In practice, it is very important to investigate the characteristics of the validation
data before choosing the validation measures. In particular, one needs to check the level
of censoring and the distribution of the prognostic index, assuming that the standard
model assumptions such as proportional hazards hold. It is not clear that this is
routinely done in practice.
6.2.2 Validation measures for clustered data
Chapter 4 shows extensions of some of the standard validation measures for use with
models for clustered binary outcomes. These are the C-index [45] and D-statistic
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[49] (both assess discrimination), the calibration slope [39, 42] (assesses calibration),
and the Brier score [55] (assesses predictive accuracy). Two approaches, termed as
the `overall' and `pooled cluster-specic' are proposed to calculate these measures for
clustered data. Each approach can produce three dierent measures depending on how
the random eects estimates are used in predictions from the model. For example,
conditional predictions can be obtained by either using the random eects estimates in
predictions or setting them at their mean value of zero. Marginal predictions can be
obtained by integrating out the random eects.
The new validation measures are illustrated by developing a model that predicts
in-hospital mortality following heart valve surgery in UK hospitals and validating its
predictive performance. Both the `overall' and `pooled cluster-specic' measures are
shown to have meaningful interpretation in a clustered data setting. Additionally,
the separate cluster-specic estimates can be used to identify clusters where model
performance is either good or poor compared to the average performance. It would
be of great interest to investigate the factors which explain this heterogeneity. One
possibility is the unobserved cluster level characteristics or mis-specication of the
model. Simulation studies were conducted to evaluate the performance of the measures
under a range of conditions related to clustered data. The `overall' measures based on
the conditional predictions using the estimates of the random eects showed reasonably
good performance in a range of conditions, except for those where the clusters were
small. This is because the empirical Bayes estimates of the random eects were poorly
estimated for these clusters. These ndings are similar to those obtained by Oirbeek
and Lesare [131]. The validation measures based on the marginal predictions and
the conditional predictions that set the random eects to be zero performed poorly in
the presence of clustering, because they ignore the eect of clustering. In general, the
`pooled cluster-specic' measures had reasonably good performance when the clusters
were large. They showed bias for small clusters, since this approach ignores information
from clusters that have very few events.
The validation measures for clustered binary outcome also dier in their exibility
regarding their assumptions and the form of the prognostic model. Therefore one
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needs to be careful about these before choosing the measures. Both the parametric
C-index and D statistic require that the prognostic index derived from the model
should be normally distributed. In contrast, the non-parametric C-index only requires
that the prognostic model is able to rank the patients. The calibration slope (CS)
assumes that the model is correctly specied. The Brier score only requires that a
risk algorithm can be calculated for all patients. In practice, the non-parametric C-
index, calibration slope, and Brier score are recommended since they are free from
a distributional assumption of the prognostic index. The parametric C-index and D
statistic can be used provided that the prognostic index is normally distributed.
In Chapter 5, the calibration slope, Harrell's C-index, K statistic, D statistic, and
the Integrated Brier score (IBS) are extended for use with proportional hazards frailty
model for clustered survival outcomes, using the same approach as that discussed for
clustered binary outcomes. This chapter discusses the use of these measures only for
model's conditional predictions that use empirical Bayes estimates of the frailties. Us-
ing this approach, it is straightforward to extend the measures for use with marginal
predictions and conditional predictions that set the frailties to be one or log-frailties to
be zero. An application of these validation measures is illustrated using child mortality
data from Bangladesh. A simulation study was conducted to assess the eect of censor-
ing on these measures under various clustered survival data scenarios. The validation
measures behaved similarly as the corresponding standard measures for independent
survival data, particularly in the presence of censoring. For example, the `overall' K
statistic (Kre) showed good performance against censoring in a range of conditions.
The prognostic index was specied as normal throughout the simulations and thus the
eect of censoring on the D statistic (Dre) was negligible when the clusters were large.
Similar results were observed for the calibration slope. However, the C-index (Cre)
was aected by censoring; the bias was acceptable for censoring up to 30%. Similar
to the standard measures, IBS (IBSre) had poor performance even when data have
small amount of censoring. In general, the measures were aected by the non-zero
intra-cluster correlation particularly when the clusters were small, possibly due to the
poor estimation of the frailties. Similar to the analogous measures for clustered binary
data, the `pooled' measures had poor performance for the small clusters, probably due
to ignoring the clusters that have few events.
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Similar to the standard measures, the validation measures for clustered survival
data dier in their exibility regarding their assumptions and the form of the prognostic
model. The C-index (Cre and Cw) only requires that the prognostic model is able to
rank the patients. However, the K statistic (Kre and Kw) requires that the prognostic
model was tted using the proportional hazards (PH) frailty model. The D statistic
(Dre and Dw) assumes that proportional hazards given the frailty holds and that the
prognostic index is normally distributed. Similarly, the calibration slope (CSre and
CSw) also assumes proportional hazards given the frailty. The predictive accuracy
measure IBS (IBSre and IBSw) only requires that a survival function given the frailty
can be calculated for all patients. One should be aware of these before choosing the
measures.
A similar pattern of recommendations regarding the practical use of these measures
for censored data can be made to those with the standard measures. For example, the
K statistic (Kre and Kw) and calibration slope (CSre and CSw) can be recommended
for validating prognostic model developed with PH frailty model. The D statistic (Dre
and Dw) can be recommended provided that the distribution of prognostic index is
normal. The C-index (Cre and Cw) cannot be recommended for censoring more than
30%. IBS (IBSre and IBSw) cannot be recommended.
In practice, both the `overall' and `pooled cluster-specic' measures are recom-
mended to use when validating models for clustered data. However, one needs to
investigate whether the clusters in the validation data are suciently large (for exam-
ple, greater than 30) and each of these contains at least two events before using the
`pooled' measures.
An important issue that one should consider when validating model for clustered
data is whether the validation data involve the same clusters as the development data
or involve new clusters. If the clusters are the same for which the random eects are
known, conditional predictions using the random eects and the validation measures
based on this approach are recommended to assess the predictive ability of the model.
It is not straightforward to use this approach for validating model using subjects from
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new clusters, since the random eects are unknown. In such circumstances, one option
would be to investigate the characteristics of the new clusters to see whether they
match those of the clusters in the development data. For example, when predicting
clinical outcomes in hospitals one could investigate the prevalence of the outcome,
the geographical location, the experience of the clinicians, sta to patient ratios, and
information on other relevant factors that could be obtained from routinely collected
hospital data. If these important characteristics are similar for the development and
validation hospitals, it may then be appropriate to assume that the development and
validation hospitals come from the same population. Then the random eects could be
estimated from the validation data using the information from the development data,
provided that the number of patients in each hospital is not small, for example, not
less than 30. When the random eects are estimated from the validation data and
used in the predictions, this may be considered as a form of model re-calibration. One
could also inspect the value of the between cluster variance in the development data
to examine how closely it agrees with that in the validation data and infer whether it
is reasonable to use predictions based on the random eects from the validation data.
Thus the estimate of the between cluster variance for development data clusters will
need to be published along with the risk algorithm by the model developers. If the
number of clusters in both validation and development data are of reasonable size, one
could use more formal method of comparison such as examining whether the condence
intervals for the between cluster variances from the two datasets overlap or use F-test
(for models with normally distributed random eects). However, the equality in the
level of clustering between both datasets may be unlikely in practice.
Alternatively, the marginal predictions or conditional predictions setting the ran-
dom eects at their mean value and the validation measures based on these approach
could be used. However, if the validation dataset involves several new clusters, and there
is a moderate to high degree of variation between these clusters, then the validation
measures based on these two approaches may not produce optimal results regarding
the model predictive performance. However, they are conservative with the level of
clustering so that high (low for Brier score) values would still imply a model with good
predictive ability. However, any form of validation for clustered data would require
expert statistical skills and thus may not be suitable to be done by clinicians
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6.3 Conclusions
This research describes and evaluates a range of existing and new statistical measures
for validating prognostic models for both independent survival outcomes and clustered
binary and survival outcomes. In one part of this research (Chapter 3), recommen-
dations for the practical use of some of the validation measures for standard survival
models have been presented. In other parts (Chapters 4 and 5), this research extended
the calibration slope (CS), C-index, D statistic, K statistic, and Brier score for use
with models for clustered binary and survival outcomes. The use of these measures
when making predictions in validation data that includes either the same or dierent
clusters to those in the development data are also discussed.
An important point to note is that one needs to investigate the characteristics of
the validation data before choosing the validation measures. In particular, one needs
to check whether the clusters in the validation data are the same or dierent to those
with the development data, the level clustering, cluster size, the level of censoring (for
survival outcome), and the distribution of the prognostic index.
6.4 Possibilities for future research
A number of areas have been identied where further research is possible. These are
now described as follows.
In Chapter 3, the investigation of validation measures for standard survival models
is conducted based on the Cox proportional hazards model under a range of scenar-
ios. Further investigation could be conducted based on other survival models such as
lognormal and accelerated failure time (AFT) models to assess whether the measures
perform well for these models. Based on the simulation results one could recommend
whether these measures are generalisable to all of these survival models. In addition,
further investigation may be required to see whether the measures are sensitive to model
mis-specication (if a wrong model is tted).
1546.4 Possibilities for future research
In Chapter 4 and 5, the `overall' validation measures that use the random eects
showed bias when the clusters are small. The bias is due to the use of the empirical
Bayes estimates of the random eects that are not well estimated for small clusters.
Therefore, methods for estimating random eects for small clusters would be another
area of research. Simple alternatives are to consider empirical Bayes mode rather than
empirical Bayes mean of the posterior distribution of the random eects or to t clusters
as xed eects rather than random eects.
The validation measures for clustered data are estimated and assessed only under
the Normal or Gamma distribution of the random or frailty eects for the logistic
and Cox models, respectively. Therefore, estimation and assessment of the validation
measures assuming other distributions of the random eects, for example, log-normal
(random eects logistic models) and inverse Gaussian (frailty models), could be an area
of further research. With this one could assess the sensitivity of the measures to the
distribution of the random or frailty eects.
The simulation studies for clustered data were conducted by generating data from a
true model based on random eects logistic or frailty models. A possible alternative to
these models are marginal models. It may be interesting if one generates clustered data
where the true model is marginal and assess the performance of the validation measures
based on the random eects models. This would help us to assess the sensitivity of the
measures to model mis-specication (a random eects or frailty model is tted where
true model is marginal).
In reality there is likely to be imbalance in the cluster sizes. A more detailed
investigation could be conducted to assess whether the degree of imbalance in cluster
sizes for validation data may aect the performance of the validation measures, both
for binary and survival outcomes.
It may also be of interest to examine how the validation measures developed for
clustered data respond to omission of important predictors.
1556.4 Possibilities for future research
External validation in prognostic modelling process is essential. Therefore, future
research is required to identify the best approach to validate a model's predictive per-
formance through an external validation exercise where the validation data include a
number of new clusters
Further work could involve in devising approaches to investigate the performance
of Hosmer-Lemeshow test for clustered binary data.
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Additional Results for Chapter 3
Table A.1 describes the results of the breast cancer and sudden cardiac death simula-
tions with dierent risk proles, under administrative censoring mechanism. Table A.2
shows the estimates of the Cox PH model obtained from breast cancer data. Similarly,
Table A.3 shows the Cox PH estimates obtained from sudden cardiac death data.
157Table A.1: Relative bias (%) and 95% CIs are given by censoring proportions. The results are from the (a) breast cancer simulations
(maximum Monte Carlo standard error (%)=0.88) and (b) sudden cardiac death simulations (maximum Monte Carlo standard error
(%)=0.82), with dierent risks prole (low, medium, and high) and under administrative censoring mechanism.
CS IBS D K() C-index V R2
IBS
Scenarios% cens bias CIs bias CIs bias CIs bias CIs bias CIs bias CIs bias CIs
0 -0.4 [-0.9, 0.2] -0.7 [-1.4, 0.0] -0.5 [-1.1, 0.1] -0.2 [-0.7, 0.3] -0.8 [-1.4, -0.3] -0.4 [-0.8, 0] -0.3 [-0.6, 0]
low 20 -0.1 [-0.7, 0.6] 2.1 [1.6, 2.7] 1.4 [0.8, 2.1] -0.4 [-0.9, 0.1] 2.0 [1.3, 2.6] -8.3 [-9.8, -7.1] -3.3 [-6.7, -0.1]
50 -0.2 [-0.9, 0.5] 10.4 [9.5, 11.5] 4.0 [3.2, 4.9] -0.6 [-1.2, 0.0] 5.6 [4.7, 6.4] -19.4 [-20.9, -17.8] -7.3 [-12.1, -2.3]
80 0.2 [-0.8, 1.3] 19.4 [17.8, 21.1] 7.8 [6.6, 9.1] -0.4 [-1.2, 0.5] 11.5 [10.2, 12.7] -39.2 [-40.8, -37.8] -18.2 [-24.4, -12.5]
0 -0.3 [-0.8, 0.3] 0.5 [-0.2, 1.2] -0.3 [-0.8, 0.3] 0.1 [-0.5, 0.3] -0.2 [-0.7, 0.3] -0.3 [-0.7, 0.1] 0.1 [-0.3, 0.5]
(a) medium 20 0.0 [-0.5, 0.5] 2.2 [1.6, 3.8] 0.4 [-0.2, 1.0] 0.1 [-0.3, 0.5] 1.7 [1.1, 2.2] -10.2 [-11.7, -8.9] -4.1 [-8.2, -0.1]
50 0.2 [-0.5, 0.9] 11.5 [10.5, 12.5] 0.8 [-0.1, 1.6] 0.2 [-0.4, 0.7] 4.5 [3.7, 5.2] -21.1 [-22.6,-19.5] -8.0 [-12.9, -3.2]
80 0.7 [-0.4, 1.8] 16.5 [14.8, 18.3] 0.8 [-0.3, 1.9] 0.3 [-0.5, 1.2] 7.7 [6.5, 8.8] -31.9 [-33.2, -30.1] -14.9 [-20.5, -8.6]
0 0.2 [-0.4, 0.8] -0.3 [-0.8, 0.2] 0.2 [-0.4, 0.8] 0.0 [-0.5, 0.5] -0.2 [-0.8, 0.4] 0.3 [-0.1, 0.7] -0.3 [-0.7, 0.1]
high 20 -0.4 [-1.0, 0.3] 2.8 [1.8, 3.3] 1.2 [0.5, 1.8] -0.5 [-1.0, 0.0] 1.3 [0.4, 1.9] -8.2 [-10.4, -6.4] -3.6 [-10.7, -0.6]
50 0.1 [-0.7, 0.9] 10.5 [9.5, 11.1] 2.2 [1.5, 3.0] -0.2 [-0.8, 0.4] 2.6 [1.6, 3.4] -18.3 [-20.2, -16.5] -10.8 [-15.0, -6.6]
80 1.0 [-0.1, 2.2] 14.5 [13.6, 15.5] 2.8 [1.8, 3.9] 0.3 [-0.6, 1.3] 3.9 [2.8, 5.2] -38.1 [-39.3, -36.8] -16.5 [-21.5, -11.4]
0 0.2 [-0.2, 0.7] 0.1 [-0.3, 0.5] 0.1 [-0.4, -0.5] 0.2 [-0.3, 0.7] 0.2 [-0.3, 0.7] -0.3 [-0.7, 0.1] -0.1 [-0.6, 0.5]
low 20 -0.1 [-0.5, 0.4] 2.7 [2.2, 3.2] 3.5 [2.9, 3.9] -0.1 [-0.5, 0.3] 3.1 [2.5, -3.6] -9.8 [-12.7, -7.8] -11.9 [-14.2, -12.0]
50 -0.2 [-0.7, 0.3] 11.1 [10.2, 12.0] 8.7 [7.5, 9.9] -0.1 [-0.6, 0.4] 9.1 [8.2, 10.1] -24.1 [-28.1, -20.9] -16.3 [-18.5, -14.1]
80 0.1 [-0.7, 0.8] 18.6 [17.1, 20.1] 17.6 [16.5, 18.7] 0.5 [-0.1, 1.1] 17.7 [15.7, 19.6] -43.7 [-47.3, -39.2] -25.2 [-29.5, -21.0]
0 0.0 [-0.4, 0.4] -0.2 [-0.5, 0.1] 0.0 [-0.4, 0.4] 0.2 [-0.1, 0.5] 0.1 [-0.3, 0.5] 0.5 [-0.1, 1.0] 0.3 [-0.2, 0.8]
(b) medium 20 0.1 [0.0, 0.2] 4.6 [4.1, 5.1] 2.7 [2.3, 3.1] 0.2 [-0.2, 0.5] 2.7 [2.3, 3.1] -10.9 [-12.1, -10.0] -7.8 [-8.9, -6.7]
50 -0.1 [-0.4, 0.3] 10.2 [9.7, 11.0] 7.1 [6.5, 7.6] 0.2 [-0.2, 0.6] 7.5 [6.9, 8.0] -17.7 [-19.6, -15.6] -14.3 [-16.4, -11.8]
80 0.1 [-0.4, 0.5] 17.7 [16.7, 18.8] 11.2 [10.3, 12.3] 0.2 [-0.4, 0.8] 13.9 [13.0, 14.7] -35.2 [-38.7, -32.4] -21.9 [-24.1, -21.4]
0 -0.1 [-0.4, 0.3] 0.5 [-0.1, 1.1] 0.1 [-0.2, 0.4] -0.1 [-0.3, 0.1] 0.5 [0.3, 0.9] 0.3 [-0.2, 0,8] 0.3 [-0.2, 0.8]
high 20 0.1 [-0.4, 0.5] 3.3 [2.8, 3.8] 1.8 [1.5, 2.0] 0.3 [-0.1, 0.7] 2.4 [1.9, 2.8] -12.5 [-14.8, -10.3] -6.7 [-8.8, -4.6]
50 -0.1 [-0.6, 0.3] 8.5 [7.4, 9.6] 4.1 [3.6, 4.5] 0.2 [-0.3, 0.7] 5.8 [5.2, 6.3] -25.1 [-29.1, -21.0] -10.4 [-12.7, -8.1]
80 0.4 [-0.4, 1.1] 12.4 [11.4, 13.4] 7.4 [6.7, 8.2] 0.1 [-0.5, 0.7] 10.6 [9.7, 11.5] -35.1 [-39.1, -31.3] -20.2 [-23.6, -17.1]
1
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8Table A.2: The Cox model estimates for the breast cancer data
Predictors Meas. scale Mean(SD)/% HR 95% CI P-value
lymph nodes (lnod) log 1.16(0.94) 1.61 [1.41, 1.83] < 0:001
progesterone status (progst) log 3.35(1.93) 0.82 [0.76, 0.89] < 0:001
hormone no 64.1 1.00 < 0:01
yes 35.9 0.68 [0.53, 0.87]
menopausal status (menst) pre 42.3 1.00 < 0:01
post 57.7 1.33 [0.95, 1.88]
age  45 22.3 1.00 0.068
45-60 50.3 0.66 [0.46, 0.94]
> 60 27.4 0.65 [0.41, 1.02]
tumour grade (tgrad) 1 11.8 1.00 0.102
 2 64.7 1.69 [1.03, 2.77]
3 23.5 1.74 [1.01, 3.00]
tumour size (tsize) log 3.27(0.46) 1.21 [0.93, 1.56] 0.151
-2loglikelihood= 3436.10; Likelihood Ratio=138.91 with d.f=9
Table A.3: The Cox model estimates for the sudden cardiac death data
Predictors Meas. scale Mean(SD)/% HR 95% CI P-value
runs-ventricular-tachycardia (runvent) none 83.5 1.00 < 0:001
1 10.4 2.40 [1.32, 4.33]
2+ 6.1 2.69 [1.36, 5.28]
obstruction to blood ow (BF) mmHg 30.8(35.2) 1.01 [1.00, 1.02] < 0:001
blood pressure during exercise (BP) normal 74.7 1.00 < 0:01
abnormal 25.3 1.82 [1.14,2.89]
thickness of heart muscle (HM) mm 19.5(6.1) 1.04 [1.00,1.07] < 0:05
age years 37.8 (16.2) 0.98 [0.97, 1.00] 0.11
-2loglikelihood= 1032.70; Likelihood Ratio=36.03 with d.f=6
159Appendix B
Stata code for validation
measures
Figure B.1: Stata code for calculating D-statistic, Gonen and Heller'
K, Integrated Brier score, and Schemper and Henderson' V measures
for independent survival data.
set obs 500
qui gen index=_n
qui gen IBSx=.
qui gen IBS0=.
qui gen IRsq=.
qui gen V=.
qui gen D=.
qui gen K=.
local reps 500
local seed=6734535
set seed `seed'
forvalues j=1/`reps'{
preserve
***generating data***
qui set obs 500
local haz=0.2 // this gives 20% censoring on average
qui gen x=invnormal(runiform()) // x from standard normal
qui gen xb0=1.2*x // beta=1.2
qui gen t_fail=(-1/exp(xb0)*log(uniform()))^(1/0.45) //shape=0.45 and scale=1
qui gen t_cens=(-1/(`haz')*log(uniform()))^(1/0.45)
qui gen time_sm=min(t_fail,t_cens)
qui gen byte d=(t_fail<=t_cens)
160***fitting Cox Model***
qui stset time_sm, f(d)
qui stcox x, nohr basesurv(bsurv) // model with covariates x
predict xb, xb
qui stcox, estimate basesurv(st0) // null model
***D statistics***
sort xb
gen z= invnorm(((_n-3/8)/(_N+1/4)))/sqrt(8/_pi)
qui stcox z, nohr
local D=_b[z]
***Gonen & Heller's K***
qui tempvar Phi
qui gen double Phi=.
qui gen wv=1
qui local i=1
qui while `i'<=_N {
qui local x=xb[`i']
qui tempvar phi Fhi
qui gen float phi=wv if xb<`x'
qui replace phi= 0 if xb>`x'
qui gen float Fhi=phi/(1+exp(xb-`x'))
qui sum Fhi, meanonly
qui replace Phi=r(sum) if _n==`i'
qui drop phi Fhi
qui local i=`i'+1
}
qui sum Phi, meanonly
qui gen sumPhi=r(sum)
qui gen K=2*sumPhi/(_N*(_N-1))
***Graf et al.'s IBS and IRsq, and Schemper and Henderson's V***
qui sort time_sm
qui gen tm_d=time_sm if d==1
qui sum tm_d
local tau=r(max) //maximum event-time; we calculate IBS up-to this time point
qui gen yt=0 if time_sm<=`tau'
qui replace yt=1 if time_sm>`tau'
qui sts gen km=s //K-M survival probability to calculate weight function
set obs 501
qui replace _t=`tau' in 501
ipolate km _t, gen(ks2) epolate
qui summarize ks2 if _t==`tau'
local gt1=r(mean)
qui gen wt1=(1-km)/(1-`gt1') // calculate weight function to use in IBS
qui gen exb=exp(xb)
qui gen delta=1 if d==0
qui replace delta=0 if d==1
161qui stset time_sm, f(delta) // censoring indicator reverse
qui sts gen gt=s //calculate K-M estimate of not being censored
qui gen wt=1/gt //calculate weight to compensate earlier censoring
tempvar Mt Mt0 Bst Bst0
qui gen double Mt=.
qui gen double Mt0=.
qui gen double Bst=.
qui gen double Bst0=.
sort time_sm
qui gen sumd=sum(d) if d==1
qui gen wv=1
qui gen bsurvj=bsurv if d==1 // baseline survival probability at each event-time
qui gen st0j=st0 if d==1 // survival estimate of null model at each event-time
local i=1
while `i'<=_N {
sort time_sm
local time=time_sm[`i']
local st0=st0[`i']
local st0j=st0j[`i']
local bsurv=bsurv[`i']
local bsurvj=bsurvj[`i']
local wtg=wt[`i']
tempvar y st bs bs0 mt mt0 stj
qui gen float y=wv if time_sm>`time' //actual survival status at each time point
qui replace y= 0 if time_sm<`time'
qui gen float st=(`bsurv')^exb //based on model with x at each observed time
qui gen float stj=(`bsurvj')^exb //based on model with x at each event-time
*Brier score********
qui gen float bs=d*(1-y)*(0-st)^2*(wt)+y*(1-st)^2*(`wtg')//from model with x
sum bs, meanonly
qui replace Bst=r(mean) if _n==`i'
qui gen float bs0=d*(1-y)*(0-`st0')^2*(wt)+y*(1-`st0')^2*(`wtg')//from null model
sum bs0, meanonly
qui replace Bst0=r(mean) if _n==`i'
*Mtx and Mt0 part of V*******
qui gen float mt=y*(1-stj)+(1-y)*stj+(1-d)*(1-y)*((1-stj)*(stj/st)
+stj*(1-stj/st)) if d==1 // based on model with x
sum mt, meanonly
qui replace Mt=r(mean) if _n==`i'
qui gen float mt0=y*(1-`st0j')+(1-y)*`st0j'+(1-d)*(1-y)*((1-`st0j')*(`st0j'/`st0')
+`st0j'*(1-`st0j'/`st0')) if d==1 // based on null model
sum mt0, meanonly
qui replace Mt0=r(mean) if _n==`i'
drop y st bs bs0 mt mt0 stj
local i=`i'+1
}
***Integrated BS***
162qui integ Bst wt1 if yt==0, trapezoid gen(BS_x)
local IBSx=r(integral) //integrated Brier score based on the model with x
qui integ Bst0 wt1 if yt==0, trapezoid gen(BS_0)
local IBS0=r(integral) //integrated Brier score based on the null model
local IRsq=1-`IBSx'/`IBS0' // R-square
***Dx and D0 part of V***
qui gen w=sumd/gt if d==1
qui replace Mt0=Mt0*w
qui replace Mt=Mt*w
qui sum w if yt==0
local sumw=r(sum)
qui sum Mt0 if yt==0
local Mt00=r(sum)
local D0=`Mt00'/`sumw'
qui sum Mt if yt==0
local Mtx=r(sum)
local Dx=`Mtx'/`sumw'
local V=1-`Dx'/`D0'
**line Bst Bst0 time_sm if yt==0 //to draw graph for BS over the entire follow-period
restore
qui replace IBSx=`IBSx' if index==`j'
qui replace IBS0=`IBS0' if index==`j'
qui replace IRsq=`IRsq' if index==`j'
qui replace V=`V' if index==`j'
qui replace D=`D' if index==`j'
}
Figure B.2: Stata code for calculating validation measures for clus-
tered binary data: C-index, D-statistic, Calibration slope, and Brier
score.
qui set obs 500
local seed=1677445
qui gen index=_n
qui gen Cre=.
qui gen Dre=.
qui gen CSre=.
qui gen BSre=.
qui gen seCre=.
qui gen seDre=.
qui gen seCSre=.
set seed `seed'
local reps=500
forvalues j=1/`reps'{
preserve
163********************************
*generate development data*
********************************
qui set obs 10000
qui gen rnd=uniform()
qui xtile cluster=rnd, n(100)
qui gen u=invnormal(runiform())
qui bysort cluster:replace u=u[1]
qui gen x=invnormal(runiform())
local total sigmau+sigmae=1.4 //varying sigmau gives different ICC values
*local sigmau=0.0 // ICC 0%
*local sigmau=0.44 // ICC 5%
*local sigmau=0.68 // ICC 10%
local sigmau=0.88 // ICC 20%
local sigmae=sqrt(1.4^2-`sigmau'^2)
qui gen z=-1.8+`sigmae'*x+`sigmau'*u
qui gen p=1/(1+exp(-z))
qui gen y=(runiform()<p)
***Fitting random intercept logistic model*****
qui gllamm y x, i(cluster) link(logit) family(binomial) adapt nip(20)
qui estimates store gllamm
clear
******************************************************
*generate validation data of 10 clusters of size 300*
******************************************************
qui set obs 3000
qui gen rnd=uniform()
qui xtile cluster=rnd, n(10)
qui gen u=invnormal(runiform())
qui bysort cluster:replace u=u[1]
qui gen x=invnormal(runiform())
local total sigmau+sigmae=1.4 //total variability is fixed
*local sigmau=0.0 // ICC 0%
*local sigmau=0.44 // ICC 5%
*local sigmau=0.68 // ICC 10%
local sigmau=0.88 // ICC 20%
local sigmae=sqrt(1.4^2-`sigmau'^2)
qui gen z=-1.8+`sigmae'*x+`sigmau'*u
qui gen p=1/(1+exp(-z))
qui gen y=(runiform()<p)
******************************************************************
*calculation of the C-index, D-statistic and Brier score measures*
******************************************************************
qui estimates restore gllamm // estimates from development data are restored
qui gllapred eb, u fsample // empirical Bayes estimates from validation data
qui gllapred condpred, mu us(ebm) fsample // cond. pred. with random effect(u)
164qui gllapred margpred, mu marginal fsample // marginal predictions
qui gen zeta1=0
qui gllapred condpred0, mu us(zeta) fsample // cond. pred. with u set to zero
qui gen xb=ln(condpred/(1-condpred))
qui gen xb0=ln(condpred0/(1-condpred0))
qui gen xbm=ln(margpred/(1-margpred))
**** nonparametric Overall C-index****
qui sum xb if y==1
local N1=r(N)
qui sum xb if y==0
local N0=r(N)
tempvar Phi
qui gen double Phi=.
qui gen wv=1
sort cluster y xb
local i=1
while `i'<=_N {
tempvar phi Fhi
local x=xb[`i']
if y[`i']==1 {
sort cluster
qui by cluster:gen float phi=wv if xb<`x' & y==0
qui by cluster:replace phi= 0.5*wv if xb==`x' & y==0
qui by cluster:replace phi= 0 if xb>`x' & y==0
qui by cluster:egen float Fhi=sum(phi)
qui by cluster:replace Fhi=0 if _n!=1
sum Fhi, meanonly
qui replace Phi=r(sum) if _n==`i'
}
else {
qui by cluster:gen float phi=wv if xb>`x' & y==1
qui by cluster:replace phi= 0.5*wv if xb==`x' & y==1
qui by cluster:replace phi= 0 if xb<`x' & y==1
qui by cluster:egen float Fhi=sum(phi)
qui by cluster:replace Fhi=0 if _n!=1
sum Fhi, meanonly
qui replace Phi=r(sum) if _n==`i'
}
qui drop phi Fhi
local i=`i'+1
}
qui gen Phi1=Phi if y==1
qui by cluster:egen theta00=sum(Phi1)
qui by cluster:replace theta00=0 if _n!=1
sum theta00, meanonly
qui gen theta22 =r(sum)
local Cre=theta22/(`N1'*`N0')
qui drop theta00 theta22 Phi1
165****SE of C-index****
qui by cluster:gen v10=Phi/(`N0') if y==1
qui by cluster:egen v10_s=sum(v10)
qui by cluster:gen v01=Phi/(`N1') if y==0
qui by cluster:egen v01_s=sum(v01)
sort cluster y
qui by cluster y:gen Ng=_N
qui by cluster:gen mi=Ng if y==1
qui by cluster:egen m=mean(mi)
qui by cluster: replace m=0 if m==.
qui by cluster:gen ni=Ng if y==0
qui by cluster:egen n=mean(ni)
qui by cluster: replace n=0 if n==.
qui by cluster:gen D10_1=(v10_s-m*`Cre')
qui by cluster:gen D10=D10_1^2 if _n==1
qui by cluster:replace D10=0 if _n!=1
qui by cluster:gen D01_1=(v01_s-n*`Cre')
qui by cluster:gen D01=D01_1^2 if _n==1
qui by cluster:replace D01=0 if _n!=1
qui tab cluster if y==1
local N10=r(r)
qui tab cluster if y==0
local N01=r(r)
qui egen S10=sum(D10)
qui replace S10=(S10*`N10')/((`N10'-1)*`N1')
qui egen S01=sum(D01)
qui replace S01=(S01*`N01')/((`N01'-1)*`N0')
qui by cluster:gen DD=D10_1*D01_1
qui by cluster:replace DD=0 if _n!=1
qui egen DD1=sum(DD)
qui tab cluster
local I=r(r)
qui gen S11=(DD1*`I')/(`I'-1)
qui gen var_Cbcn=S10/`N1'+S01/`N0'+(2*S11)/(`N1'*`N0')
local seCre=sqrt(var_Cbcn)
qui drop v* S* D* mi ni Ng
****D-statistics****
sort xb
qui gen zre= invnorm(((_n-3/8)/(_N+1/4)))/sqrt(8/_pi)
qui logit y zre
local Dre=_b[zre]
local seDre=_se[zre]
***CalibrationSlope***
qui logit y xb
local CSre=_b[xb]
local seCSre=_se[xb]
166***Brier score***
qui gen bs=(y-condpred)^2
sum bs, meanonly
local BSre=r(mean)
*******************************
di `j'
restore
qui replace Cre=`Cre' if index==`j'
qui replace Dre=`Dre' if index==`j'
qui replace CSre=`CSre' if index==`j'
qui replace BSre=`BSre' if index==`j'
qui replace seCre=`seCre' if index==`j'
qui replace seDre=`seDre' if index==`j'
qui replace seCSre=`seCSre' if index==`j'
}
Figure B.3: Stata code for calculating validation measures for clus-
tered survival data: Harrell's C-index, Gonen and Heller's K, D statis-
tic, Integrated Brier score (IBS).
qui set obs 500
qui gen index=_n
qui gen Cre=.
qui gen Kre=.
qui gen Dre=.
qui gen CSre=.
qui gen seCre=.
qui gen seKre=.
qui gen seDre=.
qui gen seCSre=.
qui gen IBSx=.
qui gen IBS0=.
qui gen IRsq=.
local reps=500
forvalues j=1/`reps'{
preserve
***************************
*generate development data
***************************
set obs 1500
gen cluster=int(uniform()*50)+1
*local theta=0.0 // no corr
local theta=0.58 // moderate corr
*local theta=0.98 // high corr
local beta=1.35
local lambda=0.0 //censoring 0%
local gamma=1.1
167gen mu=rgamma(1/`theta', `theta')
qui bysort cluster:replace mu=mu[1]
qui gen x=invnormal(runiform())
qui gen xb0=`beta'*x
qui gen t_fail=(-1/(mu*exp(xb0))*log(uniform()))^(1/`gamma')
*qui gen t_fail=(-1/(exp(xb0))*log(uniform()))^(1/`gamma') // if theta=0
qui gen t_cens=(-1/(mu*`lambda')*log(uniform()))^(1/`gamma')
*qui gen t_cens=(-1/(`lambda')*log(uniform()))^(1/`gamma') // if theta=0
qui gen time_sm=min(t_fail,t_cens)
qui gen byte d=(t_fail<=t_cens)
qui stset time_sm, f(d)
***Fit PH frailty model***
qui stcox x, nohr shared(cluster)
local sebeta=_se[x]
qui estimates store stcox
clear
****************************
*generate validation data
**************************
set obs 1500
gen cluster=int(uniform()*50)+1
*local theta=0.0 // no corr
local theta=0.58 // moderate corr
*local theta=0.98 // high corr
local beta=1.35
*local lambda=0.0 //censoring 0%
local lambda=0.20 //censoring 20%
*local lambda=0.99 //censoring 50%
*local lambda=5.0// censoring 80%
local gamma=1.1
gen mu=rgamma(1/`theta', `theta')
qui bysort cluster:replace mu=mu[1]
qui gen x=invnormal(runiform())
qui gen xb0=`beta'*x
qui gen t_fail=(-1/(mu*exp(xb0))*log(uniform()))^(1/`gamma')
*qui gen t_fail=(-1/(exp(xb0))*log(uniform()))^(1/`gamma') // if theta=0
qui gen t_cens=(-1/(mu*`lambda')*log(uniform()))^(1/`gamma')
*qui gen t_cens=(-1/(`lambda')*log(uniform()))^(1/`gamma') // if theta=0
qui gen time_sm=min(t_fail,t_cens)
qui gen byte d=(t_fail<=t_cens)
qui stset time_sm, f(d)
******************************************
*Calculation of validation measures
******************************************
qui estimates restore stcox
predict xbf, xb
qui stcox, estimate shared(cluster) offset(xbf)
168predict xbu,effects
qui gen xb=xbf+xbu
qui sort cluster
qui egen sdx=sd(xb)
qui gen h=(0.5*sdx)/(_N)^(1/3)
tempvar Phi Psi Psi0 Chi Chi0
qui gen double Phi=.
qui gen double Psi=.
qui gen double Psi0=.
qui gen double Chi=.
qui gen double Chi0=.
qui gen double Chij=.
qui gen double Dhij=.
qui gen wv=1
qui gen xb_1=xb if d==1
qui gen time_1=time_sm if d==1
local i=1
while `i'<=_N {
local x=xb[`i']
local x1=xb_1[`i']
local time1=time_1[`i']
tempvar fhi Fhi chi chi0 fhi0 Fhi0 Csi0 chij dhij chij0 dhij0
sort cluster
qui by cluster:gen float fhi=normal(-(xb-`x')/h)/(1+exp(xb-`x'))
qui by cluster:egen float Fhi=sum(fhi)
qui by cluster:replace Fhi=0 if _n!=1
sum Fhi, meanonly
qui replace Phi=r(sum) if _n==`i'
qui by cluster:gen float chi=wv if xb<`x1'
qui by cluster:replace chi= 0 if xb>`x1'
qui by cluster:gen float chi0=wv if time_sm>`time1'
qui by cluster:replace chi0= 0 if time_sm<`time1'
qui by cluster:gen float fhi0=chi*chi0
qui by cluster:egen float Fhi0=sum(fhi0)
qui by cluster:replace Fhi0=0 if _n!=1
qui by cluster:egen float Csi0=sum(chi0)
qui by cluster:replace Csi0=0 if _n!=1
sum Fhi0, meanonly
qui replace Chi=r(sum) if _n==`i'
sum Csi0, meanonly
qui replace Chi0=r(sum) if _n==`i'
qui by cluster:egen chij=count(fhi0) if fhi0==1
qui by cluster: replace chij=0 if chij==.
qui by cluster: egen chij0=mean(chij)
qui by cluster:replace chij0=0 if _n!=1
sum chij0, meanonly
qui replace Chij=r(sum) if _n==`i'
qui by cluster: egen dhij=count(fhi0) if fhi0==0
qui by cluster: replace dhij=0 if dhij==.
169qui by cluster: egen dhij0=mean(dhij)
qui by cluster:replace dhij0=0 if _n!=1
sum dhij0, meanonly
qui replace Dhij=r(sum) if _n==`i'
drop fhi Fhi chi chi0 fhi0 Fhi0 Csi0 chij dhij chij0 dhij0
local i=`i'+1
}
qui by cluster:egen Kn0=sum(Phi)
qui by cluster:replace Kn0=0 if _n!=1
sum Kn0, meanonly
qui gen sumPhi=r(sum)
qui gen Knre=2*sumPhi/(_N*(_N-1))
local Kre=Knre
qui by cluster:egen C1=sum(Chi)
qui by cluster:replace C1=0 if _n!=1
sum C1, meanonly
qui gen sumChi1=r(sum)
qui by cluster:egen C0=sum(Chi0)
qui by cluster:replace C0=0 if _n!=1
sum C0, meanonly
qui gen sumChi0=r(sum)
qui gen Cre=sumChi1/sumChi0
local Cre=Cre
***SE of C for clustered data***
qui by cluster:egen Chij0=sum(Chij)
qui by cluster:replace Chij0=0 if _n!=1
sum Chij0, meanonly
gen sumChij0=r(sum)
gen Pc=sumChij0/(_N*(_N-1))
qui by cluster:egen Dhij0=sum(Dhij)
qui by cluster:replace Dhij0=0 if _n!=1
sum Dhij0, meanonly
qui gen sumDhij0=r(sum)
gen Pd=sumDhij0/(_N*(_N-1))
qui by cluster:gen Ch=Chij*(Chij-1)
qui by cluster:gen Dh=Dhij*(Dhij-1)
qui by cluster:egen Ch0=sum(Ch)
qui by cluster:replace Ch0=0 if _n!=1
sum Ch0, meanonly
gen sumCh0=r(sum)
gen Pcc=sumCh0/(_N*(_N-1)*(_N-2))
qui by cluster:egen Dh0=sum(Dh)
170qui by cluster:replace Dh0=0 if _n!=1
sum Dh0, meanonly
gen sumDh0=r(sum)
gen Pdd=sumDh0/(_N*(_N-1)*(_N-2))
qui by cluster:gen ChDh=Chij*Dhij
qui by cluster:egen ChDh0=sum(ChDh)
qui by cluster:replace ChDh0=0 if _n!=1
sum ChDh0, meanonly
gen sumChDh0=r(sum)
gen Pcd=sumChDh0/(_N*(_N-1)*(_N-2))
gen var_p=(4/(Pc+Pd)^4)*(Pd^2*Pcc-2*Pc*Pd*Pcd+Pc^2*Pdd)
local seCre=sqrt(var_p/_N)
****SE of Kre****
local i=1
while `i'<=_N {
local x=xb[`i']
local xi=x[`i']
tempvar phi dji phi0 Dji
sort cluster
qui by cluster:gen float phi=(normal(-(xb-`x')/h)/(1+exp(xb-`x'))-Knre)
*(normal(-(xb[_n+1]-`x')/h)/(1+exp(xb[_n+1]-`x'))-Knre)
qui by cluster:gen float dji=(-(x-`xi')/h)*normalden(-(xb-`x')/h)*(1+exp(xb-`x'))^(-1)
+normal(-(xb-`x')/h)*(-(x-`xi'))*exp(xb-`x')*(1+exp(xb-`x'))^(-2)
qui by cluster:egen float phi0=sum(phi)
qui by cluster:replace phi0=0 if _n!=1
sum phi0, meanonly
qui replace Psi=r(sum) if _n==`i'
qui by cluster:egen float Dji=sum(dji)
qui by cluster:replace Dji=0 if _n!=1
sum Dji, meanonly
qui replace Psi0=r(sum) if _n==`i'
drop phi dji phi0 Dji
local i=`i'+1
}
qui by cluster: egen Knre0=sum(Psi)
qui by cluster:replace Knre0=0 if _n!=1
sum Knre0, meanonly
qui gen sumPsi=r(sum)
qui gen var_Knre0=(4*sumPsi)/(_N*(_N-1))^2
qui by cluster: egen Dji0=sum(Psi0)
qui by cluster:replace Dji0=0 if _n!=1
sum Dji0, meanonly
qui gen sumPsi0=r(sum)
qui gen Delji=(2*sumPsi0)/(_N*(_N-1))
qui gen var_Knre=var_Knre0+Delji*`sebeta'^2*Delji
171local seKre=sqrt(var_Knre)
qui drop Ch* Dh* Ph* Ps* sumCh* sumDh* Pd* Pc* var_p
****D and calibration Slope******
sort xb
qui gen z = invnorm(((_n-3/8)/(_N+1/4)))/sqrt(8/_pi)
qui stcox z, nohr
local Dre=_b[z]
local seDre=_se[z]
qui stcox xb, nohr basesurv(bsurv)
local CSre=_b[xb]
local seCSre=_se[xb]
*** IBS*********
qui sort time_sm
qui gen tm_d=time_sm if d==1
qui sum tm_d
local tau=r(max) //maximum event-time; we calculate IBS up-to this time point
qui gen yt=0 if time_sm<=`tau'
qui replace yt=1 if time_sm>`tau'
qui sts gen km=s
set obs 1501
qui replace _t=`tau' in 1501
ipolate km _t, gen(ks2) epolate
qui summarize ks2 if _t==`tau'
local gt1=r(mean)
qui gen wt1=(1-km)/(1-`gt1')
qui gen exb=exp(xb)
local gamma=1.1
qui gen st0=km
qui gen delta=1 if d==0
qui replace delta=0 if d==1
qui stset time_sm, f(delta)
qui sts gen gt=s
****************************
tempvar Bst Bst0
qui gen double Bst=.
qui gen double Bst0=.
qui sort time_sm
qui gen wt=1/gt
qui sort time_sm
local i=1
while `i'<=_N {
local time=time_sm[`i']
local st0=st0[`i']
local wtg=wt[`i']
local bsurv=bsurv[`i']
tempvar bs bs0 y st
qui gen float y=wv if time_sm>`time'
172qui replace y= 0 if time_sm<`time'
qui gen float st=(`bsurv')^exb
qui gen float bs=d*(1-y)*(0-st)^2*(wt)+y*(1-st)^2*(`wtg')
*qui gen float bs=(y-st)^2 // if there is no censoring
sum bs, meanonly
qui replace Bst=r(mean) if _n==`i'
qui gen float bs0=d*(1-y)*(0-`st0')^2*(wt)+y*(1-`st0')^2*(`wtg')
*qui gen float bs0=(y-`st0')^2 // if there is no censoring
sum bs0, meanonly
qui replace Bst0=r(mean) if _n==`i'
drop bs bs0 y st
local i=`i'+1
}
qui integ Bst wt1 if yt==0, trapezoid gen(BS_x)
local IBSx=r(integral)
qui integ Bst0 wt1 if yt==0, trapezoid gen(BS_0)
local IBS0=r(integral)
local IRsq=1-`IBSx'/`IBS0'
line Bst Bst0 time_sm if yt==0
di `j' // print number of simulations completed
restore
qui replace Cre=`Cre' if index==`j'
qui replace Kre=`Kre' if index==`j'
qui replace Dre=`Dre' if index==`j'
qui replace CSre=`CSre' if index==`j'
qui replace seCre=`seCre' if index==`j'
qui replace seKre=`seKre' if index==`j'
qui replace seDre=`seDre' if index==`j'
qui replace seCSre=`seCSre' if index==`j'
qui replace IBSx=`IBSx' if index==`j'
qui replace IBS0=`IBS0' if index==`j'
qui replace IRsq=`IRsq' if index==`j'
}
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